Science.gov

Sample records for agreement mta confidential

  1. Material Transfer Agreement (MTA) | FNLCR

    Cancer.gov

    Material Transfer Agreements are appropriate for exchange of materials into or out of the Frederick National Labfor research or testing purposes, with no collaborative research by parties involving the materials.

  2. 40 CFR 2.215 - Confidentiality agreements.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 1 2011-07-01 2011-07-01 false Confidentiality agreements. 2.215 Section 2.215 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY GENERAL PUBLIC INFORMATION Confidentiality of Business Information § 2.215 Confidentiality agreements. (a) No EPA officer,...

  3. 40 CFR 2.215 - Confidentiality agreements.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 1 2010-07-01 2010-07-01 false Confidentiality agreements. 2.215 Section 2.215 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY GENERAL PUBLIC INFORMATION Confidentiality of Business Information § 2.215 Confidentiality agreements. (a) No EPA officer,...

  4. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 30 Mineral Resources 1 2010-07-01 2010-07-01 false Confidentiality agreement and remedies. 47.85... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement and remedies. (a) The confidentiality agreement authorized by § 47.84— (1) May restrict the use of the...

  5. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement... trade secret chemical identity to the health purposes indicated in the written statement of need; (2... designated representative, or the health professional to disclose the trade secret chemical identity to...

  6. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement... trade secret chemical identity to the health purposes indicated in the written statement of need; (2... designated representative, or the health professional to disclose the trade secret chemical identity to...

  7. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... TRAINING HAZARD COMMUNICATION (HazCom) Trade Secret Hazardous Chemical § 47.85 Confidentiality agreement... trade secret chemical identity to the health purposes indicated in the written statement of need; (2... designated representative, or the health professional to disclose the trade secret chemical identity to...

  8. 48 CFR 1552.227-76 - Project employee confidentiality agreement.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 6 2010-10-01 2010-10-01 true Project employee confidentiality agreement. 1552.227-76 Section 1552.227-76 Federal Acquisition Regulations System ENVIRONMENTAL... electrical services, provisions which shall conform substantially to the language of this clause, including...

  9. Are School Districts' Confidential Settlement Agreements Legally Enforceable?

    ERIC Educational Resources Information Center

    Fossey, Richard; And Others

    1991-01-01

    Unlike private parties, school districts have legal restraints on their ability to settle disputes in secret. Open records laws, state reporting statutes, judicial interpretations of public policy, and the First Amendment to the U.S. Constitution may all restrict a school district's ability to enter into valid settlement agreements containing…

  10. MTA: A Clinical Review

    PubMed Central

    Tawil, Peter Z; Duggan, Derek J.; Galicia, Johnah C.

    2016-01-01

    MTA has been a revolutionary material in endodontics. Since it’s introduction in the 1990’s several studies have demonstrated its use in several clinical applications. MTA has been extensively studied and is currently used for perforation repairs, apexifications, regenerative procedures, apexogenesis, pulpotomies & pulp capping. This article will review the history, composition, research findings and clinical applications of this versatile material. PMID:25821936

  11. Confidential Searches.

    ERIC Educational Resources Information Center

    Kenney, Linda Chion

    2003-01-01

    Will the stealth superintendent hunt in Cincinnati become tomorrow's standard approach? Search consultants and superintendents offer their views on how far confidentiality should go. Also includes a search firm's process for shielding identities and a confidentiality pledge. (MLF)

  12. Confidential Searches.

    ERIC Educational Resources Information Center

    Kenney, Linda Chion

    2003-01-01

    Will the stealth superintendent hunt in Cincinnati become tomorrow's standard approach? Search consultants and superintendents offer their views on how far confidentiality should go. Also includes a search firm's process for shielding identities and a confidentiality pledge. (MLF)

  13. Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1965-01-01

    A concept of a possible Lunar Roving Vehicle (LRV) built for NASA's Marshall Space Flight Center (MSFC). This Mobility Test Article (MTA) is one of many that provided data contributing to the design of the LRV, developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  14. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed. ...

  15. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed. ...

  16. 7 CFR 1210.352 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND PROMOTION PLAN Watermelon Research and Promotion Plan Reports, Books, and Records § 1210.352 Confidential...

  17. 7 CFR 1210.352 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND PROMOTION PLAN Watermelon Research and Promotion Plan Reports, Books, and Records § 1210.352 Confidential...

  18. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed. ...

  19. 7 CFR 1210.352 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND PROMOTION PLAN Watermelon Research and Promotion Plan Reports, Books, and Records § 1210.352 Confidential...

  20. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed....

  1. 7 CFR 1210.607 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE WATERMELON RESEARCH AND..., or importer of watermelons shall be held strictly confidential and shall not be disclosed....

  2. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential treatment...

  3. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential treatment...

  4. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential treatment...

  5. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE POTATO RESEARCH AND PROMOTION PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential treatment...

  6. Grumman Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1965-01-01

    This Mobility Test Article (MTA) was a concept of a possible dual mode Lunar Roving Vehicle (LRV) built by the Grumman Industries for NASA's Marshall Space Flight Center (MSFC). The data provided by the MTA helped in designing the Lunar Roving Vehicle (LRV), developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  7. Grumman Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1964-01-01

    A concept of a possible Lunar Roving Vehicle (LRV) built by the Grumman Industries for NASA's Marshall Space Flight Center (MSFC), this Mobility Test Article (MTA) is undergoing a full fledged test, complete with space suit attire. The data provided by the MTA helped in designing the LRV, developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  8. Bendix Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1965-01-01

    A concept of a possible Lunar Roving Vehicle (LRV) built by the Bendix Corporation for NASA's Marshall Space Flight Center (MSFC). This Mobility Test Article (MTA) is being inspected by a Bendix technician. The data provided by the MTA helped in designing the LRV, developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  9. MTA applications in pediatric dentistry

    PubMed Central

    MATURO, P.; COSTACURTA, M.; BARTOLINO, M.; DOCIMO, R.

    2010-01-01

    SUMMARY The aim of this paper is to show and asses the clinical applications of the Mineral Trioxide Aggregate (MTA) in pediatric dentistry, either on primary teeth or on immature apex permanent teeth. We have described the primary tooth pulpotomy technique using MTA, that is characterized by a superior biocompatibility and a sealing ability that make it a more suitable compound compared to other materials in terms of result prediction on a long-term basis. We have also reported the direct capping technique using MTA on immature apex teeth; in these particular cases, MTA is undoubtedly preferable to conventional materials, especially in what its sealing characteristics concern. Furthermore, we have explained the apexogenesis clinical procedure, in which after a chamber pulpotomy on incomplete root development teeth, MTA is used in direct contact with the pulpar stump in order to save the root pulp vitality, allowing the apex and relative canal walls physiological maturation to take place. In case of necrotic teeth with immature apex, we describe the possibility of using MTA as an apical barrier making the apexification treatment faster and predictable, taking profit from its biocompatibility quality, its sealing ability and setting characteristic in humid environments. In all described applications, MTA has demonstrated to be a very versatile and extremely trustworthy material. Either literature and results obtained from the present experience, show how the use of MTA in Pediatric Dentistry, compared to commonly used materials, translates into pulp or periapical tissues being less swollen and, thus, guaranteeing a higher prediction of the therapeutic result on a short-term basis and on a long-term one. PMID:23285367

  10. 7 CFR 900.309 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 900.309 Section 900.309... to Agricultural Marketing Agreement Act of 1937, as Amended § 900.309 Confidential information. The... information furnished to, compiled by, or in the possession of the referendum agent, shall be regarded as...

  11. 7 CFR 900.407 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 900.407 Section 900.407... to the Agricultural Marketing Agreement Act of 1937, as Amended § 900.407 Confidential information... voted or the manner in which any person voted) and all information furnished to, compiled by, or in...

  12. 36 CFR 222.23 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... resolution communications as defined in 5 U.S.C. 571(5) shall be confidential. Any mediation agreement signed... 36 Parks, Forests, and Public Property 2 2013-07-01 2013-07-01 false Confidentiality. 222.23 Section 222.23 Parks, Forests, and Public Property FOREST SERVICE, DEPARTMENT OF AGRICULTURE RANGE...

  13. 7 CFR 1221.234 - Confidentiality

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidentiality 1221.234 Section 1221.234 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS... persons voting in the referendum and ballots shall be confidential and the contents of the ballots...

  14. MTA Computer Based Evaluation System.

    ERIC Educational Resources Information Center

    Brenner, Lisa P.; And Others

    The MTA PLATO-based evaluation system, which has been implemented by a consortium of schools of medical technology, is designed to be general-purpose, modular, data-driven, and interactive, and to accommodate other national and local item banks. The system provides a comprehensive interactive item-banking system in conjunction with online student…

  15. MTA Computer Based Evaluation System.

    ERIC Educational Resources Information Center

    Brenner, Lisa P.; And Others

    The MTA PLATO-based evaluation system, which has been implemented by a consortium of schools of medical technology, is designed to be general-purpose, modular, data-driven, and interactive, and to accommodate other national and local item banks. The system provides a comprehensive interactive item-banking system in conjunction with online student…

  16. Livin' with the MTA

    ERIC Educational Resources Information Center

    Mirowski, Philip

    2008-01-01

    Although the push to get universities to accumulate IP by commercializing their scientific research was a conscious movement, dealing with the blowback in the form of contracts over the transfer of research tools and inputs, called materials transfer agreements (MTAs), was greeted by universities as an afterthought. Faculty often regarded them as…

  17. Livin' with the MTA

    ERIC Educational Resources Information Center

    Mirowski, Philip

    2008-01-01

    Although the push to get universities to accumulate IP by commercializing their scientific research was a conscious movement, dealing with the blowback in the form of contracts over the transfer of research tools and inputs, called materials transfer agreements (MTAs), was greeted by universities as an afterthought. Faculty often regarded them as…

  18. Collective Bargaining Agreement between Board of Trustees of the University of Massachusetts and the Massachusetts Society of Professors, Faculty Staff Union, MTA/NEA, July 1, 1983-June 30, 1986.

    ERIC Educational Resources Information Center

    National Education Association, Washington, DC.

    The collective bargaining agreement between the Board of Trustees of the University of Massachusetts and the Massachusetts Society of Professors, Faculty Staff Union (1,643 members) of the National Education Association, covering the period July 1, 1983-June 30, 1986 is presented. Items covered in the agreement include: unit recognition,…

  19. Agreement between the Board of Trustees of the University of Massachusetts on Behalf of the Board of Regents of Higher Education and the Massachusetts Society of Professors Faculty Staff Union/MTA/NEA.

    ERIC Educational Resources Information Center

    National Education Association, Washington, DC.

    The collective bargaining agreement between the Board of Trustees of the University of Massachusetts and the Board of Regents of Higher Education and the Massachusetts Society of Professors, an affiliate of the National Education Association, covering the period July 1, 1986-June 30, 1987, is presented. Items covered in the agreement include: unit…

  20. Deconvolution of the particle size distribution of ProRoot MTA and MTA Angelus.

    PubMed

    Ha, William Nguyen; Shakibaie, Fardad; Kahler, Bill; Walsh, Laurence James

    2016-01-01

    Objective Mineral trioxide aggregate (MTA) cements contain two types of particles, namely Portland cement (PC) (nominally 80% w/w) and bismuth oxide (BO) (20%). This study aims to determine the particle size distribution (PSD) of PC and BO found in MTA. Materials and methods The PSDs of ProRoot MTA (MTA-P) and MTA Angelus (MTA-A) powder were determined using laser diffraction, and compared to samples of PC (at three different particle sizes) and BO. The non-linear least squares method was used to deconvolute the PSDs into the constituents. MTA-P and MTA-A powders were also assessed with scanning electron microscopy. Results BO showed a near Gaussian distribution for particle size, with a mode distribution peak at 10.48 μm. PC samples milled to differing degrees of fineness had mode distribution peaks from 19.31 down to 4.88 μm. MTA-P had a complex PSD composed of both fine and large PC particles, with BO at an intermediate size, whereas MTA-A had only small BO particles and large PC particles. Conclusions The PSD of MTA cement products is bimodal or more complex, which has implications for understanding how particle size influences the overall properties of the material. Smaller particles may be reactive PC or unreactive radiopaque agent. Manufacturers should disclose particle size information for PC and radiopaque agents to prevent simplistic conclusions being drawn from statements of average particle size for MTA materials.

  1. Structure, expression and functions of MTA genes.

    PubMed

    Kumar, Rakesh; Wang, Rui-An

    2016-05-15

    Metastatic associated proteins (MTA) are integrators of upstream regulatory signals with the ability to act as master coregulators for modifying gene transcriptional activity. The MTA family includes three genes and multiple alternatively spliced variants. The MTA proteins neither have their own enzymatic activity nor have been shown to directly interact with DNA. However, MTA proteins interact with a variety of chromatin remodeling factors and complexes with enzymatic activities for modulating the plasticity of nucleosomes, leading to the repression or derepression of target genes or other extra-nuclear and nucleosome remodeling and histone deacetylase (NuRD)-complex independent activities. The functions of MTA family members are driven by the steady state levels and subcellular localization of MTA proteins, the dynamic nature of modifying signals and enzymes, the structural features and post-translational modification of protein domains, interactions with binding proteins, and the nature of the engaged and resulting features of nucleosomes in the proximity of target genes. In general, MTA1 and MTA2 are the most upregulated genes in human cancer and correlate well with aggressive phenotypes, therapeutic resistance, poor prognosis and ultimately, unfavorable survival of cancer patients. Here we will discuss the structure, expression and functions of the MTA family of genes in the context of cancer cells.

  2. Physiological functions of MTA family of proteins.

    PubMed

    Sen, Nirmalya; Gui, Bin; Kumar, Rakesh

    2014-12-01

    Although the functional significance of the metastasic tumor antigen (MTA) family of chromatin remodeling proteins in the pathobiology of cancer is fairly well recognized, the physiological role of MTA proteins continues to be an understudied research area and is just beginning to be recognized. Similar to cancer cells, MTA1 also modulates the expression of target genes in normal cells either by acting as a corepressor or coactivator. In addition, physiological functions of MTA proteins are likely to be influenced by its differential expression, subcellular localization, and regulation by upstream modulators and extracellular signals. This review summarizes our current understanding of the physiological functions of the MTA proteins in model systems. In particular, we highlight recent advances of the role MTA proteins play in the brain, eye, circadian rhythm, mammary gland biology, spermatogenesis, liver, immunomodulation and inflammation, cellular radio-sensitivity, and hematopoiesis and differentiation. Based on the growth of knowledge regarding the exciting new facets of the MTA family of proteins in biology and medicine, we speculate that the next burst of findings in this field may reveal further molecular regulatory insights of non-redundant functions of MTA coregulators in the normal physiology as well as in pathological conditions outside cancer.

  3. Deconvolution of the particle size distribution of ProRoot MTA and MTA Angelus

    PubMed Central

    Ha, William Nguyen; Shakibaie, Fardad; Kahler, Bill; Walsh, Laurence James

    2016-01-01

    Abstract Objective Mineral trioxide aggregate (MTA) cements contain two types of particles, namely Portland cement (PC) (nominally 80% w/w) and bismuth oxide (BO) (20%). This study aims to determine the particle size distribution (PSD) of PC and BO found in MTA. Materials and methods The PSDs of ProRoot MTA (MTA-P) and MTA Angelus (MTA-A) powder were determined using laser diffraction, and compared to samples of PC (at three different particle sizes) and BO. The non-linear least squares method was used to deconvolute the PSDs into the constituents. MTA-P and MTA-A powders were also assessed with scanning electron microscopy. Results BO showed a near Gaussian distribution for particle size, with a mode distribution peak at 10.48 μm. PC samples milled to differing degrees of fineness had mode distribution peaks from 19.31 down to 4.88 μm. MTA-P had a complex PSD composed of both fine and large PC particles, with BO at an intermediate size, whereas MTA-A had only small BO particles and large PC particles. Conclusions The PSD of MTA cement products is bimodal or more complex, which has implications for understanding how particle size influences the overall properties of the material. Smaller particles may be reactive PC or unreactive radiopaque agent. Manufacturers should disclose particle size information for PC and radiopaque agents to prevent simplistic conclusions being drawn from statements of average particle size for MTA materials. PMID:27335899

  4. The nature of confidentiality.

    PubMed Central

    Thompson, I E

    1979-01-01

    This paper examines confidentiality and its nature and analyses the guidelines laid down by the Hippocratic Oath as well as the British and World Medical Associations for maintaining such confidentiality between doctor and patient. There are exceptions to practically any code of rules and this is true also for confidentiality. Some of these exceptions make it appear that very little is confidential. The three values implicit in confidentiality would seem to be privacy, confidence and secrecy. Each of these values is discussed and developed in this paper. In conclusion, the question is suggested that maybe in the face of death, doctor and patient need to re-examine the pre-suppositions of privacy, confidence and secrecy on which the confidential relationship is based. PMID:469872

  5. Mineral trioxide aggregate (MTA)-like materials: an update review.

    PubMed

    Mohammadi, Zahed; Shalavi, Sousan; Soltani, Mohammad Karim

    2014-09-01

    Mineral trioxide aggregate (MTA) is a multi-application material used in endodontics. It is a mixture of a refined Portland cement and bismuth oxide and trace amounts of SiO₂, CaO, MgO, K₂SO₄, and Na₂SO₄. MTA powder is mixed with supplied sterile water in a 3:1 powder/liquid. Hydrated MTA has an initial pH of 10.2, which rises to 12.5 three hours after mixing. There are several materials derived from MTA such as Endo-CPM Sealer, Ortho MTA, MTA-Fillapex, DiaRoot BioAggregate, MTA Bio, light-cured MTA, tricalcium silicate, and iRoot SP. The purpose of this article is to review MTA-like materials.

  6. The influence of chlorhexidine on the antibacterial effects of MTA.

    PubMed

    Mittag, Sven-Georg; Eissner, Christof; Zabel, Lutz; Wrbas, Karl-Thomas; Kielbassa, Andrej M

    2012-01-01

    To investigate the influence of chlorhexidine in different concentrations when mixed with mineral trioxide aggregate gray (MTA-G) or white (MTA-W). The antibacterial effect on Enterococcus faecalis was used as the primary parameter. Similar to the agar diffusion test, Mueller-Hinton agar plates were inoculated with E faecalis (ATCC 19433), and 14 groups (n = 21) were prepared. The specimens consisted of MTA-W and MTA-G, and these were enriched with chlorhexidine concentrations of 0.1%, 0.2%, 0.5%, 1.0%, 1.5%, and 2.0%. Pure MTA-W and MTA-G (each combined with distilled water) were used as controls. After incubation periods of 24 and 48 hours, the inhibiting areolae were measured. Pure MTA-W, in contrast to pure MTA-G, had no bactericidal effects. With increasing chlorhexidine concentrations of up to 1.5%, a linear increase in bactericidal activity was observed. In contrast, MTA-G showed only a low self-bactericidal influence, and the antibacterial effects with increasing chlorhexidine concentrations were significantly lower than those of MTA-W (P < .001). When mixed with distilled water, pure MTA-G revealed a low bactericidal effect against E faecalis. The use of chlorhexidine with MTA mixtures leads to an antibacterial effect against E faecalis, and within the first 48 hours, this effect is significantly higher in combination with MTA-W when compared with MTA-G.

  7. Confidentiality and death.

    PubMed

    Ong, B B; Kaur, S

    1997-12-01

    The duty of confidentiality in the normal doctor-patient relationship is well recognized. However, the duty of confidentiality between the pathologist who performs the autopsy and the requesting authorities and the next-of-kin is not as clearly spelt out. This article discusses the problems faced by the pathologist with regards to hospital and medico-legal autopsies in Malaysia. A proposed ethical guideline is included on how to deal with peculiar issues regarding confidentiality and the pathologist.

  8. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 19 Customs Duties 2 2014-04-01 2014-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of Business...

  9. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 2 2013-04-01 2013-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of Business...

  10. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 19 Customs Duties 2 2012-04-01 2012-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of Business...

  11. 19 CFR 181.121 - Maintenance of confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 19 Customs Duties 2 2011-04-01 2011-04-01 false Maintenance of confidentiality. 181.121 Section 181.121 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY (CONTINUED) NORTH AMERICAN FREE TRADE AGREEMENT Confidentiality of Business...

  12. Respecting patient confidentiality.

    PubMed

    Price, Bob

    2015-02-03

    Nurses face a particular challenge in respecting the confidentiality of patients in a world where information is quickly shared and where information about illness can be sensitive. We have a duty of care towards patients. That duty includes maintaining privacy (protecting them from undue intrusion), and confidentiality (by the discreet management of information about themselves that they share with us). Legislation on confidentiality comes from different sources and should be interpreted in the clinical setting. This article summarises the principal requirements set out in the legislation and directs readers to questions and tools designed to help them explore the extent to which patient confidentiality is respected where they work.

  13. Confidentiality in Sports Medicine.

    PubMed

    Malcolm, Dominic

    2016-04-01

    This article synthesizes existing literature to provide a summary of the ethical issues concerning patient confidentiality in sport. It outlines the medical principle of confidentiality and identifies cross-cultural ethicolegal variations that shape its implementation. Clinicians' multiple obligations, physical environments, and practice and policy contexts are discussed, and research detailing experiences of maintaining patient confidentiality in sport is reviewed. Policy recommendations for enhancing compliance with this ethical principle are summarized. It is argued that the context of sport exacerbates pressures on clinicians to break patient confidentiality, breaches occur regularly, and interventions are required to enhance ethical compliance in sports medicine. Copyright © 2016 Elsevier Inc. All rights reserved.

  14. Comparative analysis of the biological effects of the endodontic bioactive cements MTA Angelus, MTA Repair HP and NeoMTA Plus on human dental pulp stem cells.

    PubMed

    Tomás-Catalá, C J; Collado-González, M; García-Bernal, D; Oñate-Sánchez, R E; Forner, L; Llena, C; Lozano, A; Castelo-Baz, P; Moraleda, J M; Rodríguez-Lozano, F J

    2017-09-11

    To evaluate the biological effects in vitro of MTA Angelus (MTA-Ang; Angelus, Londrina, PR, Brazil), MTA Repair HP (MTA-HP; Angelus,) and NeoMTA Plus (NeoMTA-P; Avalon Biomed Inc, Bradenton, FL, USA) on human dental pulp stem cells (hDPSCs). Cell viability and cell migration assays were performed using eluates of each material. To evaluate cell morphology and cell attachment to the different materials, hDPSCs were directly seeded onto the material surfaces and analyzed by immunocytofluorescence and scanning electron microscopy, respectively. The chemical composition of the materials was determined by energy dispersive X-ray (EDX) and eluates were analyzed by inductively coupled plasma-mass spectrometry (ICP-MS). Statistical analysis was performed with analysis of variance and Bonferroni or Tukey post-test (α <0.05). Undiluted MTA-Ang, MTA-HP and NeoMTA-P displayed a significant increase in cell viability greater than that obtained using complete medium alone (control) (*p<0.05; **p<0.01; ***p<0.001). Moreover, a cell migration assay revealed cell migration rates after incubation with extracts of MTA-Ang, MTA-HP and NeoMTA-P, that were similar to levels obtained in the control group. In addition, stretched cytoskeletal F-actin fibres were detected in the cells treated with the three material extracts. SEM studies revealed a high degree of cell proliferation and attachment on all three materials. EDX analysis demonstrated similar weight percentages of C, O and Ca in all three materials, while other elements such as Al, Si and S were also found. MTA-Ang, MTA-HP, and NeoMTA-P were associated with biological effects on hDPSCs in terms of cell proliferation, morphology, migration and attachment. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

  15. Medical confidentiality: an intransigent and absolute obligation.

    PubMed Central

    Kottow, M H

    1986-01-01

    Clinicians' work depends on sincere and complete disclosures from their patients; they honour this candidness by confidentially safeguarding the information received. Breaching confidentiality causes harms that are not commensurable with the possible benefits gained. Limitations or exceptions put on confidentiality would destroy it, for the confider would become suspicious and un-co-operative, the confidant would become untrustworthy and the whole climate of the clinical encounter would suffer irreversible erosion. Excusing breaches of confidence on grounds of superior moral values introduces arbitrariness and ethical unreliability into the medical context. Physicians who breach the agreement of confidentiality are being unfair, thus opening the way for, and becoming vulnerable to, the morally obtuse conduct of others. Confidentiality should not be seen as the cosy but dispensable atmosphere of clinical settings; rather, it constitutes a guarantee of fairness in medical actions. Possible perils that might accrue to society are no greater than those accepted when granting inviolable custody of information to priests, lawyers and bankers. To jeopardize the integrity of confidential medical relationships is too high a price to pay for the hypothetical benefits this might bring to the prevailing social order. PMID:3761330

  16. Medical confidentiality: an intransigent and absolute obligation.

    PubMed

    Kottow, M H

    1986-09-01

    Clinicians' work depends on sincere and complete disclosures from their patients; they honour this candidness by confidentially safeguarding the information received. Breaching confidentiality causes harms that are not commensurable with the possible benefits gained. Limitations or exceptions put on confidentiality would destroy it, for the confider would become suspicious and un-co-operative, the confidant would become untrustworthy and the whole climate of the clinical encounter would suffer irreversible erosion. Excusing breaches of confidence on grounds of superior moral values introduces arbitrariness and ethical unreliability into the medical context. Physicians who breach the agreement of confidentiality are being unfair, thus opening the way for, and becoming vulnerable to, the morally obtuse conduct of others. Confidentiality should not be seen as the cosy but dispensable atmosphere of clinical settings; rather, it constitutes a guarantee of fairness in medical actions. Possible perils that might accrue to society are no greater than those accepted when granting inviolable custody of information to priests, lawyers and bankers. To jeopardize the integrity of confidential medical relationships is too high a price to pay for the hypothetical benefits this might bring to the prevailing social order.

  17. Threats to Confidentiality

    ERIC Educational Resources Information Center

    Reynolds, Mildred M.

    1976-01-01

    With the growing demands from insurance companies, employers, review boards, and the like for information from personal health care records, how much assurance can a helping professional give clients that what he tells them will be kept confidential? The author alerts practitioners to the conflicts that threaten confidentiality. (Author)

  18. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  19. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  20. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  1. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  2. 7 CFR 984.79 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 984.79 Section 984.79 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE WALNUTS GROWN IN CALIFORNIA...

  3. 7 CFR 1219.108 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1219.108 Section 1219.108 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HASS AVOCADO PROMOTION,...

  4. 7 CFR 1219.108 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1219.108 Section 1219.108 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HASS AVOCADO PROMOTION,...

  5. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  6. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  7. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  8. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  9. 7 CFR 1206.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1206.107 Section 1206.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE MANGO PROMOTION, RESEARCH,...

  10. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND IMPORTERS...

  11. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  12. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND...

  13. 7 CFR 1214.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1214.107 Section 1214.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE CHRISTMAS TREE PROMOTION...

  14. 7 CFR 1214.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1214.107 Section 1214.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE CHRISTMAS TREE PROMOTION...

  15. 7 CFR 1214.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1214.107 Section 1214.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE CHRISTMAS TREE PROMOTION...

  16. 7 CFR 983.65 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 983.65 Section 983.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE PISTACHIOS GROWN IN...

  17. 7 CFR 983.65 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 983.65 Section 983.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE PISTACHIOS GROWN IN...

  18. 7 CFR 983.65 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 983.65 Section 983.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE PISTACHIOS GROWN IN...

  19. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY PROMOTION...

  20. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY PROMOTION...

  1. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY PROMOTION...

  2. 7 CFR 1208.107 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential information. 1208.107 Section 1208.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE PROCESSED RASPBERRY PROMOTION...

  3. 7 CFR 983.65 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 983.65 Section 983.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE PISTACHIOS GROWN IN...

  4. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  5. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  6. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  7. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 932.63 Section 932.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE OLIVES GROWN IN CALIFORNIA...

  8. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES...

  9. 7 CFR 1170.12 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... Agreements and Orders; Milk), DEPARTMENT OF AGRICULTURE DAIRY PRODUCT MANDATORY REPORTING § 1170.12... information, statistics, or documents obtained from or submitted by any person in compliance with the Dairy Product Mandatory Reporting program other than in a manner that ensures that confidentiality is...

  10. 7 CFR 1250.207 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1250.207 Section 1250.207 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE EGG RESEARCH AND...

  11. 7 CFR 1212.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1212.107 Section 1212.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE HONEY PACKERS AND IMPORTERS...

  12. 7 CFR 1245.107 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential information. 1245.107 Section 1245.107 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MISCELLANEOUS COMMODITIES), DEPARTMENT OF AGRICULTURE U.S. HONEY PRODUCER RESEARCH...

  13. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MILK), DEPARTMENT OF AGRICULTURE DAIRY PROMOTION PROGRAM Dairy Promotion and Research...

  14. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; MILK), DEPARTMENT OF AGRICULTURE DAIRY PROMOTION PROGRAM Dairy Promotion and Research...

  15. Confidentiality and Faculty Representation in Academic Governance

    ERIC Educational Resources Information Center

    American Association of University Professors, 2013

    2013-01-01

    This report argues that requiring faculty members to sign confidentiality agreements as a requirement to serve on university committees is in most cases inconsistent with widely accepted standards of shared governance and with the concept of serving as a representative. This argument does not apply to faculty serving on promotion and tenure…

  16. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  17. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  18. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  19. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  20. 7 CFR 982.70 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 982.70 Section 982.70 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE HAZELNUTS GROWN IN OREGON...

  1. 7 CFR 900.407 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... the Conduct of Referenda in Connection With Marketing Orders for Fruits, Vegetables, and Nuts Pursuant to the Agricultural Marketing Agreement Act of 1937, as Amended § 900.407 Confidential...

  2. 7 CFR 900.407 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... the Conduct of Referenda in Connection With Marketing Orders for Fruits, Vegetables, and Nuts Pursuant to the Agricultural Marketing Agreement Act of 1937, as Amended § 900.407 Confidential...

  3. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 8 2014-01-01 2014-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES OF...

  4. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 8 2012-01-01 2012-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES OF...

  5. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 8 2013-01-01 2013-01-01 false Confidential information. 929.65 Section 929.65 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING AGREEMENTS AND ORDERS; FRUITS, VEGETABLES, NUTS), DEPARTMENT OF AGRICULTURE CRANBERRIES GROWN IN STATES OF...

  6. 19 CFR 356.29 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 19 Customs Duties 3 2012-04-01 2012-04-01 false Confidentiality. 356.29 Section 356.29 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES AND RULES FOR IMPLEMENTING ARTICLE 1904 OF THE NORTH AMERICAN FREE TRADE AGREEMENT Violation of a Protective Order or a Disclosure...

  7. 19 CFR 356.29 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 19 Customs Duties 3 2011-04-01 2011-04-01 false Confidentiality. 356.29 Section 356.29 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES AND RULES FOR IMPLEMENTING ARTICLE 1904 OF THE NORTH AMERICAN FREE TRADE AGREEMENT Violation of a Protective Order or a Disclosure...

  8. 19 CFR 356.29 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 19 Customs Duties 3 2014-04-01 2014-04-01 false Confidentiality. 356.29 Section 356.29 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES AND RULES FOR IMPLEMENTING ARTICLE 1904 OF THE NORTH AMERICAN FREE TRADE AGREEMENT Violation of a Protective Order or a Disclosure...

  9. 19 CFR 356.29 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 3 2013-04-01 2013-04-01 false Confidentiality. 356.29 Section 356.29 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES AND RULES FOR IMPLEMENTING ARTICLE 1904 OF THE NORTH AMERICAN FREE TRADE AGREEMENT Violation of a Protective Order or a Disclosure...

  10. Staining Potential of Neo MTA Plus, MTA Plus, and Biodentine Used for Pulpotomy Procedures.

    PubMed

    Camilleri, Josette

    2015-07-01

    Mineral trioxide aggregate (MTA) used for pulpotomy procedures in immature permanent teeth can reduce treatment to 1 session as opposed to classic calcium hydroxide therapy, which necessitates multiple appointments. The main disadvantage of MTA use is crown discoloration after treatment. The aim of this study was to characterize 3 materials that are used for pulpotomy procedures in immature permanent teeth and assess their color stability in the presence of sodium hypochlorite solution. Hydrated Neo MTA Plus (Avalon Biomed Inc, Bradenton, FL), MTA Plus (Avalon Biomed Inc), and Biodentine (Septodont, Saint-Maur-des-Fossés, France) were characterized after immersion in Hank's balanced salt solution for 1 day and 28 days using a combination of scanning electron microscopy, energy-dispersive spectroscopy, and X-ray diffraction analysis. The color stability of the 3 materials in contact with water or sodium hypochlorite was evaluated by photography, spectrophotometry, and X-ray diffraction analysis. All the materials hydrated and produced calcium hydroxide as a by-product of hydration at early age. All materials interacted with synthetic tissue fluid, forming a calcium phosphate phase. MTA Plus exhibited discoloration in contact with sodium hypochlorite. All the materials tested are suitable to be used in the treatment of immature teeth because they all produced calcium hydroxide, which is necessary to induce dentin bridge formation and continued root formation. Neo MTA Plus and Biodentine are suitable alternatives to MTA, and they do not exhibit discoloration. Copyright © 2015 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

  11. [Waiver of medical confidentiality].

    PubMed

    Kaplan, Ofer

    2004-04-01

    The duty to maintain medical confidentiality is one of the fundamental and well-known obligations imposed on physicians, and is incorporated in the Law of Patient's Rights 1996 (the Law). Medical confidentiality applies to information conveyed to a physician for medical purposes trusting that the physician will not disclose it. The patient's identity and financial arrangements are not confidential. Any physician who breaches this duty may face civil, disciplinary or criminal lawsuits. The Law, as well as specific provisions in other rulings, defines the exceptions to the duty of upholding medical confidentiality. According to these provisions there are special circumstances in which a physician may, and even should, transfer medical data relating to his/her patients. One of these exclusions is the patient's consent to reveal the information. This article presents the legal infrastructure of medical confidentiality, and the means and circumstances in which medical confidentiality can be waived. Waiver of medical confidentiality does not constitute permission to convey all the information to one and all, and the Law determines that only the data required for specific purposes should be transferred. The way by which the patient waives his right for confidentiality is not defined by the Law or by regulations. A patient's consent to waive his right for confidentiality can be allegedly obtained in writing, orally or by behavior. It seems that the appropriate manner of waiving medical confidentiality is in writing. The waiver form should specify the nature and extent of information that can be conveyed, and it must be signed by the patient. The doctor is also responsible to ensure privacy during the transmission of the data. Specific subjects which are associated with the duty to maintain medical confidentiality are also discussed in this paper. In cases when a man's life or safety is at stake, the duty of a physician to protect life overweighs his duty to entrusted

  12. Can MTA be: Miracle trioxide aggregate?

    PubMed Central

    Naik, Reshma M; Pudakalkatti, Pushpa S; Hattarki, Sanjeevini A

    2014-01-01

    Mineral trioxide aggregate (MTA) has been used for more than 10 years in the dental community and has often been thought of as a material of choice for the endodontist. The dental pulp is closely related to periodontal tissues through apical foramina, accessory canals, and dentinal tubules. Due to this interrelationship, pulpal diseases may influence periodontal health and periodontal infections may affect pulpal integrity. It is estimated that pulpal and periodontal problems are responsible for more than 50% of tooth mortality. Thus, these associations recommend an interdisciplinary approach. MTA appears to exhibit significant results even in periodontal procedures as it is the first restorative material that consistently allows for over-growth of cementum and may facilitate periodontal tissue regeneration. Thus, in the present review, an attempt is made to discuss the clinical applications of MTA as an interdisciplinary approach. PMID:24744536

  13. Confidentiality and the law.

    PubMed Central

    McConnell, T

    1994-01-01

    Codes of medical ethics issued by professional organizations typically contain statements affirming the importance of confidentiality between patients and health-care practitioners. Seldom, however, is the confidentiality obligation depicted as absolute. Instead, exceptions are noted, the most common of which is that health-care professionals are justified in breaching the confidence of a patient if required by law to do so. Reasons that might be given to support this exception are critically discussed in this paper. The conclusion argued for is that this is not a legitimate exception to the confidentiality rule. PMID:8035440

  14. North Adams State College Institutional Self-Evaluation Study Report, Vol. 2. Appendix 1: Agreement Between the Board of Trustees of State Colleges and North Adams State College Association, Massachusetts; Appendix 2: Agreement Between The Board of Trustees of State Colleges and the North Adams State College Mark Hopkins Faculty Association-MTA/NEA.

    ERIC Educational Resources Information Center

    Massachusetts State Coll. System, Boston.

    The two agreements included in this document are in effect until June 30, 1976 and June 30, 1977, respectively. Articles cover: recognition and definitions, relationship between the board and the association, use of college facilities, faculty fringe benefits, statement on academic freedom, responsibilities of department chairmen, participation in…

  15. Minors' request for confidentiality.

    PubMed

    Naidoo, S

    2014-07-01

    Dentists must be cognisant of what the law requires and how they are expected to respond. When the law does not address an issue, the dentist would need to weigh the circumstances and consequences and do what he/she thinks is ethically appropriate and acceptable. The need to maintain confidentiality of any information given to us in our professional capacity is paramount. Patient autonomy and their absolute right to confidentiality must be ensured in almost all but the most exceptional circumstances. Patients have the ethical and legal right to expect a health professional to keep confidential the information provided during the course of their care. Disclosure of patient information is only permitted with the patient's consent or if there is an overwhelming public interest in disclosure as prescribed by the law.

  16. Confidentiality and medical records

    PubMed Central

    Jones, R. V. H.; Richards, S. Jane

    1978-01-01

    Protecting confidential information disclosed to doctors has been one of the most important ethical traditions of the medical profession. However, the patient's right to such confidentiality is threatened because it is legally unclear how far ownership by Government of the paper on which NHS records are kept or of the computer system in which they are stored confers right of access. We hope the medical profession will examine this problem urgently and offer some suggestions as to how patients' confidences can continue to be protected in the future. PMID:702427

  17. Confidentiality: the confusion continues

    PubMed Central

    Kenny, D J

    1982-01-01

    The author, a regional health authority administrator, argues that `ownership' is a side issue in legal and moral arguments over confidentiality of medical records. Nor is it practicable, he argues, for doctors alone to control all access to the medical records. He proposes the principle of `custodianship' of confidential information, to be accepted by an institution as a whole, as a possible way of resolving the problem. In commentaries on this and the following article an academic lawyer and a practising physician respond. PMID:7069738

  18. Comparative chemical study of MTA and Portland cements.

    PubMed

    Oliveira, Marília Gerhardt de; Xavier, Cristina Braga; Demarco, Flávio Fernando; Pinheiro, Antônio Luis Barbosa; Costa, Aline Tempel; Pozza, Daniel Humberto

    2007-01-01

    Portland cement has been analyzed and compared to mineral trioxide aggregate (MTA) because of their chemical similarity. The possibility of using this material as a less expensive alternative to MTA in dental practice should be considered. In view of this, the present study compared the components of a Portland cement (Votoran) to two commercial brands of MTA (Pro-Root and MTA-Angelus). Twelve specimens of each material were fabricated and examined by scanning electron microscopy (SEM) with energy dispersive spectroscopy (EDS) to obtain their percentage of chemical elements. The means of the chemical elements found in each material was compared by descriptive statistics. Bismuth was present only in MTA cements to provide radiopacity. In conclusion, the tested cements have similar components, which supports, as far as composition is concerned, the possible clinical use of Portland as an option to MTA.

  19. A GP's duty of confidentiality.

    PubMed

    Bird, Sara

    2005-10-01

    Confidentiality is an accepted and fundamental basis of the doctor-patient relationship. Patients have a right to expect that information held about them will be held in confidence by their general practitioner. This article examines the concept of doctor-patient confidentiality and outlines the exceptions to the duty of confidentiality.

  20. Evaluation of cytotoxicity of MTA employing various additives.

    PubMed

    Jafarnia, Behnam; Jiang, Jin; He, Jianing; Wang, Yu-Hsiung; Safavi, Kamran E; Zhu, Qiang

    2009-05-01

    Various additives have been suggested to be used with MTA to improve its handling characteristics. The objective of this study was to evaluate the effects of various additives on cytotoxicity of MTA. Freshly mixed or set MTA pellet (1-mm diameter and 1-mm high cylinder) was prepared by mixing MTA with various additives. Additives tested included water, saline, 2% lidocaine, 5% CaCl(2), 3% NaOCl gel, and K-Y liquid. L929 cells were seeded into 96-well plates at 3 x 10(4) cells per well and incubated with MTA pellets for 24 hours, 48 hours, and 72 hours. Cells without treatment served as a control group. Cell viability was evaluated by MTT assay and calculated as the percentage of the control group. The results were analyzed with 1-way ANOVA. For the set MTA, there were no significant cell viability differences (P > .05) among the various additives at each tested time. For the freshly mixed MTA, 3% NaOCl gel has lower cell viability (P < .05) than all the other groups. The cell viability of 3% NaOCl gel group was 29% to 50%. Gray and white MTA have similar results. This study shows that the various additives have no effect on the cytotoxicity of MTA when it becomes set. Also, all the tested additives, except 3% NaOCl gel, had no effect on the cytotoxicity of MTA when it was freshly mixed. The cytotoxicity of 3% NaOCl gel probably has no clinical significance considering there is still 29% to 50% of cell viability after cells were treated with MTA pellet in a 0.32-cm(2) culture well. MTA is biocompatible when mixed with the various additives.

  1. Confidentiality and Accreditation.

    ERIC Educational Resources Information Center

    Heilbron, Louis H.

    The author shows that one branch of the Federal Government can and does largely protect the confidentiality of the accrediting process through legislation while another has legislative authority to secure any and all documents--both from another federal agency or from the accrediting body directly. Legislation proposed in the State of California,…

  2. Confidentiality principles in psychiatry.

    PubMed

    Carasevici, B

    2015-01-01

    Confidentiality stands out in psychiatry through its multiple connotations as an intrinsic necessity in the ethics of professional relationships. Thus it represents an important characteristic of this profession and at the same time a stringent request which, through its specificity, implies a direct contact with persons in need for help. Despite being inserted in professional codes and legislative systems, confidentiality in psychiatry is far from being considered a clarified matter and does not stand aside from ethical controversy. Keeping the professional secret is often a hard task due to the pressure of the law or of other professional groups who can bring multiple justifications, including that of action for the benefit of society. The therapist is often sub- mitted to a tension caused on the one hand by the promise of keeping the professional secret and on the other hand by multiple requests of breaking the confidentiality. So the problem of confidentiality in Psychiatry deserves special attention because in this profession, more than in other branches of medicine, the gain of the patient's trust is essential in the psychotherapeutic relationship.

  3. MTA3 regulates CGB5 and Snail genes in trophoblast

    SciTech Connect

    Chen, Ying; Miyazaki, Jun; Nishizawa, Haruki; Kurahashi, Hiroki; Leach, Richard; Wang, Kai

    2013-04-19

    Highlights: •Impaired MTA3, raised CGB5 and Snail expression are associated with preeclampsia. •Knock-down of MTA3 causes up-regulation of CGB5 and Snail genes in BeWo cells. •MTA3 occupies CGB5 and Snail gene promoters in BeWo cells. -- Abstract: Secreted by the placental trophoblast, human chorionic gonadotropin (hCG) is an important hormone during pregnancy and is required for the maintenance of pregnancy. Previous studies have shown that dys-regulation of hCG expression is associated with preeclampsia. However, the exact relationship between altered hCG levels and development of preeclampsia is unknown. Metastasis associated protein 3 (MTA3), a chromatin remodeling protein, is abundantly expressed in the placental trophoblasts, but its function is unknown. In breast cancer, MTA3 has been shown to repress the expression of Snail and cell migration. However, whether MTA3 acts similarly in the trophoblast has not been investigated. In the present study, we examined the role of MTA3 in regulating the hCG β-subunit gene (gene name: CGB5) and Snail expression in the trophoblast cell line, BeWo, as well as its relevance to the high hCG expression levels seen in preeclampsia. First, we investigated MTA3 expression in preeclamptic placenta as compared to normal control placenta via gene expression microarray and qRT-PCR and found that MTA3 was significantly down-regulated, whereas both CGB5 and Snail were up-regulated in preeclamptic placenta. Secondly, we knocked down MTA3 gene in trophoblast cell line BeWo and found Snail and hCG were both up-regulated, suggesting that MTA3 represses Snail and hCG gene expression in trophoblasts. Next, we cloned the CGB5 and Snail promoters into the pGL3-basic vector individually and found that silencing of MTA3 by siRNA resulted in an increase of both CGB5 and Snail promoter activities. To confirm that this MTA3 inhibition is a direct effect, we performed a chromatin immune-precipitation (ChIP) assay and found that MTA3

  4. 3-Year Follow-up of the NIMH MTA Study

    ERIC Educational Resources Information Center

    Jensen, Peter S.; Arnold, L. Eugene; Swanson, James M.; Vitiello, Benedetto; Abikoff, Howard B.; Greenhill, Laurence L.; Hechtman, Lily; Hinshaw, Stephen P.; Pelham, William E.; Wells, Karen C.; Conners, C. Keith; Elliott, Glen R.; Epstein, Jeffery N.; Hoza, Betsy; March, John S.; Molina, Brooke S. G.; Newcorn, Jeffrey H.; Severe, Joanne B.; Wigal, Timothy; Gibbons, Robert D.; Hur, Kwan

    2007-01-01

    Objective: In the intent-to-treat analysis of the Multimodal Treatment Study of Children With ADHD (MTA), the effects of medication management (MedMgt), behavior therapy (Beh), their combination (Comb), and usual community care (CC) differed at 14 and 24 months due to superiority of treatments that used the MTA medication algorithm (Comb+MedMgt)…

  5. Test of Lunar Roving Vehicle (LRV) Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1969-01-01

    A test engineer drives a Mobility Test Article (MTA) during a test of a Lunar Roving Vehicle (LRV) concept through the mountains of Arizona. The data provided by the MTA helped in designing the LRV, developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  6. Adolescents and confidentiality.

    PubMed

    Bird, Sara

    2007-08-01

    Recently the right of adolescents to confidential health care has come under threat. In 2004, the Minister for Health proposed the introduction of legislation to give parents access to all information held by Medicare Australia (formerly the Health Insurance Commission) concerning their child/ren under 16 years of age. Ultimately this legislation was withdrawn in the face of concern that it would have been detrimental to the health of adolescents. This article examines the duty of general practitioners to maintain confidentiality when treating adolescent patients. Case histories are based on actual medical negligence claims or medicolegal referrals, however, certain facts have been omitted or changed by the author to ensure the anonymity of the parties involved.

  7. Disclosure, Confidentiality, and Families

    PubMed Central

    Plantinga, Laura; Natowicz, Marvin R.; Kass, Nancy E.; Hull, Sara Chandros; Gostin, Lawrence O.; Faden, Ruth R.

    2016-01-01

    Despite policy attention to medical privacy and patient confidentiality, little empirical work exists documenting and comparing experiences of persons with genetic versus nongenetic medical conditions concerning persons’ disclosure to others as well as their views about appropriate confidentiality to and within families. The goal of this cross-sectional interview study with nearly 600 participants was to document and compare the experiences, attitudes, and beliefs of persons with strictly genetic conditions to those of persons with or at risk for other serious medical conditions in terms of the degree to which they have disclosed to others that they have the condition and their views about how others ought to maintain the confidentiality of that information. While almost all participants reported that family members knew about their condition, results suggest participants want to control that disclosure themselves and do not want doctors to disclose information to family members without their knowledge. Similarly, participants do not think family members should be able to get information about them without their knowledge but feel overwhelmingly that it is a person’s responsibility to disclose information about hereditary conditions to other family members. Ambivalence about confidentiality was evident: while most participants did not mind doctors sharing information with other doctors when it was for their benefit, the majority also felt that doctors should be punished for releasing information without their permission. The views and experiences reported here generally did not differ by whether participants had genetic versus nongenetic conditions, suggesting that the extensive policy focus on genetic information may be unwarranted. PMID:12704638

  8. Boon of MTA Apexification in Young Permanent Posterior Teeth

    PubMed Central

    Kumar, Vinod; Prasad, Vijaya; Mahantesh, T.

    2014-01-01

    Single visit apexification using mineral trioxide aggregate (MTA) is a new boon in effective management of nonvital tooth with an open apex which has steadily gained popularity with clinicians; also it shortens the treatment period and improves patient compliance. Importance of this approach lies in expedient cleaning and shaping of the root canal system, followed by its apical seal with MTA. There are several case reports available describing the use of MTA as an apexification agent in incisors and premolar, but presented cases are the unique case reports demonstrating successful apexification procedure using MTA in young permanent mandibular molars. After eight-month follow-up, teeth were without any abnormal clinical symptoms; rather there were radiographic resolution of the periapical lesion and induction of root end closure with new hard tissue formation over MTA. PMID:25431690

  9. [Professional confidentiality and forensic medicine].

    PubMed

    Das, C; van der Wal, G

    2003-10-18

    Medical confidentiality is a complex subject. The legal position of a physician depends on his or her role (medical advisor, attending physician, official, or medical examiner) as well as the physician's task and commission. In common with all physicians, the forensic physician has a duty to provide confidentiality. As a medical examiner, he or she has a limited professional confidentiality: there is an oath of secrecy, but not a right of refusal to testify with respect to the information obtained in carrying out the commission. When the forensic physician assumes the role of the attending physician, the professional confidentiality applies in full.

  10. 47 CFR 90.665 - Authorization, construction and implementation of MTA licenses.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... of MTA licenses. 90.665 Section 90.665 Telecommunication FEDERAL COMMUNICATIONS COMMISSION (CONTINUED... Licensing and Use of Mta-Based Smr Systems in the 896-901/935-940 Mhz Band § 90.665 Authorization, construction and implementation of MTA licenses. (a) MTA licenses in the 896-901/935-940 MHz band will...

  11. 31 CFR 9.6 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... ON THE NATIONAL SECURITY § 9.6 Confidential information. Information submitted in confidence which... be accorded confidential treatment. All information submitted in confidence must be on separate pages marked “Business Confidential.” ...

  12. Spheroid model study comparing the biocompatibility of Biodentine and MTA.

    PubMed

    Pérard, Matthieu; Le Clerc, Justine; Watrin, Tanguy; Meary, Fleur; Pérez, Fabienne; Tricot-Doleux, Sylvie; Pellen-Mussi, Pascal

    2013-06-01

    The primary objective of this study was to assess the biological effects of a new dentine substitute based on Ca₃SiO₅ (Biodentine™) for use in pulp-capping treatment, on pseudo-odontoblastic (MDPC-23) and pulp (Od-21) cells. The secondary objective was to evaluate the effects of Biodentine and mineral trioxide aggregate (MTA) on gene expression in cultured spheroids. We used the acid phosphatase assay to compare the biocompatibility of Biodentine and MTA. Cell differentiation was investigated by RT-qPCR. We investigated the expression of genes involved in odontogenic differentiation (Runx2), matrix secretion (Col1a1, Spp1) and mineralisation (Alp). ANOVA and PLSD tests were used for data analysis. MDPC-23 cells cultured in the presence of MTA had higher levels of viability than those cultured in the presence of Biodentine and control cells on day 7 (P = 0.0065 and P = 0.0126, respectively). For Od-21 cells, proliferation rates on day 7 were significantly lower in the presence of Biodentine or MTA than for control (P < 0.0001). Col1a1 expression levels were slightly lower in cells cultured in the presence of MTA than in those cultured in the presence of Biodentine and in control cells. Biodentine and MTA may modify the proliferation of pulp cell lines. Their effects may fluctuate over time, depending on the cell line considered. The observed similarity between Biodentine and MTA validates the indication for direct pulp-capping claimed by the manufacturers.

  13. [Mineral trioxide aggregate (MTA) a success story in apical surgery].

    PubMed

    von Arx, Thomas

    2016-01-01

    The objective of apical surgery is to retain teeth with persistent apical pathosis following orthograde root canal treatment if endodontic non-surgical revision is difficult or associated with risks, or is even declined by the patient. Since the most frequent cause of recurrent apical disease is bacterial reinfection from the (remaining) root canal system, the bacteria-tight root-end filling is the most important step in apical surgery. In the early 1990s, mineral trioxide aggregate (MTA) was developed at the Loma Linda University in California/USA. Preclinical studies clearly showed that MTA has a high sealing capability, a good material stability and an excellent biocompatbility. Multiple experimental studies in animals highlighted the mild tissue reactions observed adjacent to this material. Furthermore, histological analysis of the periapical regions demonstrated a frequent deposition of new cementum not only onto the resection plane (cut dentinal surface), but also directly onto MTA. For these reasons, MTA is considered a bioactive material. In 1997 MTA was cleared for clinical use in patients. Multiple prospective clinical and randomized studies have documented high and constant success rates of MTA-treated teeth in apical surgery. A recently published longitudinal study showed that MTA-treated teeth remained stable over five years; hence the high healed rates documented after one year are maintained during long-term observation.

  14. Confidentiality. 1: Nurses' duty to respect patient confidentiality.

    PubMed

    Dimond, B

    Trust is at the heart of the nurse/patient relationship, yet many nurses find themselves in situations where they are tom between their duty of confidentiality to the patient and other duties. This series of articles seeks to analyse the source of the duty of confidentiality and discusses individual situations giving rise to conflict within the statutory law context.

  15. Confidentiality in Childbirth Education

    PubMed Central

    Philipsen, Nayna C.

    2010-01-01

    Protecting the confidentiality of the personal information that childbirth educators receive from their clients is crucial. Without this respect for privacy, educators will not be able to get the information essential to meeting their objectives. Childbirth educators who work in schools may come under federal law that protects individual student records (Family Educational Rights and Privacy Act, or FERPA). Childbirth educators who are employed in a health-care facility may come under federal law that protects individual health information (Health Insurance Portability and Accountability Act, or HIPAA). All childbirth educators must be thoughtful advocates of the rights to privacy and self-determination of expectant parents. PMID:21358833

  16. AIDS and confidentiality.

    PubMed

    Kirkman, M B; Bell, S K

    1989-01-01

    AIDS has created many challenges for those who provide care for AIDS patients. One major challenge has been the request of many public officials for healthcare professionals to abandon the traditional view of confidentiality and to reveal AIDS patients' names. This ethical dilemma is explored and some ethical theories are presented as possible resolutions. The conclusion presented is that healthcare professionals must recognize that the power of the healthcare system over an AIDS patient is immense. Therefore, healthcare professionals must make a commitment to protect the patient's right to privacy by preventing any unauthorized disclosure at all costs.

  17. Treatment of Strip Perforation Using Root MTA: A Case Report

    PubMed Central

    Froughreyhani, Mohammad; Salem Milani, Amin; Barakatein, Behnaz; Shiezadeh, Vahhab

    2013-01-01

    Root perforations are an undesired complication of endodontic treatment which result in loss of integrity of the root, and adversely affect the prognosis of the treatment. Recently, Iranian mineral trioxide aggregate [Root MTA] has been introduced as an ideal material for perforation repair. In this article a successful repair of strip root perforation of mandibular molar using Root MTA is presented with 15-month follow-up. This case suggests that Root MTA may be a substitute material for the treatment of strip perforation; however, more clinical studies with larger sample size and longer follow-ups are needed. PMID:23717336

  18. Patient Perspectives of Medical Confidentiality

    PubMed Central

    Sankar, Pamela; Mora, Susan; Merz, Jon F; Jones, Nora L

    2003-01-01

    OBJECTIVE To lay the groundwork for a better understanding of patient views on medical confidentiality. DESIGN Studies were found by searching medline, bioethicsline, and selected bibliographies. Articles concerning physician perspectives or implications of legal and administrative regulations were excluded. Only peer-reviewed journal articles reporting original research on patients' confidentiality views and conduct were included. MAIN RESULTS Many patients are unaware of or misunderstand their legal or ethical right to medical confidentiality protections, which leads them to both over- and underestimate confidentiality protections. The possibility that medical information might be revealed, intentionally or not, to acquaintances in a clinic or other social community troubles patients as much as information release to insurers or employers. A significant minority of patients distrust confidentiality protections, leading some to report that they delay or forgo medical care. If doubtful that confidentiality will be upheld, patients will act independently to protect information. CONCLUSIONS Our review found a wider variety of understandings and beliefs about medical confidentiality among patients than are often indicated in the writings of practitioners or legal experts. As medical confidentiality regulations evolve, these differences need to be recognized and accounted for in interactions between practitioners and patients. PMID:12911650

  19. Postmortem Confidentiality: An Ethical Issue

    ERIC Educational Resources Information Center

    Bradley, Loretta J.; Hendricks, Bret; Kabell, Douglas R.

    2011-01-01

    In an era of increased need and expectation for confidentiality, the counseling record of the deceased client challenges confidentiality. Using ethical codes and legal mandates, the authors explore whether the counseling record of a deceased client should be released when the client's will and the client's counseling records are silent on this…

  20. Special Education Issues in Confidentiality.

    ERIC Educational Resources Information Center

    Utah State Univ., Logan. Mountain Plains Regional Resource Center.

    This document provides a variety of materials concerned with confidentiality issues in special education and suggested activities for using the materials in staff development. The first item is a list of 13 general rules for maintaining confidentiality in the internal communications of a school or school system. The second item is a list of 10…

  1. Postmortem Confidentiality: An Ethical Issue

    ERIC Educational Resources Information Center

    Bradley, Loretta J.; Hendricks, Bret; Kabell, Douglas R.

    2011-01-01

    In an era of increased need and expectation for confidentiality, the counseling record of the deceased client challenges confidentiality. Using ethical codes and legal mandates, the authors explore whether the counseling record of a deceased client should be released when the client's will and the client's counseling records are silent on this…

  2. MTA1 and MTA3 Regulate HIF1a Expression in Hypoxia-Treated Human Trophoblast Cell Line HTR8/Svneo

    PubMed Central

    Wang, Kai; Chen, Ying; Ferguson, Susan D.; Leach, Richard E.

    2015-01-01

    Hypoxia plays an important role in placental trophoblast differentiation and function during early pregnancy. Hypoxia-inducible factor 1 alpha (HIF1a) is known to regulate cellular adaption to hypoxic conditions. However, our current understanding of the role of HIF1a in trophoblast physiology is far from complete. Metastasis Associated Protein 1 and 3 (MTA1 and MTA3) are components of the Nucleosome Remodeling and Deacetylase (NuRD) complex, a chromatin remodeling complex, and are highly expressed in term placental trophoblasts. However, the role of MTA1 and MTA3 in the hypoxic placental environment of early pregnancy is unknown. In the present study, we examined the association among MTA1, MTA3 and HIF1a expression under hypoxic conditions in trophoblasts both in vivo and in vitro. We first investigated the localization of MTA1 and MTA3 with HIF1a expression in the placental trophoblast of 1st trimester placenta via immunohistochemistry. Our data reveals that under physiologically hypoxic environment, MTA1 and MTA3 along with HIF1a are highly expressed by villous trophoblasts. Next, we investigated the effect of hypoxia on these genes in vitro using the first trimester-derived HTR8/SVneo cell line and observed up-regulation of MTA1 and MTA3 as well as HIF1a protein following hypoxia treatment. To investigate the direct effect of MTA1 and MTA3 upon HIF1a, we over-expressed MTA1 and MTA3 genes in HTR8/SVneo cells respectively and examined protein levels of HIF1a via Western blot as well as HIF1a target gene expression using a luciferase assay driven by a hypoxia-response element promoter (HRE-luciferase). We found that over-expressions of MTA1 and MTA3 up-regulate both HIF1a protein level and HRE-luciferase activity under hypoxic condition. In summary, both MTA1 and MTA3 are induced by hypoxia and up-regulate HIF1a expression and HIF1a target gene expression in trophoblasts. These data suggest that MTA1 and MTA3 play critical roles in trophoblast function and

  3. 46 CFR 535.608 - Confidentiality of submitted material.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 9 2010-10-01 2010-10-01 false Confidentiality of submitted material. 535.608 Section 535.608 Shipping FEDERAL MARITIME COMMISSION REGULATIONS AFFECTING OCEAN SHIPPING IN FOREIGN COMMERCE OCEAN COMMON CARRIER AND MARINE TERMINAL OPERATOR AGREEMENTS SUBJECT TO THE SHIPPING ACT OF 1984 Action...

  4. 7 CFR 983.9 - Confidential data or information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential data or information. 983.9 Section 983.9 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE PISTACHIOS GROWN IN...

  5. 7 CFR 983.9 - Confidential data or information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 8 2011-01-01 2011-01-01 false Confidential data or information. 983.9 Section 983.9 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing Agreements and Orders; Fruits, Vegetables, Nuts), DEPARTMENT OF AGRICULTURE PISTACHIOS GROWN IN...

  6. 26 CFR 301.6111-2 - Confidential corporate tax shelters.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... satisfied by an IRS position that would be merely arguable or that would constitute merely a colorable claim... position must take into account the entirety of the transaction and any combination of tax consequences... under conditions of confidentiality, whether or not such understanding or agreement is legally binding...

  7. Prognostic correlation between MTA2 expression level and colorectal cancer.

    PubMed

    Ding, Weijun; Hu, Wei; Yang, Haihua; Ying, Ting; Tian, Ye

    2015-01-01

    Association of MTA2 expression with presence, development, metastasis and prognosis of colorectal cancer (CRC) was investigated. 90 CRC-related cases with follow-up information were made into tissue microarrays according to the paired principle of cancer tissues and the adjacent tissues. Subsequently, the expression of MAT2 was detected with immunohistochemical analysis and SPSS software was finally utilized to analyze the relationships between experimental data and clinical indicatives. Expression of MTA2 in CRC tissues were notably higher than their adjacent tissues (P < 0.001) and showed significant positive correlation with tumor grade (r(2) > 0, P < 0.01). Moreover, survival analysis indicated that MTA2 expression in cancer tissues, serving as an independent correlation factor, was significantly correlated with poor prognosis (P = 0.004). MTA2 is a crucial biomarker that is closely related with prognosis of CRC and also a potential molecular target for evaluating the prognosis and treatment of CRC.

  8. Mineral trioxide aggregate (MTA): its history, composition, and clinical applications.

    PubMed

    Tawil, Peter Z; Duggan, Derek J; Galicia, Johnah C

    2015-04-01

    Mineral trioxide aggregate (MTA) has been a revolutionary material in endodontics. Since its introduction in the 1990s several studies have demonstrated its use in various clinical applications. MTA has been extensively studied and is currently used for perforation repairs, apexifications, regenerative procedures, apexogenesis, pulpotomies, and pulp capping. This article will review the history, composition, research findings, and clinical applications of this versatile endodontic material.

  9. MTA1 expression in human cancers - Clinical and pharmacological significance.

    PubMed

    Malisetty, Vijaya Lakshmi; Penugurti, Vasudevarao; Panta, Prashanth; Chitta, Suresh Kumar; Manavathi, Bramanandam

    2017-09-11

    Remarkably, majority of the cancer deaths are due to metastasis, not because of primary tumors. Metastasis is one of the important hallmarks of cancer. During metastasis invasion of primary tumor cells from the site of origin to a new organ occurs. Metastasis associated proteins (MTAs) are a small family of transcriptional coregulators that are closely associated with tumor metastasis. These proteins are integral components of nuclear remodeling and deacetylation complex (NuRD). By virtue of being integral components of NuRD, these proteins regulate the gene expression by altering the epigenetic changes such as acetylation and methylation on the target gene chromatin. Among the MTA proteins, MTA1 expression is very closely correlated with the aggressiveness of several cancers that includes breast, liver, colon, pancreas, prostate, blood, esophageal, gastro-intestinal etc. Considering its close association with aggressiveness in human cancers, MTA1 may be considered as a potential therapeutic target for cancer treatment. The recent developments in its crystal structure further strengthened the idea of developing small molecule inhibitors for MTA1. In this review, we discuss the recent trends on the diverse functions of MTA1 and its role in various cancers, with the focus to consider MTA1 as a 'druggable' target in the control of human cancers. Copyright © 2017 Elsevier Masson SAS. All rights reserved.

  10. Confidentiality and Huntington's chorea.

    PubMed Central

    Adams, J

    1990-01-01

    A doctor has duties towards his patients of both confidentiality and veracity and at times these may conflict, as in the following case. A mother who has the symptoms of Huntington's chorea does not wish her daughters to know. The doctor must try to make her realise how valuable the information can be to the daughters, and thus obtain her consent to inform them. If the mother's consent cannot be obtained, then the doctor must tell the mother that he cannot allow her attitude to deprive the daughters of this information, especially at this crucial time as they plan to have children. The well-being of the daughters' future families must take precedence over the mother's desire for secrecy regarding her condition. PMID:2149571

  11. 32 CFR 806b.9 - Confidentiality promises.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 32 National Defense 6 2010-07-01 2010-07-01 false Confidentiality promises. 806b.9 Section 806b.9... PROGRAM Obtaining Law Enforcement Records and Confidentiality Promises § 806b.9 Confidentiality promises. Promises of confidentiality must be prominently annotated in the record to protect from disclosure any...

  12. 25 CFR 571.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 25 Indians 2 2010-04-01 2010-04-01 false Confidentiality. 571.3 Section 571.3 Indians NATIONAL... INVESTIGATIONS General § 571.3 Confidentiality. Unless confidentiality is waived, the Commission shall treat as... appropriate law enforcement officials. The confidentiality of documents submitted in a multiple-party...

  13. 34 CFR 300.610 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 34 Education 2 2010-07-01 2010-07-01 false Confidentiality. 300.610 Section 300.610 Education... DISABILITIES Monitoring, Enforcement, Confidentiality, and Program Information Confidentiality of Information § 300.610 Confidentiality. The Secretary takes appropriate action, in accordance with section 444 of...

  14. The inadvertent breach of confidentiality.

    PubMed

    Erlen, J A

    1998-01-01

    Patients believe that personal information that they share with their health care providers will be kept strictly confidential. Safeguarding a confidence has been and continues to be an expected professional behavior. Yet, a common ethical problem that nurses face in their everyday practice is the inadvertent disclosure of private information about particular patients to individuals who have no need for this information. This article discusses the inadvertent breach of confidentiality and its related ethical concepts: privacy, respect for persons, trust and fidelity, and the potential for harm or injury. Recommendations are provided to enable nurses to avoid and manage situations that involve an inadvertent breach of confidentiality.

  15. Treatment of Furcal Perforation of Primary Molars with ProRoot MTA versus Root MTA: A Laboratory Study

    PubMed Central

    Haghgoo, Roza; Abbasi, Farid

    2013-01-01

    Introduction Furcal perforations are one of the most challenging causes of endodontic failures. Several materials including MTA have been used for non surgical repair of these perforations. The aim of this study was to compare treatment outcome of furcal perforation treatment in primary molars using Root MTA and ProRoot MTA. Materials and Methods This in vitro study was conducted on 54 primary first molars that were randomly divided into the two experimental groups of 24 teeth each and two control groups (n=6). After preparation of access cavities, perforations were made and the perforation areas were repaired using either Root or ProRoot MTAs. After staining and preparation of mesiodistal longitudinal sections, dye leakage was measured using a stereomicroscope. The data was analyzed by the Mann Whitney statistical test. Significant level was set at 0.05. Results The data indicated that the dye leakage of ProRoot MTA is significantly lesser than Root MTA (P=0.001). Conclusion ProRoot MTA showed good sealing ability in repairing furcal perforations of primary molars. PMID:23717329

  16. In vitro cytotoxicity of white MTA, MTA Fillapex® and Portland cement on human periodontal ligament fibroblasts.

    PubMed

    Yoshino, Patrícia; Nishiyama, Celso Kenji; Modena, Karin Cristina da Silva; Santos, Carlos Ferreira; Sipert, Carla Renata

    2013-01-01

    The aim of this study was to compare the in vitro cytotoxicity of white mineral trioxide aggregate (MTA), MTA Fillapex® and Portland cement (PC) on human cultured periodontal ligament fibroblasts. Periodontal ligament fibroblast culture was established and the cells were used for cytotoxic tests after the fourth passage. Cell density was set at 1.25 X10 4 cells/well in 96-well plates. Endodontic material extracts were prepared by placing sealer/cement specimens (5x3mm) in 1mL of culture medium for 72 h. The extracts were then serially two-fold diluted and inserted into the cell-seeded wells for 24, 48 and 72 h. MTT assay was employed for analysis of cell viability. Cell supernatants were tested for nitric oxide using the Griess reagent system. MTA presented cytotoxic effect in undiluted extracts at 24 and 72 h. MTA Fillapex® presented the highest cytotoxic levels with important cell viability reduction for pure extracts and at ½ and ¼ dilutions. In this study, PC did not induce alterations in fibroblast viability. Nitric oxide was detected in extract-treated cell supernatants and also in the extracts only, suggesting presence of nitrite in the soluble content of the tested materials. In the present study, MTA Fillapex displayed the highest cytotoxic effect on periodontal ligament fibroblasts followed by white MTA and PC.

  17. Confidential Business Information under TSCA

    EPA Pesticide Factsheets

    This website informs businesses, policymakers, and the public about the confidential business information (CBI) provisions of § 14 of the Toxic Substances Control Act (TSCA), as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act.

  18. MTA monoblock obturation technique in endodontic retreatment.

    PubMed

    Iqbal, Zahid; Qureshi, Abdul Hakeem

    2014-11-01

    A 48-year-old male patient presented to the Department of Endodontics for evaluation of right first permanent molar, which had received non-surgical root canal treatment two years ago and was restored with core material. The presenting symptoms included swelling in the buccal vestibule and pain overnight. Clinical examination demonstrated that the mandibular right first molar was sensitive to percussion and also showed fluctuant swelling in the vestibule proximal to the molar and mild mobility. Radiographic examination revealed a poor quality obturation of the mesial and distal root, distal root resorption, extensive periapical and furcation radiolucency and bone loss. A diagnosis of acute periapical abscess of the mandibular right first molar was made. Tooth was treated non-surgically by the manual application of MTA in the root canal. Follow-up evaluation was performed at one year after the treatment. Clinically, treatment was considered successful due to the absence of clinical signs, symptoms and radiographic appearance with substantial reduction (more than 50%) in the diameter of the periapical radiolucency. Mineral trioxide aggregate monoblock obturation technique appears to be a valid technique to obtain periradicular healing in re-treatment of previously root canal treated teeth with periapical lesion.

  19. Cryogenics for the MuCool Test Area (MTA)

    SciTech Connect

    Darve, Christine; Norris, Barry; Pei, Liu-Jin; /Fermilab

    2005-09-01

    MuCool Test Area (MTA) is a complex of buildings at Fermi National Accelerator Laboratory, which are dedicated to operate components of a cooling cell to be used for Muon Collider and Neutrino Factory R&D. The long-term goal of this facility is to test ionization cooling principles by operating a 25-liter liquid hydrogen (LH{sub 2}) absorber embedded in a 5 Tesla superconducting solenoid magnet. The MTA solenoid magnet will be used with RF cavities exposed to a high intensity beam. Cryogens used at the MTA include LHe, LN{sub 2} and LH{sub 2}. The latter dictates stringent system design for hazardous locations. The cryogenic plant is a modified Tevatron refrigerator based on the Claude cycle. The implementation of an in-house refrigerator system and two 300 kilowatt screw compressors is under development. The helium refrigeration capacity is 500 W at 14 K. In addition the MTA solenoid magnet will be batch-filled with LHe every 2 days using the same cryo-plant. This paper reviews cryogenic systems used to support the Muon Collider and Neutrino Factory R&D programs and emphasizes the feasibility of handling cryogenic equipment at MTA in a safe manner.

  20. 47 CFR 90.661 - MTA-based SMR service areas.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 47 Telecommunication 5 2010-10-01 2010-10-01 false MTA-based SMR service areas. 90.661 Section 90..., 851-869, 896-901, and 935-940 MHz Bands Policies Governing the Licensing and Use of Mta-Based Smr Systems in the 896-901/935-940 Mhz Band § 90.661 MTA-based SMR service areas. MTA licenses for...

  1. MTA1 regulation of ERβ pathway in salivary gland carcinoma cells

    SciTech Connect

    Ohshiro, Kazufumi Kumar, Rakesh

    2015-09-04

    Abstracts: Although Metastatic-tumor antigen 1 (MTA1) is differentially expressed in metastatic cancer and coregulates the status and activity of nuclear receptors, its role upon estrogen receptor β (ERβ) – a potent tumor suppressor, remains poorly understood. Here we investigated whether MTA1 regulates the expression and functions of ERβ, an ER isoform predominantly expressed in salivary gland cancer cells. We found that the depletion of the endogenous MTA1 in the HSG and HSY salivary duct carcinoma cell lines enhances the expression of ERβ while MTA1 overexpression augmented the expression of ERβ in salivary duct carcinoma cells. Furthermore, MTA1 knockdown inhibited the proliferations and invasion of HSG and HSY cells. The noted ERβ downregulation by MTA1 overexpression involves the process of proteasomal degradation, as a proteasome inhibitor could block it. In addition, both MTA1 knockdown and ERβ overexpression attenuated the cell migration and inhibited the ERK1/2 signaling in the both cell lines. These findings imply that MTA1 dysregulation in a subset of salivary gland cancer might promote aggressive phenotypes by compromising the tumor suppressor activity of ERβ, and hence, MTA1-ERβ axis might serve a new therapeutic target for the salivary gland cancer. - Highlights: • MTA1 silencing upregulates ERβ expression in salivary gland carcinoma cells. • MTA1 overexpression downregulates ERβ expression via proteasomal degradation. • Upregulation of ERβ expression inhibits cell migration and ERK signaling. • MTA1 knockdown inhibits cell proliferation and invasion.

  2. Protection of privacy and confidentiality.

    PubMed

    Curran, W J; Laska, E M; Kaplan, H; Bank, R

    1973-11-23

    A multistate, cooperative program seeking to develop better methods for the effective and efficient gathering. storing, analyzing, and utilizing of mental patient records has made a comprehensive effort to protect the confidentiality and privacy of these psychiatric patient records. Administrative, technical, and legal safeguards have been implemented. The discussion of legal safeguards involves two areas: the protection of the system itself, located at Rockland State Hospital; and the specific legal environment of confidentiality and privacy of mental health records and information in the group of cooperating jurisdictions. On the whole, adequate legal and administrative protection can be afforded the confidentiality and privacy of an electronic data system in the mental health field, and access to the records can be restricted for the welfare of the patients. At the same time, access to aggregate data in the system can be allowed, under proper standards, for important research and planning purposes. The methods adopted by MSIS to preserve confidentiality and privacy by limiting access to such records could well prove an important model for the development of protective methods in other electronic data programs-not only those in psychiatry, but those in other fields where the data collected are sensitive and confidential.

  3. Dr. von Braun on the Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1966-01-01

    In this June 1966 photograph, Marshall Space Flight Center Director Dr. Wernher von Braun test-drives the Mobility Test Article (MTA), a developmental vehicle built by the Bendix Corporation to test lunar mobility vehicle concepts. The data provided by the MTA helped in designing the Lunar Roving Vehicle (LRV), developed under the direction of the MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions. The LRVs were deployed during the last three Apollo missions; Apollo 15, Apollo 16, and Apollo 17.

  4. 30 CFR 47.85 - Confidentiality agreement and remedies.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... the trade secret chemical identity to the health purposes indicated in the written statement of need... designated representative, or the health professional to disclose the trade secret chemical identity to MSHA... professional inform the operator who provided the trade secret chemical identity prior to or at the same...

  5. 10 CFR 429.7 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... confidential and exempt by law from public disclosure should—at the time of submission—submit: (1) One complete... disclosure, (vi) A date upon which such information might lose its confidential nature due to the passage...

  6. Data Confidentiality Challenges in Big Data Applications

    SciTech Connect

    Yin, Jian; Zhao, Dongfang

    2015-12-15

    In this paper, we address the problem of data confidentiality in big data analytics. In many fields, much useful patterns can be extracted by applying machine learning techniques to big data. However, data confidentiality must be protected. In many scenarios, data confidentiality could well be a prerequisite for data to be shared. We present a scheme to provide provable secure data confidentiality and discuss various techniques to optimize performance of such a system.

  7. 37 CFR 382.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Confidential information. 382... SATELLITE DIGITAL AUDIO RADIO SERVICES Preexisting Subscription Services § 382.5 Confidential information. (a) For purposes of this subpart, confidential information shall include statements of account and...

  8. 37 CFR 380.14 - Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Confidential Information. 380... Confidential Information. (a) Definition. For purposes of this subpart, “Confidential Information” shall include the statements of account and any information contained therein, including the amount of royalty...

  9. 37 CFR 262.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Confidential information. 262... Confidential information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein, including the amount of royalty payments...

  10. 7 CFR 983.65 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 983.65 Section 983.65..., ARIZONA, AND NEW MEXICO Reports, Books and Records § 983.65 Confidential information. All reports and records furnished or submitted by handlers to the committee which include confidential data or information...

  11. 37 CFR 380.24 - Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Confidential Information. 380... Webcasters § 380.24 Confidential Information. (a) Definition. For purposes of this subpart, “Confidential Information” shall include the statements of account and any information contained therein, including the...

  12. 37 CFR 384.5 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Confidential information. 384... BUSINESS ESTABLISHMENT SERVICES § 384.5 Confidential information. (a) Definition. For purposes of this section, “Confidential Information” shall include the statements of account and any information contained...

  13. 37 CFR 380.5 - Confidential Information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2014-07-01 2014-07-01 false Confidential Information. 380... Noncommercial Webcasters § 380.5 Confidential Information. (a) Definition. For purposes of this subpart, “Confidential Information” shall include the statements of account and any information contained therein...

  14. 37 CFR 261.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 261... THE MAKING OF EPHEMERAL REPRODUCTIONS § 261.5 Confidential information. (a) For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein, including...

  15. 37 CFR 384.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 384... BUSINESS ESTABLISHMENT SERVICES § 384.5 Confidential information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein, including...

  16. 32 CFR 806b.9 - Confidentiality promises.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 32 National Defense 6 2011-07-01 2011-07-01 false Confidentiality promises. 806b.9 Section 806b.9 National Defense Department of Defense (Continued) DEPARTMENT OF THE AIR FORCE ADMINISTRATION PRIVACY ACT PROGRAM Obtaining Law Enforcement Records and Confidentiality Promises § 806b.9 Confidentiality...

  17. 14 CFR 406.117 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 14 Aeronautics and Space 4 2012-01-01 2012-01-01 false Confidential information. 406.117 Section... Practice in FAA Space Transportation Adjudications § 406.117 Confidential information. (a) Filing confidential information. If a party wants certain information that the party is filing not made available...

  18. 14 CFR 406.117 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 14 Aeronautics and Space 4 2013-01-01 2013-01-01 false Confidential information. 406.117 Section... Practice in FAA Space Transportation Adjudications § 406.117 Confidential information. (a) Filing confidential information. If a party wants certain information that the party is filing not made available...

  19. Confidentiality and privileged communication in group psychotherapy.

    PubMed

    Lasky, Gina B; Riva, Maria T

    2006-10-01

    The concept of confidentiality is fundamental to all forms of psychotherapy. The idea of protecting confidential material goes as far back as the Hippocratic Oath in ancient Greek history. Centuries later, authors continue to assert that "only by maintaining confidentiality can the essential groundwork of trust in treatment be developed" (Hough, 1992, p. 106). Others have even argued that without confidentiality, psychotherapy has no value (Epstein, Steingarten, Weinstein, & Nashel, 1977). Confidentiality in group psychotherapy is more complicated than in individual therapy because self-disclosure is at the core of group therapy and there are numerous people hearing the disclosures. Confidentiality in group therapy, once ignored in the literature on ethics, is gaining more attention as this modality becomes more widely practiced; so too is an acknowledgement that ethical dilemmas surrounding confidentiality in groups are commonplace. This article discusses the major considerations and dilemmas on confidentiality in group psychotherapy. We first review confidentiality broadly and discuss the ethical principles that are related to confidentiality. In the next section, we discuss the complexities of confidentiality in group psychotherapy. Finally, we review research on confidentiality in groups and describe common ethical dilemmas.

  20. 29 CFR 1641.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 4 2010-07-01 2010-07-01 false Confidentiality. 1641.3 Section 1641.3 Labor Regulations... SUBCONTRACTS § 1641.3 Confidentiality. When the Department of Labor receives information obtained by EEOC, the Department of Labor shall observe the confidentiality requirements of sections 706(b) and 709(e) of title VII...

  1. 29 CFR 1691.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 4 2010-07-01 2010-07-01 false Confidentiality. 1691.3 Section 1691.3 Labor Regulations... EMPLOYMENT DISCRIMINATION FILED AGAINST RECIPIENTS OF FEDERAL FINANCIAL ASSISTANCE § 1691.3 Confidentiality. When an agency receives information obtained by EEOC, the agency shall observe the confidentiality...

  2. 29 CFR 1640.4 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 4 2010-07-01 2010-07-01 false Confidentiality. 1640.4 Section 1640.4 Labor Regulations... WITH DISABILITIES ACT AND SECTION 504 OF THE REHABILITATION ACT OF 1973 § 1640.4 Confidentiality. (a... shall observe the confidentiality requirements of section 706(b) and section 709(e) of the Civil Rights...

  3. 14 CFR 413.9 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 14 Aeronautics and Space 4 2010-01-01 2010-01-01 false Confidentiality. 413.9 Section 413.9... TRANSPORTATION LICENSING LICENSE APPLICATION PROCEDURES § 413.9 Confidentiality. (a) Any person furnishing... for which any person or agency requests confidentiality must be clearly marked with an identifying...

  4. 19 CFR 207.105 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 3 2010-04-01 2010-04-01 false Confidentiality. 207.105 Section 207.105 Customs... and Committee Proceedings § 207.105 Confidentiality. (a) Protection of proprietary and privileged.... (b) Confidentiality of proceedings. Upon the request of any charged party pursuant to § 207.106 of...

  5. 40 CFR 707.75 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 707.75 Section 707.75... IMPORTS AND EXPORTS Notices of Export Under Section 12(b) § 707.75 Confidentiality. (a) A person may assert a claim of confidentiality for any information which is submitted to EPA in a notice. (b) Any...

  6. 40 CFR 712.15 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 712.15 Section 712.15... INFORMATION RULES General Provisions § 712.15 Confidentiality. (a) Any person submitting information under this part may assert business confidentiality claims for the information as described in the pertinent...

  7. 14 CFR 414.13 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 14 Aeronautics and Space 4 2010-01-01 2010-01-01 false Confidentiality. 414.13 Section 414.13... TRANSPORTATION LICENSING SAFETY APPROVALS Application Procedures § 414.13 Confidentiality. (a) To ensure confidentiality of data or information in the application, the applicant must— (1) Send a written request with the...

  8. 15 CFR 801.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 3 2010-01-01 2010-01-01 false Confidentiality. 801.5 Section 801.5 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) BUREAU OF... FOREIGN PERSONS § 801.5 Confidentiality. Information collected pursuant to § 801.3 is confidential (see...

  9. 8 CFR 1003.108 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 8 Aliens and Nationality 1 2010-01-01 2010-01-01 false Confidentiality. 1003.108 Section 1003.108....108 Confidentiality. (a) Complaints and preliminary inquiries. Except as otherwise provided by law or... conduct is the subject of a complaint or preliminary inquiry, however, may waive confidentiality, except...

  10. 24 CFR 574.440 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 24 Housing and Urban Development 3 2010-04-01 2010-04-01 false Confidentiality. 574.440 Section... Grantees and Project Sponsors § 574.440 Confidentiality. The grantee shall agree, and shall ensure that each project sponsor agrees, to ensure the confidentiality of the name of any individual assisted under...

  11. 42 CFR 93.108 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Confidentiality. 93.108 Section 93.108 Public... MISCONDUCT General § 93.108 Confidentiality. (a) Disclosure of the identity of respondents and complainants... prescribed by applicable law, confidentiality must be maintained for any records or evidence from which...

  12. 40 CFR 717.19 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 717.19 Section 717.19... THE ENVIRONMENT General Provisions § 717.19 Confidentiality. (a) Any person submitting copies of records may assert a business confidentiality claim covering all or part of the submitted information. Any...

  13. 46 CFR 249.11 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 8 2010-10-01 2010-10-01 false Confidentiality. 249.11 Section 249.11 Shipping MARITIME... UNDERWRITERS FOR MARINE HULL INSURANCE § 249.11 Confidentiality. (a) If the data submitted under this rule... for confidentiality at the time of any request for production of information under the FOIA by third...

  14. 28 CFR 37.4 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 28 Judicial Administration 1 2010-07-01 2010-07-01 false Confidentiality. 37.4 Section 37.4... DISABILITIES ACT AND SECTION 504 OF THE REHABILITATION ACT OF 1973 § 37.4 Confidentiality. (a) When a section... the confidentiality requirements of section 706(b) and section 709(e) of the Civil Rights Act of 1964...

  15. 42 CFR 59.11 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Confidentiality. 59.11 Section 59.11 Public Health... Project Grants for Family Planning Services § 59.11 Confidentiality. All information as to personal facts... confidentiality. Otherwise, information may be disclosed only in summary, statistical, or other form which does...

  16. 46 CFR 502.405 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 9 2010-10-01 2010-10-01 false Confidentiality. 502.405 Section 502.405 Shipping... Alternative Dispute Resolution § 502.405 Confidentiality. (a) Except as provided in paragraphs (d) and (e) of... govern the confidentiality of the dispute resolution proceeding, in accordance with the guidance on...

  17. 28 CFR 42.603 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 28 Judicial Administration 1 2010-07-01 2010-07-01 false Confidentiality. 42.603 Section 42.603... Financial Assistance § 42.603 Confidentiality. When an agency receives information obtained by EEOC, the agency shall observe the confidentiality requirements of sections 706(b) and 709(e) of title VII as would...

  18. 41 CFR 60-742.3 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 41 Public Contracts and Property Management 1 2010-07-01 2010-07-01 true Confidentiality. 60-742.3... HOLDING GOVERNMENT CONTRACTS OR SUBCONTRACTS § 60-742.3 Confidentiality. When the Department of Labor receives information obtained by EEOC, the Department of Labor shall observe the confidentiality...

  19. The subcellular distribution and function of MTA1 in cancer differentiation.

    PubMed

    Liu, Jian; Xu, Dongkui; Wang, Haijuan; Zhang, Ying; Chang, Yanan; Zhang, Jinlong; Wang, Jia; Li, Chunxiao; Liu, Huan; Zhao, Mei; Lin, Chen; Zhan, Qimin; Huang, Changzhi; Qian, Haili

    2014-07-15

    The functions and mechanisms of metastasis-associated protein 1 (MTA1) in cancer progression are still unclear due to a lagged recognition of the subcellular localization. In the present study, using multiple molecular technologies we confirmed for the first time that MTA1 localizes to the nucleus, cytoplasm and nuclear envelope. MTA1 is primarily localized in the nucleus of normal adult tissues but in the cytoplasm of embryonic tissues. While in colon cancer, both distributions have been described. Further investigation revealed that MTA1 localizes on the nuclear envelope in a translocated promoter region (TPR)-dependent manner, while in the cytoplasm, MTA1 shows an obvious localization on microtubules. Both nuclear and cytoplasmic MTA1 are associated with cancer progression. However, these functions may be associated with different mechanisms because only nuclear MTA1 has been associated with cancer differentiation. Overexpression of MTA1 in HCT116 cells inhibited differentiation and promoted proliferation, whereas MTA1 knockdown resulted in cell differentiation and death. Theses results not only suggest that nuclear MTA1 is a good marker for cancer differentiation diagnosis and a potential target for the treatment of cancers but also reveal the necessity to differentially examine the functions of nuclear and cytoplasmic MTA1.

  20. MTA pulpotomy of human permanent molars with irreversible pulpitis.

    PubMed

    Eghbal, Mohammad Jafar; Asgary, Saeed; Baglue, Reza Ali; Parirokh, Masoud; Ghoddusi, Jamileh

    2009-04-01

    The histological success of mineral trioxide aggregate (MTA) pulpotomy for treatment of irreversible pulpitis in human teeth as an alternative treatment was investigated in this study. Fourteen molars which had to be extracted were selected from patients 16-28 years old. The selection criteria include carious pulp exposure with a history of lingering pain. After isolation, caries removal and pulp exposure, MTA was used in pulpotomy treatment. Patients were evaluated for pain after 24 h. Two patients were lost from this study. Twelve teeth were extracted after 2 months and were assessed histologically. Recall examinations confirmed that none of the patients experienced pain after pulpotomy. Histological observation revealed that all samples had dentin bridge formation completely and that the pulps were vital and free of inflammation. Although the results favour the use of MTA as a pulpotomy material, more studies with larger samples and a longer recall period are suggested to justify the use of MTA for treatment of irreversible pulpitis in human permanent teeth.

  1. von Braun Examines Bendix Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1964-01-01

    Marshall Space Flight Center (MSFC) director, Wernher von Braun, and others examine one concept of a possible Lunar Roving Vehicle (LRV) built by the Bendix Corporation. The data provided by the MTA helped in designing the LRV, developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  2. von Braun Examines Bendix Mobility Test Article (MTA)

    NASA Technical Reports Server (NTRS)

    1965-01-01

    Marshall Space Flight Center (MSFC) director, Wernher von Braun, and a visitor, examine one concept of a possible Lunar Roving Vehicle (LRV) built by the Bendix Corporation. The data provided by the MTA helped in designing the LRV, developed under the direction of MSFC. The LRV was designed to allow Apollo astronauts a greater range of mobility during lunar exploration missions.

  3. College Confidential: A Field Guide

    ERIC Educational Resources Information Center

    Hoover, Eric

    2013-01-01

    Day and night the locals chatter. They counsel and console, bicker and rant. Their questions are endless. Though often hopeful, they never stop pounding the drums of worry. This is College Confidential, a vast virtual realm where visitors can find the best and worst of human nature. Here, in moderated discussion forums, people help strangers. They…

  4. Confidential inquiry into malaria deaths.

    PubMed Central

    Dürrheim, D. N.; Frieremans, S.; Kruger, P.; Mabuza, A.; de Bruyn, J. C.

    1999-01-01

    The results of a confidential inquiry into mortality attributed to malaria in South Africa's Mpumalanga Province are being used to guide the design of strategies for improving the management of cases and reducing the probability of deaths from the disease. PMID:10212518

  5. Student Education Records and Confidentiality.

    ERIC Educational Resources Information Center

    Oregon State Dept. of Education, Salem. Office of Student Services.

    Significant changes in administration of student records for Oregon students occurred as the result of House Bill 2062, which became effective in November 1993. This publication provides help to Oregon school personnel and patrons in the proper handling of student records and confidentiality as affected by that bill and other Federal and state…

  6. College Confidential: A Field Guide

    ERIC Educational Resources Information Center

    Hoover, Eric

    2013-01-01

    Day and night the locals chatter. They counsel and console, bicker and rant. Their questions are endless. Though often hopeful, they never stop pounding the drums of worry. This is College Confidential, a vast virtual realm where visitors can find the best and worst of human nature. Here, in moderated discussion forums, people help strangers. They…

  7. Confidential Training Needs Assessment Report.

    ERIC Educational Resources Information Center

    Williams, Jean; Ingram, Cynthia

    In 1988, Patrick Henry Community College (PHCC), in cooperation with Virginia Polytechnic Institute and State University, conducted a confidential survey of members of the Henry County Sheriff's Department and the Martinsville Police Department to determine training needs. Groups of between 1 and 15 employees from all shifts and departments were…

  8. Effect of Oral Tissue Fluids on Compressive Strength of MTA and Biodentine: An In vitro Study

    PubMed Central

    Vasantharajan, Madhusudhan

    2017-01-01

    Introduction Over the past many years various root end filling materials have been used which have been tested for their physical properties but each of them had certain limitations. In clinical practice, root end filling materials are exposed to oral tissue fluids which may compromise their longevity. Aim The aim of this study was to investigate the effects of oral tissue fluids on compressive strength of Mineral Trioxide Aggregate (MTA) and biodentine. Materials and Methods MTA and biodentine cylinders measuring 6 mm × 4 mm were prepared using acrylic blocks. They were divided into six groups; (Group 1) (MTA) (n=3), (Group 2) MTA contaminated with saliva, (MTA-S) (n=3), Group 3: MTA contaminated with blood, MTA-B (n=3), Group 4: Biodentine (BD), Group 5: Biodentine contaminated with saliva (BD-S) (n=5), Group 6: Biodentine contaminated with blood (BD-B) (n=5). The mould was contaminated with saliva and blood and incubated at 37°C at 100% humidity for three days and compressive strength (MPa) was measured using universal testing machine and the data was analyzed statistically using one-way ANOVA test. Results There was no significant difference in the compressive strength between the three groups i.e., MTA, MTA-S, MTA-B (p > 0.05). However, there was higher compressive strength in the MTA-B group when compared to MTA and MTA-S. Also, there was no statistical significant difference between BD, BD-S, BD-B (p>0.05). Conclusion This study showed that the compressive strength of MTA and biodentine was not adversely affected by contamination with oral tissue fluids like blood and saliva. PMID:28571272

  9. Effect of Oral Tissue Fluids on Compressive Strength of MTA and Biodentine: An In vitro Study.

    PubMed

    Subramanyam, Divya; Vasantharajan, Madhusudhan

    2017-04-01

    Over the past many years various root end filling materials have been used which have been tested for their physical properties but each of them had certain limitations. In clinical practice, root end filling materials are exposed to oral tissue fluids which may compromise their longevity. The aim of this study was to investigate the effects of oral tissue fluids on compressive strength of Mineral Trioxide Aggregate (MTA) and biodentine. MTA and biodentine cylinders measuring 6 mm × 4 mm were prepared using acrylic blocks. They were divided into six groups; (Group 1) (MTA) (n=3), (Group 2) MTA contaminated with saliva, (MTA-S) (n=3), Group 3: MTA contaminated with blood, MTA-B (n=3), Group 4: Biodentine (BD), Group 5: Biodentine contaminated with saliva (BD-S) (n=5), Group 6: Biodentine contaminated with blood (BD-B) (n=5). The mould was contaminated with saliva and blood and incubated at 37°C at 100% humidity for three days and compressive strength (MPa) was measured using universal testing machine and the data was analyzed statistically using one-way ANOVA test. There was no significant difference in the compressive strength between the three groups i.e., MTA, MTA-S, MTA-B (p > 0.05). However, there was higher compressive strength in the MTA-B group when compared to MTA and MTA-S. Also, there was no statistical significant difference between BD, BD-S, BD-B (p>0.05). This study showed that the compressive strength of MTA and biodentine was not adversely affected by contamination with oral tissue fluids like blood and saliva.

  10. ProRoot MTA, MTA-Angelus and IRM used to repair large furcation perforations: sealability study.

    PubMed

    Hashem, Ahmed Abdel Rahman; Hassanien, Ehab E

    2008-01-01

    The ability of two mineral trioxide aggregate (MTA) compounds and Intermediate Restorative Material (IRM) to seal large furcation perforations were evaluated using a dye-extraction leakage method. The furcation perforations were repaired with and without the use of internal matrix before placement of repair material. Eighty extracted human mandibular first molars were divided into positive (n = 10), negative (n = 10), and three experimental groups (n = 20) according to the repair material used. Each experimental group was divided into two subgroups (n = 10) according to whether internal matrix was used or not. Dye leakage was tested from an orthograde direction, and dye extraction was performed using full concentration nitric acid. Dye absorbance was measured at 550 nm using spectrophotometer. ProRoot MTA (Maillfer, Dentsply, Switzerland) with and without internal matrix and MTA-Angelus (Angelus, Londrina, PR, Brazil) with internal matrix showed the least dye absorbance. IRM (Caulk, Dentsply, Milford, DE) without internal matrix showed the highest dye absorbance. IRM with internal matrix and MTA-Angelus without internal matrix had insignificant difference and came at intermediate level between the other groups.

  11. Medical confidentiality and patient safety: reporting procedures.

    PubMed

    Abbing, Henriette Roscam

    2014-06-01

    Medical confidentiality is of individual and of general interest. Medical confidentiality is not absolute. European countries differ in their legislative approaches of consent for data-sharing and lawful breaches of medical confidentiality. An increase of interference by the legislator with medical confidentiality is noticeable. In The Netherlands for instance this takes the form of new mandatory duties to report resp. of legislation providing for a release of medical confidentiality in specific situations, often under the condition that reporting takes place on the basis of a professional code that includes elements imposed by the legislator (e.g. (suspicion of) child abuse, domestic violence). Legislative interference must not result in the patient loosing trust in healthcare. To avoid erosion of medical confidentiality, (comparative) effectiveness studies and privacy impact assessments are necessary (European and national level). Medical confidentiality should be a subject of permanent education of health personnel.

  12. An In Vitro Comparison of Marginal Adaptation of MTA and MTA-Like Materials in the Presence of PBS at One-Week and Two-Month Intervals

    PubMed Central

    Ghorbanzadeh, Abdollah; Shokouhinejad, Noushin; Fathi, Bita; Raoof, Maryam; Khoshkhounejad, Mehrfam

    2014-01-01

    Objective: This study compared the marginal adaptation of mineral trioxide aggregate (MTA) and MTA-like materials as root-end fillings after incubation in phosphate buffer saline (PBS), a synthetic tissue fluid, for either 1 week or 2 months. Materials and Methods: In this experimental study, seventy-two extracted human single-rooted teeth were prepared and obturated with gutta-percha and AH26 sealer. The apical 3 mm of the roots were resected. Root-end cavities were prepared with an ultrasonic retrotip. The specimens were randomly divided into three groups (n=24) and filled with either ProRoot MTA, OrthoMTA, or RetroMTA. Half of the specimens in each group were stored in PBS for 1 week the other half for 2 months. Epoxy resin replicas from the resected root-end surfaces and longitudinally sectioned roots were fabricated. The gaps at the material/dentin interface were measured using a scanning electron microscope (SEM). Transversal, longitudinal, and overall gap sizes were measured. The data were analyzed using Kruskal-Wallis and Mann-Whitney tests. The significance level was set at p < 0.05. Results: There were no significant differences between the marginal adaptation of ProRoot MTA, RetroMTA, and OrthoMTA in both transverse and longitudinal sections after incubation for either 1 week or 2 months (p > 0.05). In addition, the test groups were not significantly different regarding the overall mean gap values (p > 0.05). Conclusion: Under the conditions of this study, there was no difference between the marginal adaptation of ProRoot MTA, OrthoMTA, and RetroMTA as root-end filling materials after exposure to PBS for either 1 week or 2 months. PMID:25628683

  13. Evaluation of Antibacterial Efficacy of MTA with and without Additives Like Silver Zeolite and Chlorhexidine

    PubMed Central

    Patil, Anand; Giriyappa, Ramesh Halebathi; Singh, Thakur Veerandar; Jyotsna, Sistla Venkata; Rairam, Surabhi

    2016-01-01

    Introduction Microorganisms, predominantly Enterococcus faecalis are found responsible in the progression of pulpal, periradicular diseases and in endodontic failures. Unsuccessful conventional treatment might necessitate the need for a surgical approach; where in retrograde restorative materials are used to seal the apex. Among the root end filling materials, Mineral Trioxide Aggregate (MTA) is considered biocompatible and is most commonly used in clinical applications but it has limited antibacterial activity. Metallic silver and chlorhexidine have been added into various dental materials to enhance the antibacterial activity. Aim This study aimed to compare the antibacterial effect of MTA, MTA mixed with silver zeolite and MTA mixed with chlorhexidine against Enterococcus faecalis. Materials and Methods Test materials used in the study were divided into three groups namely Group 1- MTA, Group 2-MTA + Silver Zeolite, Group 3-MTA + Chlorhexidine. Direct contact test was done by placing a standardized suspension of Enterococcus faecalis on the test materials in a 96 well microtiter plate. The bacterial growth was measured spectrophotometrically using ELISA reader at intervals of one, three and seven days. Statistical Analysis Data was collected by recording the optical density and analyzed using two-way ANOVA and Tukey’s multiple post hoc test followed by paired-t test. Results and Conclusion All test groups showed antibacterial activity against Enterococcus faecalis at day one, three and seven. MTA with silver zeolite showed the maximum antibacterial activity followed by MTA with 2% chlorhexidine. The least antibacterial effect was shown by MTA mixed with sterile water. PMID:27504400

  14. Cytotoxicity and Antimicrobial Effects of a New Fast-Set MTA

    PubMed Central

    Shin, Michelle; Chen, Jung-Wei; Tsai, Chi-Yang; Aprecio, Raydolfo; Zhang, Wu; Yochim, Ji Min; Torabinejad, Mahmoud

    2017-01-01

    Purpose. To compare the biocompatibility and antimicrobial effectiveness of the new Fast-Set MTA (FS-MTA) with ProRoot MTA (RS-MTA). Methods. The agar overlay method with neutral red dye was used. L929 mouse fibroblast cells were cultured. The liquid and oil extracts and solid test material were placed on the agar overlay, four samples for each material. Phenol was used as the positive control and cottonseed oil and MEM extracts were used as negative controls. Cytotoxicity was examined by measuring the zones of decolorization and evaluating cell lysis under an inverted microscope using the established criteria after 24 and 48 hours. The antimicrobial test was performed using the Kirby-Bauer disk-diffusion method against S. mutans, E. faecalis, F. nucleatum, P. gingivalis, and P. intermedia. The size of the zone of inhibition was measured in millimeters. Results. There was no zone of decolorization seen under or around the test materials for FS-MTA and RS-MTA at 24 and 48 hours. The antimicrobial test demonstrated no inhibitory effect of FS-MTA or RS-MTA on any bacterial species after 24 and 48 hours. Conclusions. There was no cytotoxicity or bacterial inhibition observed by the new Fast-Set MTA when compared to the ProRoot MTA after setting. PMID:28303246

  15. [Professional confidentiality and the family].

    PubMed

    Louvrier, P

    2006-09-01

    The roots of " doctor-patient privilege " or professional confidentiality go back to the Greek island of Cos - Hippocrates' birthplace. The Cos school advocated silence about what the doctor might learn during his visits. In 1868 the Napoleonic Criminal Code sanctioned those who divulged secrets that were entrusted to them by virtue of their profession or estate. The [Belgian medical association's] Code of Professional Ethics extends the bounds of professional confidentiality to include everything that the doctor sees, has knowledge of, learns of, ascertains, discovers, or surprises. Confidentiality as a matter of public policy is relative. It is a tool for the preservation of values, allowing access to health care without fear of divulgation. This leads to possible conflicts of values, conflicts between two duties involving a value that can be protected only to the detriment of another value. The family's rights are specified in Belgium's law on patient's rights, to wit: indirect consultation of the medical file after an individual's death and representation of a patient who is not able to exercise her/his rights her/himself. Silence is nevertheless the rule. The care that an illness calls for generally forces the doctor to make certain disclosures to the patient's family about the state of the illness. This usually goes no farther if the ailment is benign. However, in some sensitive situations (HIV, alcoholism, and divorce), the doctor must bear in mind that the patient may oppose the disclosure of any and all information. A good understanding of the foundations of professional confidentiality, informing the patient, and the doctor's own human qualities should make it possible to get hitherto stalled situations to move forward. The patient remains the doctor's primary focus.

  16. Odontoblastic Differentiation, Inflammatory Response, and Angiogenic Potential of 4 Calcium Silicate-based Cements: Micromega MTA, ProRoot MTA, RetroMTA, and Experimental Calcium Silicate Cement.

    PubMed

    Chang, Seok-Woo; Bae, Won-Jung; Yi, Jin-Kyu; Lee, Soojung; Lee, Deok-Won; Kum, Kee-Yeon; Kim, Eun-Cheol

    2015-09-01

    The aim of this study was to analyze the effects of different calcium silicate-based cements (CSCs) for pulp capping materials including MicroMega MTA (MMTA; MicroMega, Besanchon, France), RetroMTA (RMTA; BioMTA, Seoul, Korea), ProRoot MTA (PMTA; Dentsply, Tulsa, OK), and experimental CSC (ECSC) on odontoblastic differentiation, in vitro angiogenesis, and the inflammatory response in human dental pulp cells. Differentiation was evaluated by alkaline phosphatase activity, alizarin red staining, and reverse-transcriptase polymerase chain reaction (RT-PCR) for the marker genes. The levels of inflammatory mediators and cytokines were measured by RT-PCR and an enzyme-linked immunosorbent assay. In vitro angiogenesis was assessed by RT-PCR for angiogenic genes and an endothelial tube formation assay. PMTA, MMTA, and ECSC increased the alkaline phosphatase activity and mineralization nodule formation and up-regulated messenger RNA (mRNA) expression of odontoblastic markers compared with RMTA. In addition, PMTA, MMTA, and ECSC up-regulated the mRNA of angiogenic genes in human dental pulp cells and increased the capillary tube formation of endothelial cells compared with RMTA. However, all CSCs showed similar expression levels of inducible nitric oxide synthase and cyclooxygenase-2 protein as well as proinflammatory mediators such as nitric oxide, prostaglandin E2, tumor necrosis factor alpha, interleukin (IL)-1β, IL-6, and IL-8 mRNA. Taken together, our experimental results suggest that all CSCs are favorable materials for pulp capping, but PMTA, MMTA, and ECSC may be recommended over RMTA. Copyright © 2015 American Association of Endodontists. All rights reserved.

  17. Effectiveness of MTA pulpotomy in primary molars: a critical assessment of relevant studies.

    PubMed

    Elkhadem, Ahmed; Nagi, Passant

    2013-01-01

    Medline. Studies that evaluated the efficacy of MTA as a pulpotomy medicament in primary teeth were included, abstracts, observational studies and case reports were excluded. Only English language studies were considered. Studies were assessed and graded by two reviewers using a weighted criteria based system and a qualitative summary of the evidence provided. Twenty-two studies were included, 17 studies compared MTA with formocresol, four studies compared MTA with calcium hydroxide, ferric sulphate, Portland cement, calcium-enriched mixture cement (CEM) and one study compared white MTA with grey MTA. Based on the assessment criteria employed, there was no evidence that MTA was better than present materials and techniques as a pulpotomy medicament.

  18. Confidentiality through a feminist lens. Reaction piece.

    PubMed

    Pinch, W J

    1999-12-01

    An ethical foundation for confidentiality is found in the AAOHN Code, grounded in a respect for autonomy. Confidentiality is a phenomenon involving a trust relationship between at least two people. An undesirable outcome could result if the confidential information or observation is revealed. Although confidentiality has an impact regardless of the individual's gender, women can be at higher risk for compromises to confidentiality. The implications for women include but are not limited to the inherent inequality in client/professional relationships, paternalistic practices in health care delivery, and the importance of autonomy as an ethical principle. The nurse's sensitivity to the possible vulnerability of women, the recognition of the importance of trust and communication in professional relationships, and an effort to ask the gender question contribute to an ethical practice in occupational health care related to the issue of confidentiality.

  19. Molecular Mechanism of Regulation of MTA1 Expression by Granulocyte Colony-stimulating Factor*

    PubMed Central

    Kumar, Arathy S.; Jagadeeshan, Sankar; Subramanian, Anirudh; Chidambaram, Saravana Babu; Surabhi, Rohan Prasad; Singhal, Mahak; Bhoopalan, Hemadev; Sekar, Sathiya; Pitani, Ravi Shankar; Duvuru, Prathiba; Venkatraman, Ganesh; Rayala, Suresh K.

    2016-01-01

    Parkinson disease (PD) is a neurodegenerative disorder with loss of dopaminergic neurons of the brain, which results in insufficient synthesis and action of dopamine. Metastasis-associated protein 1 (MTA1) is an upstream modulator of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, and hence MTA1 plays a significant role in PD pathogenesis. To impart functional and clinical significance to MTA1, we analyzed MTA1 and TH levels in the substantia nigra region of a large cohort of human brain tissue samples by Western blotting, quantitative PCR, and immunohistochemistry. Our results showed that MTA1 and TH levels were significantly down-regulated in PD samples as compared with normal brain tissue. Correspondingly, immunohistochemistry analysis for MTA1 in substantia nigra sections revealed that 74.1% of the samples had a staining intensity of <6 in the PD samples as compared with controls, 25.9%, with an odds ratio of 8.54. Because of the clinical importance of MTA1 established in PD, we looked at agents to modulate MTA1 expression in neuronal cells, and granulocyte colony-stimulating factor (G-CSF) was chosen, due to its clinically proven neurogenic effects. Treatment of the human neuronal cell line KELLY and acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model with G-CSF showed significant induction of MTA1 and TH with rescue of phenotype in the mouse model. Interestingly, the observed induction of TH was compromised on silencing of MTA1. The underlying molecular mechanism of MTA1 induction by G-CSF was proved to be through induction of c-Fos and its recruitment to the MTA1 promoter. PMID:27044752

  20. Confidentiality: a critique of the traditional view.

    PubMed

    Glen, S

    1997-09-01

    'Confidentiality' can become a somewhat embellishing signboard for paternalistic caring. In essence, one needs to distinguish between confidentiality as a respectful attitude to a patient/client, where it becomes credible that the caring professional will not misuse the information he or she obtains about the patient/client, and between confidentiality misused as an instrument of power to keep the patient/client outside of processes in which it might be important or advantageous for him or her to participate.

  1. The risks of absolute medical confidentiality.

    PubMed

    Crook, M A

    2013-03-01

    Some ethicists argue that patient confidentiality is absolute and thus should never be broken. I examine these arguments that when critically scrutinised, become porous. I will explore the concept of patient confidentiality and argue that although, this is a very important medical and bioethical issue, this needs to be wisely delivered to reduce third party harm or even detriment to the patient. The argument for absolute confidentiality is particularly weak when it comes to genetic information and inherited disease.

  2. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... for commercial distribution (including for test marketing purposes and for use in research and... because disclosure would reveal a confidential process or quantitative mixture composition should...

  3. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... for commercial distribution (including for test marketing purposes and for use in research and... because disclosure would reveal a confidential process or quantitative mixture composition should...

  4. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... for commercial distribution (including for test marketing purposes and for use in research and... because disclosure would reveal a confidential process or quantitative mixture composition should...

  5. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... for commercial distribution (including for test marketing purposes and for use in research and... because disclosure would reveal a confidential process or quantitative mixture composition should...

  6. 40 CFR 716.55 - Confidentiality claims.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... for commercial distribution (including for test marketing purposes and for use in research and... because disclosure would reveal a confidential process or quantitative mixture composition should...

  7. [Confidentiality as ethical responsibility and legal duty].

    PubMed

    Arroyo Cordero, Tamara

    2009-01-01

    The article analyzes the challenge that the health professionals encounter when trying to protect their patient's confidentiality, considering the increasing demand for globalization of the information. It discusses the importance that confidentiality has for the therapeutic alliance and how the government has protected it throughout time. It identifies weak areas in the protection of confidentiality, especially in the psychiatry field. Finally, it invites the reader to consider the real benefits of sharing patient's information when deciding whether to brake or not the patient's confidentiality.

  8. Critical Care Nurses' Knowledge of Confidentiality Legislation.

    PubMed

    Newman, Angela B; Kjervik, Diane K

    2016-05-01

    Health care legislation can be difficult to understand and apply in critical situations where patients may not be physically capable of autonomous control of confidential health information. Nurses are often the first to encounter confidential information about patients. To explore critical care nurses' knowledge of federal and North Carolina state legislation regarding confidentiality. This descriptive, qualitative study included 12 critical care nurses who were asked to describe their knowledge of federal confidentiality legislation and specific knowledge of North Carolina's confidentiality legislation. Critical care nurses were knowledgeable about federal confidentiality laws but demonstrated a need for further education about state-specific legislation. Nurses' application of confidentiality legislation demonstrates their knowledge of confidentiality legislation. To continue the trusting relationship that nurses have traditionally held with patients and patients' families, it is imperative for nurses to remain current about confidentiality legislation. Through education both before and after licensure, correct application of legislation can be achieved. Further research can aid in exploring the intersection between health care legislation and ethics. ©2016 American Association of Critical-Care Nurses.

  9. Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer.

    PubMed

    Li, Da-Qiang; Kumar, Rakesh

    2015-01-01

    Since the initial recognition of the metastasis-associated protein 1 (MTA1) as a metastasis-relevant gene approximately 20 years ago, our appreciation for the complex role of the MTA family of coregulatory proteins in human cancer has profoundly grown. MTA proteins consist of six family members with similar structural units and act as central signaling nodes for integrating upstream signals into regulatory chromatin-remodeling networks, leading to regulation of gene expression in cancer cells. Substantial experimental and clinical evidence demonstrates that MTA proteins, particularly MTA1, are frequently deregulated in a wide range of human cancers. The MTA family governs cell survival, the invasive and metastatic phenotypes of cancer cells, and the aggressiveness of cancer and the prognosis of patients with MTA1 overexpressing cancers. Our discussion here highlights our current understanding of the regulatory mechanisms and functional roles of MTA proteins in cancer progression and expands upon the potential implications of MTA proteins in cancer biology and cancer therapeutics.

  10. A laboratory assessment of bacterial leakage in MTA apical plugs exposed to phosphate-buffered saline.

    PubMed

    de Almeida, Josiane; Pimenta, Andrea L; Felippe, Wilson T

    2015-01-01

    This study evaluated the influence of the exposure of mineral trioxide aggregate (MTA) - with and without calcium chloride (CaCl2) -to phosphate-buffered saline (PBS) on apical microleakage. Sixty root segments were divided into 4 experimental groups (n=15). Apical cavities were filled with MTA with or without CaCl2, and the root canals dressed with a moistened cotton pellet or PBS: 1) MTA/cotton pellet; 2) MTA/PBS; 3) MTA+ 10%CaCl2/cotton pellet; 4) MTA+10%CaCl2/PBS. After 2 months, E. faecalis penetration was analyzed along the apical plugs. Samples were observed weekly for 70 days, and leakage was detected by turbidity of the medium in contact with the root segment. Teeth in the control groups (n=2) were either made completely impermeable or kept without an apical plug. The Kaplan-Meier method was used to analyze survival and the Logrank test was used to compare the survival curves (p<0.05). All specimens in the positive control group showed evidence of leakage within 24h, while none in the negative control group showed leakage up to 70 days. There was no statistically significant difference among the experimental groups (p=0.102). The use of PBS as intracanal dressing may improve MTA sealing ability, but cannot prevent bacterial leakage. The addition of CaCl2 to the MTA did not improve MTA sealing ability.

  11. Superintendent Searches: Public or Confidential? Why Confidentiality Contributes to Quality Searches

    ERIC Educational Resources Information Center

    Attea, William J.

    2010-01-01

    When a highly qualified candidate learns the search will be conducted confidentially, a positive response is almost certain, in the author's experience running superintendent searches since 1988. Just as likely, the prospective candidate responds negatively to being told the search process will not be confidential. Confidentiality is the item of…

  12. 7 CFR 400.702 - Confidentiality of submission and duration of confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 6 2010-01-01 2010-01-01 false Confidentiality of submission and duration of confidentiality. 400.702 Section 400.702 Agriculture Regulations of the Department of Agriculture (Continued... Submission of Policies, Provisions of Policies and Rates of Premium § 400.702 Confidentiality of submission...

  13. 28 CFR 50.23 - Policy against entering into final settlement agreements or consent decree that are subject to...

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... settlement agreements or consent decree that are subject to confidentiality provisions and against seeking or... or consent decree that are subject to confidentiality provisions and against seeking or concurring in... will not enter into final settlement agreements or consent decrees that are subject to...

  14. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE Procedural... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  15. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE Procedural... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  16. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE Procedural... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  17. Confidential communications in medical care.

    PubMed

    Gupta, S; Bhardwaj, D N; Dogra, T D

    1999-10-01

    Since the legal consequences taking in consideration of Indian evidence Act 1857 of an unwarranted release of confidential information are uncertain and even the consequences may be serious, it is necessary that a physician be most cautious when divulging any information about a patient. Although there are exceptions to the proposition that all confidential information acquired from a patient should be kept secret, the basic rule to remember is that confidential information should not be revealed without obtaining the patient's consent unless law of the land like provision in criminal procedure code of India requires the physician to report the information, to any person or insurance company. Whenever a physician believes it is necessary to reveal a professional secret to protect the welfare of a patient, a third person, or the community, he should exercise caution in the method of disclosure. The following suggestions have been made to guide physicians under these circumstances: 1. Assure yourself that the person informed is sometime entitled to the information, such as the patient's parent or guardian. 2. Do not give information by telephone if you do not recognize the voice of the person making the request. 3. Avoid the use of telegrams or letters to communicate medical information of patient. 4. If you are in doubt about your right to release the information consult your legal council. 5. A person in police custody as an undertrial prisoner has the right not to permit the doctor who has examined him, to disclose the nature of his illness to any person. If a person is convicted, he has no right and the doctor can disclose the result to the authorities. 6. Never release the treatment history without written consent from patient or its legal heirs to any insurance company.

  18. 40 CFR 89.7 - Treatment of confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... confidential information has been deleted. If a need arises to publicly release nonconfidential information, EPA will assume that the submitter has accurately deleted the confidential information from this...

  19. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 49 Transportation 6 2010-10-01 2010-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential...

  20. 10 CFR 430.75 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 10 Energy 3 2011-01-01 2011-01-01 false Confidentiality. 430.75 Section 430.75 Energy DEPARTMENT OF ENERGY ENERGY CONSERVATION ENERGY CONSERVATION PROGRAM FOR CONSUMER PRODUCTS Certification and... information or data which the person believes to be confidential and exempt law from public disclosure...

  1. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All...

  2. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment....

  3. 7 CFR 1216.62 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1216.62 Section 1216.62 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential treatment. All information obtained from books, records, or reports under the Act, this...

  4. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required...

  5. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other...

  6. 7 CFR 1207.352 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1207.352 Section 1207.352 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... PLAN Potato Research and Promotion Plan Reports, Books, and Records § 1207.352 Confidential...

  7. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 3 2010-01-01 2010-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist...

  8. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 9 2010-01-01 2009-01-01 true Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from...

  9. 7 CFR 1219.63 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1219.63 Section 1219.63 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1219.63 Confidential treatment. (a) All information obtained from the books, records, or reports...

  10. 7 CFR 1221.127 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1221.127 Section 1221.127 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidential treatment. All information obtained from books, records, or reports under the Act and this...

  11. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a)...

  12. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 25 2013-07-01 2013-07-01 false Confidential data. 158.33 Section 158.33 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) PESTICIDE PROGRAMS DATA REQUIREMENTS FOR PESTICIDES General Provisions § 158.33 Confidential data. (a) Definitions. For the purposes of...

  13. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 40 Protection of Environment 25 2012-07-01 2012-07-01 false Confidential data. 158.33 Section 158.33 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) PESTICIDE PROGRAMS DATA REQUIREMENTS FOR PESTICIDES General Provisions § 158.33 Confidential data. (a) Definitions. For the purposes of...

  14. 40 CFR 158.33 - Confidential data.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 40 Protection of Environment 24 2014-07-01 2014-07-01 false Confidential data. 158.33 Section 158.33 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) PESTICIDE PROGRAMS DATA REQUIREMENTS FOR PESTICIDES General Provisions § 158.33 Confidential data. (a) Definitions. For the purposes of...

  15. 40 CFR 57.606 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 5 2011-07-01 2011-07-01 false Confidentiality. 57.606 Section 57.606 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) PRIMARY NONFERROUS SMELTER ORDERS Research and Development Requirements § 57.606 Confidentiality. The provisions of...

  16. Data protection rights and preserving confidentiality.

    PubMed

    Dimond, Bridgit

    The last two articles considered the right of others under Data Protection legislation to access a patient's records and the right to access medical reports for employment or insurance purposes. This article considers the duty of confidentiality and the provisions of the Data Protection Act 1998, which protect the confidentiality of health records.

  17. 31 CFR 129.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 31 Money and Finance: Treasury 1 2010-07-01 2010-07-01 false Confidentiality. 129.5 Section 129.5 Money and Finance: Treasury Regulations Relating to Money and Finance PORTFOLIO INVESTMENT SURVEY REPORTING § 129.5 Confidentiality. (a) Information collected pursuant to the Act will be kept in confidence...

  18. 10 CFR 431.407 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 10 Energy 3 2010-01-01 2010-01-01 false Confidentiality. 431.407 Section 431.407 Energy DEPARTMENT OF ENERGY ENERGY CONSERVATION ENERGY EFFICIENCY PROGRAM FOR CERTAIN COMMERCIAL AND INDUSTRIAL EQUIPMENT General Provisions § 431.407 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11,...

  19. 10 CFR 431.407 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 10 Energy 3 2011-01-01 2011-01-01 false Confidentiality. 431.407 Section 431.407 Energy DEPARTMENT OF ENERGY ENERGY CONSERVATION ENERGY EFFICIENCY PROGRAM FOR CERTAIN COMMERCIAL AND INDUSTRIAL EQUIPMENT General Provisions § 431.407 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11,...

  20. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality restrictions... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment or...

  1. 40 CFR 710.38 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 710.38 Section 710.38 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT TSCA CHEMICAL INVENTORY REGULATIONS 2002 Inventory Update Reporting § 710.38 Confidentiality. (a) Any...

  2. 7 CFR 929.65 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 929.65 Section 929.65... Confidential information. All reports and records furnished or submitted by handlers to the committee and its authorized agents which include data or information constituting a trade secret or disclosing the trade...

  3. 7 CFR 985.63 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 985.63 Section 985.63... Confidential information. All reports and records furnished or submitted by handlers to, or obtained by the employees of the Committee, which contain data or information constituting a trade secret or disclosing the...

  4. 7 CFR 932.63 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 932.63 Section 932.63... Regulating Handling Reports and Records § 932.63 Confidential information. All reports and information... any person, other than the Secretary upon request therefor, data, or information obtained or extracted...

  5. 7 CFR 993.71 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 993.71 Section 993.71... CALIFORNIA Order Regulating Handling Reports and Books and Other Records § 993.71 Confidential information... information constituting a trade secret or disclosing of the trade position, financial condition, or business...

  6. 37 CFR 262.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 262... information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account, any information contained therein, including the amount of royalty payments, and any...

  7. 7 CFR 996.72 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 996.72 Section 996.72... Confidential information. All reports and records furnished or submitted by handlers and importers to USDA which include data or information constituting a trade secret or disclosing a trade position, financial...

  8. 7 CFR 900.352 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 900.352 Section 900.352... Determining the Qualification of Cooperative Milk Marketing Associations § 900.352 Confidential information. The documents and other information submitted by an applicant association and otherwise obtained by...

  9. 7 CFR 930.73 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 930.73 Section 930.73... Handling Reports and Records § 930.73 Confidential information. All reports and records furnished or submitted by handlers to the Board and its authorized agents which include data or information constituting...

  10. 7 CFR 989.75 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 989.75 Section 989.75... GROWN IN CALIFORNIA Order Regulating Handling Reports and Records § 989.75 Confidential information. All... to no person, except the Secretary upon request therefor, data or information obtained or extracted...

  11. 37 CFR 380.5 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 37 Patents, Trademarks, and Copyrights 1 2010-07-01 2010-07-01 false Confidential information. 380... information. (a) Definition. For purposes of this part, “Confidential Information” shall include the statements of account and any information contained therein, including the amount of royalty payments, and...

  12. 7 CFR 926.19 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 8 2010-01-01 2010-01-01 false Confidential information. 926.19 Section 926.19... Confidential information. All reports and records furnished or submitted pursuant to this part which include data or information constituting a trade secret or disclosing the trade position or financial condition...

  13. 7 CFR 28.960 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 2 2010-01-01 2010-01-01 false Confidential information. 28.960 Section 28.960 Agriculture Regulations of the Department of Agriculture AGRICULTURAL MARKETING SERVICE (Standards... Tests § 28.960 Confidential information. No information concerning individual tests under the...

  14. 14 CFR 414.13 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 14 Aeronautics and Space 4 2013-01-01 2013-01-01 false Confidentiality. 414.13 Section 414.13 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION LICENSING SAFETY APPROVALS Application Procedures § 414.13 Confidentiality. (a) To...

  15. 14 CFR 414.13 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 14 Aeronautics and Space 4 2012-01-01 2012-01-01 false Confidentiality. 414.13 Section 414.13 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION LICENSING SAFETY APPROVALS Application Procedures § 414.13 Confidentiality. (a) To...

  16. 14 CFR 414.13 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 4 2011-01-01 2011-01-01 false Confidentiality. 414.13 Section 414.13 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION, DEPARTMENT OF TRANSPORTATION LICENSING SAFETY APPROVALS Application Procedures § 414.13 Confidentiality. (a) To...

  17. 14 CFR 406.117 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 4 2011-01-01 2011-01-01 false Confidential information. 406.117 Section 406.117 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION... Practice in FAA Space Transportation Adjudications § 406.117 Confidential information. (a)...

  18. 14 CFR 406.117 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 14 Aeronautics and Space 4 2014-01-01 2014-01-01 false Confidential information. 406.117 Section 406.117 Aeronautics and Space COMMERCIAL SPACE TRANSPORTATION, FEDERAL AVIATION ADMINISTRATION... Practice in FAA Space Transportation Adjudications § 406.117 Confidential information. (a)...

  19. 40 CFR 710.38 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT TSCA CHEMICAL INVENTORY REGULATIONS 2002 Inventory Update Reporting § 710.38 Confidentiality. (a) Any person... if the identity of that substance is treated as confidential in the Master Inventory File as of...

  20. 40 CFR 57.606 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 5 2010-07-01 2010-07-01 false Confidentiality. 57.606 Section 57.606 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) PRIMARY... section 114 of the Act and 40 CFR part 2 shall govern the confidentiality of any data or information...

  1. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 49 Transportation 6 2013-10-01 2013-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential information...

  2. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 49 Transportation 6 2014-10-01 2014-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential information...

  3. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 49 Transportation 6 2012-10-01 2012-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential information...

  4. 40 CFR 403.14 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 29 2011-07-01 2009-07-01 true Confidentiality. 403.14 Section 403.14 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) EFFLUENT GUIDELINES AND STANDARDS GENERAL PRE-TREAT-MENT REGULATIONS FOR EXIST-ING AND NEW SOURCES OF POLLUTION § 403.14 Confidentiality....

  5. 49 CFR 537.12 - Confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 49 Transportation 6 2011-10-01 2011-10-01 false Confidential information. 537.12 Section 537.12 Transportation Other Regulations Relating to Transportation (Continued) NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION, DEPARTMENT OF TRANSPORTATION AUTOMOTIVE FUEL ECONOMY REPORTS § 537.12 Confidential...

  6. 15 CFR 806.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 3 2010-01-01 2010-01-01 false Confidentiality. 806.5 Section 806.5 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) BUREAU OF ECONOMIC ANALYSIS, DEPARTMENT OF COMMERCE DIRECT INVESTMENT SURVEYS § 806.5 Confidentiality....

  7. 31 CFR 129.5 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 31 Money and Finance: Treasury 1 2014-07-01 2014-07-01 false Confidentiality. 129.5 Section 129.5 Money and Finance: Treasury Regulations Relating to Money and Finance MONETARY OFFICES, DEPARTMENT OF THE TREASURY PORTFOLIO INVESTMENT SURVEY REPORTING § 129.5 Confidentiality. (a) Information...

  8. 14 CFR 414.13 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... application that trade secrets or proprietary commercial or financial data be treated as confidential, and...,” “Proprietary Commercial Information,” “Trade Secret,” or “Confidential Treatment Requested.” Where this marking... proposed criteria for evaluating a safety approval is secret, as classified by the U.S. Government, or...

  9. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a) All...

  10. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required to...

  11. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment. All...

  12. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including agents...

  13. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required to...

  14. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All information...

  15. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 3 2013-01-01 2013-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist providing...

  16. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All information...

  17. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other information...

  18. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a) All...

  19. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All information...

  20. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 10 2013-01-01 2013-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment. All...

  1. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from such...

  2. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including agents...

  3. 7 CFR 1260.203 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 10 2014-01-01 2014-01-01 false Confidential treatment. 1260.203 Section 1260.203 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Promotion and Research Order Reports, Books and Records § 1260.203 Confidential treatment. All information...

  4. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 9 2012-01-01 2012-01-01 false Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including agents...

  5. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment. All...

  6. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 7 Agriculture 9 2013-01-01 2013-01-01 false Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other information...

  7. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required to...

  8. 7 CFR 1230.82 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1230.82 Section 1230.82 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... § 1230.82 Confidential treatment. All information obtained from the books, records or reports required to...

  9. 7 CFR 1160.403 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Confidential treatment. 1160.403 Section 1160.403 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1160.403 Confidential treatment. (a) All persons, including agents...

  10. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a) All...

  11. 7 CFR 1250.354 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 10 2011-01-01 2011-01-01 false Confidential treatment. 1250.354 Section 1250.354 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Research and Promotion Order Reports, Books, and Records § 1250.354 Confidential treatment. (a) All...

  12. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 3 2014-01-01 2014-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist providing...

  13. 7 CFR 54.1033 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 3 2012-01-01 2012-01-01 false Confidential treatment. 54.1033 Section 54.1033 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Standards... and Poultry Products § 54.1033 Confidential treatment. Every design review specialist providing...

  14. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... 7 Agriculture 9 2014-01-01 2013-01-01 true Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other information...

  15. 7 CFR 1150.173 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Confidential treatment. 1150.173 Section 1150.173 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... Order Reports, Books and Records § 1150.173 Confidential treatment. All information obtained from such...

  16. 7 CFR 1205.340 - Confidential treatment.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidential treatment. 1205.340 Section 1205.340 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Cotton Research and Promotion Order Reports, Books, and Records § 1205.340 Confidential treatment. All...

  17. 7 CFR 1150.278 - Confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 7 Agriculture 9 2011-01-01 2011-01-01 false Confidential treatment. 1150.278 Section 1150.278 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (Marketing... of Milk Producer Organizations § 1150.278 Confidential treatment. All documents and other information...

  18. 36 CFR 222.23 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 36 Parks, Forests, and Public Property 2 2014-07-01 2014-07-01 false Confidentiality. 222.23 Section 222.23 Parks, Forests, and Public Property FOREST SERVICE, DEPARTMENT OF AGRICULTURE RANGE MANAGEMENT Mediation of Term Grazing Permit Disputes § 222.23 Confidentiality. Mediation sessions and dispute...

  19. 42 CFR 456.113 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ...) MEDICAL ASSISTANCE PROGRAMS UTILIZATION CONTROL Utilization Control: Hospitals Ur Plan: Informational Requirements § 456.113 Confidentiality. The UR plan must provide that the identities of individual recipients in all UR records and reports are kept confidential. UR Plan: Review of Need for Admission 1 1...

  20. 24 CFR 574.440 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ...) OFFICE OF ASSISTANT SECRETARY FOR COMMUNITY PLANNING AND DEVELOPMENT, DEPARTMENT OF HOUSING AND URBAN... Grantees and Project Sponsors § 574.440 Confidentiality. The grantee shall agree, and shall ensure that each project sponsor agrees, to ensure the confidentiality of the name of any individual assisted...

  1. 40 CFR 403.14 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 40 Protection of Environment 30 2013-07-01 2012-07-01 true Confidentiality. 403.14 Section 403.14 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) EFFLUENT GUIDELINES AND STANDARDS GENERAL PRETREATMENT REGULATIONS FOR EXISTING AND NEW SOURCES OF POLLUTION § 403.14 Confidentiality. (a...

  2. 19 CFR 111.24 - Records confidential.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 1 2010-04-01 2010-04-01 false Records confidential. 111.24 Section 111.24 Customs Duties U.S. CUSTOMS AND BORDER PROTECTION, DEPARTMENT OF HOMELAND SECURITY; DEPARTMENT OF THE TREASURY CUSTOMS BROKERS Duties and Responsibilities of Customs Brokers § 111.24 Records confidential....

  3. 8 CFR 244.16 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 8 Aliens and Nationality 1 2012-01-01 2012-01-01 false Confidentiality. 244.16 Section 244.16 Aliens and Nationality DEPARTMENT OF HOMELAND SECURITY IMMIGRATION REGULATIONS TEMPORARY PROTECTED STATUS FOR NATIONALS OF DESIGNATED STATES § 244.16 Confidentiality. The information contained in the...

  4. 8 CFR 244.16 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 8 Aliens and Nationality 1 2011-01-01 2011-01-01 false Confidentiality. 244.16 Section 244.16 Aliens and Nationality DEPARTMENT OF HOMELAND SECURITY IMMIGRATION REGULATIONS TEMPORARY PROTECTED STATUS FOR NATIONALS OF DESIGNATED STATES § 244.16 Confidentiality. The information contained in the...

  5. 8 CFR 244.16 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 8 Aliens and Nationality 1 2013-01-01 2013-01-01 false Confidentiality. 244.16 Section 244.16 Aliens and Nationality DEPARTMENT OF HOMELAND SECURITY IMMIGRATION REGULATIONS TEMPORARY PROTECTED STATUS FOR NATIONALS OF DESIGNATED STATES § 244.16 Confidentiality. The information contained in the...

  6. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... only if the patient's written consent is obtained in accordance with subpart C of these regulations or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality restrictions. (a) General. The patient records to which these regulations apply may be disclosed or used only...

  7. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... only if the patient's written consent is obtained in accordance with subpart C of these regulations or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality restrictions. (a) General. The patient records to which these regulations apply may be disclosed or used only...

  8. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... only if the patient's written consent is obtained in accordance with subpart C of these regulations or... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality restrictions. (a) General. The patient records to which these regulations apply may be disclosed or used only...

  9. 29 CFR 1601.22 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 4 2010-07-01 2010-07-01 false Confidentiality. 1601.22 Section 1601.22 Labor Regulations Relating to Labor (Continued) EQUAL EMPLOYMENT OPPORTUNITY COMMISSION PROCEDURAL REGULATIONS Procedure for... Confidentiality. Neither a charge, nor information obtained during the investigation of a charge of employment...

  10. 7 CFR 1220.624 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidentiality. 1220.624 Section 1220.624 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... CONSUMER INFORMATION Procedures To Request a Referendum Definitions § 1220.624 Confidentiality. The names...

  11. 8 CFR 245a.21 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 8 Aliens and Nationality 1 2010-01-01 2010-01-01 false Confidentiality. 245a.21 Section 245a.21 Aliens and Nationality DEPARTMENT OF HOMELAND SECURITY IMMIGRATION REGULATIONS ADJUSTMENT OF STATUS TO... Confidentiality. (a) No person other than a sworn officer or employee of the Department of Justice or bureau or...

  12. 7 CFR 1280.634 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidentiality. 1280.634 Section 1280.634 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... INFORMATION ORDER Procedures To Request a Referendum Definitions § 1280.634 Confidentiality. The names of...

  13. 7 CFR 1280.227 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidentiality. 1280.227 Section 1280.227 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... Confidentiality. All information obtained from books, records, or reports under the Act, this subpart, and the...

  14. 10 CFR 430.75 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 10 Energy 3 2010-01-01 2010-01-01 false Confidentiality. 430.75 Section 430.75 Energy DEPARTMENT OF ENERGY ENERGY CONSERVATION ENERGY CONSERVATION PROGRAM FOR CONSUMER PRODUCTS Certification and Enforcement § 430.75 Confidentiality. Pursuant to the provisions of 10 CFR 1004.11, any person submitting...

  15. 28 CFR 0.29f - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 28 Judicial Administration 1 2010-07-01 2010-07-01 false Confidentiality. 0.29f Section 0.29f Judicial Administration DEPARTMENT OF JUSTICE ORGANIZATION OF THE DEPARTMENT OF JUSTICE 4-Office of the Inspector General § 0.29f Confidentiality. The Inspector General shall not, during the pendency of an...

  16. 8 CFR 244.16 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 8 Aliens and Nationality 1 2010-01-01 2010-01-01 false Confidentiality. 244.16 Section 244.16 Aliens and Nationality DEPARTMENT OF HOMELAND SECURITY IMMIGRATION REGULATIONS TEMPORARY PROTECTED STATUS FOR NATIONALS OF DESIGNATED STATES § 244.16 Confidentiality. The information contained in the...

  17. 21 CFR 821.55 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Confidentiality. 821.55 Section 821.55 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES MEDICAL DEVICE TRACKING REQUIREMENTS Records and Inspections § 821.55 Confidentiality. (a) Any patient...

  18. 7 CFR 1250.537 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidentiality. 1250.537 Section 1250.537 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... and Regulations Records § 1250.537 Confidentiality. All information obtained by officers and employees...

  19. 29 CFR 4043.8 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 29 Labor 9 2010-07-01 2010-07-01 false Confidentiality. 4043.8 Section 4043.8 Labor Regulations Relating to Labor (Continued) PENSION BENEFIT GUARANTY CORPORATION PLAN TERMINATIONS REPORTABLE EVENTS AND CERTAIN OTHER NOTIFICATION REQUIREMENTS General Provisions § 4043.8 Confidentiality. In accordance with...

  20. 19 CFR 354.17 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 3 2010-04-01 2010-04-01 false Confidentiality. 354.17 Section 354.17 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES FOR IMPOSING SANCTIONS FOR VIOLATION OF AN ANTIDUMPING OR COUNTERVAILING DUTY ADMINISTRATIVE PROTECTIVE ORDER § 354.17 Confidentiality...

  1. 19 CFR 356.29 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 3 2010-04-01 2010-04-01 false Confidentiality. 356.29 Section 356.29 Customs Duties INTERNATIONAL TRADE ADMINISTRATION, DEPARTMENT OF COMMERCE PROCEDURES AND RULES FOR IMPLEMENTING... Undertaking § 356.29 Confidentiality. (a) All proceedings involving allegations of a violation of a protective...

  2. 36 CFR 906.10 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 36 Parks, Forests, and Public Property 3 2010-07-01 2010-07-01 false Confidentiality. 906.10 Section 906.10 Parks, Forests, and Public Property PENNSYLVANIA AVENUE DEVELOPMENT CORPORATION AFFIRMATIVE ACTION POLICY AND PROCEDURE Development Program § 906.10 Confidentiality. All information submitted to...

  3. 40 CFR 750.36 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 750.36 Section 750.36 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT PROCEDURES... Processing and Distribution in Commerce Exemptions § 750.36 Confidentiality. EPA encourages the submission of...

  4. 40 CFR 403.14 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 28 2010-07-01 2010-07-01 true Confidentiality. 403.14 Section 403.14 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) EFFLUENT GUIDELINES AND STANDARDS GENERAL PRE-TREAT-MENT REGULATIONS FOR EXIST-ING AND NEW SOURCES OF POLLUTION § 403.14 Confidentiality. (a...

  5. 7 CFR 1425.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 7 Agriculture 10 2010-01-01 2010-01-01 false Confidentiality. 1425.5 Section 1425.5 Agriculture Regulations of the Department of Agriculture (Continued) COMMODITY CREDIT CORPORATION, DEPARTMENT OF AGRICULTURE LOANS, PURCHASES, AND OTHER OPERATIONS COOPERATIVE MARKETING ASSOCIATIONS § 1425.5 Confidentiality...

  6. 42 CFR 456.113 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 4 2010-10-01 2010-10-01 false Confidentiality. 456.113 Section 456.113 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED... Requirements § 456.113 Confidentiality. The UR plan must provide that the identities of individual recipients...

  7. 16 CFR 1019.8 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 16 Commercial Practices 2 2010-01-01 2010-01-01 false Confidentiality. 1019.8 Section 1019.8 Commercial Practices CONSUMER PRODUCT SAFETY COMMISSION GENERAL EXPORT OF NONCOMPLYING, MISBRANDED, OR BANNED PRODUCTS Procedures for Export of Noncomplying, Misbranded, or Banned Products § 1019.8 Confidentiality. If...

  8. 42 CFR 456.413 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 4 2010-10-01 2010-10-01 false Confidentiality. 456.413 Section 456.413 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED...: Informational Requirements § 456.413 Confidentiality. The UR plan must provide that the identities of individual...

  9. 46 CFR 530.4 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 9 2010-10-01 2010-10-01 false Confidentiality. 530.4 Section 530.4 Shipping FEDERAL MARITIME COMMISSION REGULATIONS AFFECTING OCEAN SHIPPING IN FOREIGN COMMERCE SERVICE CONTRACTS General Provisions § 530.4 Confidentiality. All service contracts and amendments to service contracts filed with the...

  10. 40 CFR 750.16 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidentiality. 750.16 Section 750.16 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) TOXIC SUBSTANCES CONTROL ACT PROCEDURES... Manufacturing Exemptions § 750.16 Confidentiality. The Agency encourages the submission of nonconfidential...

  11. 8 CFR 1244.16 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 8 Aliens and Nationality 1 2010-01-01 2010-01-01 false Confidentiality. 1244.16 Section 1244.16 Aliens and Nationality EXECUTIVE OFFICE FOR IMMIGRATION REVIEW, DEPARTMENT OF JUSTICE IMMIGRATION REGULATIONS TEMPORARY PROTECTED STATUS FOR NATIONALS OF DESIGNATED STATES § 1244.16 Confidentiality. The...

  12. 18 CFR 270.506 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 18 Conservation of Power and Water Resources 1 2010-04-01 2010-04-01 false Confidentiality. 270.506 Section 270.506 Conservation of Power and Water Resources FEDERAL ENERGY REGULATORY COMMISSION... Commission Review of Jurisdictional Agency Determinations § 270.506 Confidentiality. (a) Except as provided...

  13. 15 CFR 701.5 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 15 Commerce and Foreign Trade 2 2010-01-01 2010-01-01 false Confidentiality. 701.5 Section 701.5 Commerce and Foreign Trade Regulations Relating to Commerce and Foreign Trade (Continued) BUREAU OF... FIRMS § 701.5 Confidentiality. (a) As provided by § 309(c) of the Defense Production Act of 1950, as...

  14. 46 CFR 550.104 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 9 2010-10-01 2010-10-01 false Confidentiality. 550.104 Section 550.104 Shipping FEDERAL MARITIME COMMISSION REGULATIONS AND ACTIONS TO ADDRESS RESTRICTIVE FOREIGN MARITIME PRACTICES... General Provisions § 550.104 Confidentiality. Notwithstanding any other law, the Commission may refuse to...

  15. 42 CFR 456.213 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 4 2010-10-01 2010-10-01 false Confidentiality. 456.213 Section 456.213 Public Health CENTERS FOR MEDICARE & MEDICAID SERVICES, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED...: Informational Requirements § 456.213 Confidentiality. The UR plan must provide that the identities of individual...

  16. 7 CFR 1280.634 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... 7 Agriculture 10 2012-01-01 2012-01-01 false Confidentiality. 1280.634 Section 1280.634 Agriculture Regulations of the Department of Agriculture (Continued) AGRICULTURAL MARKETING SERVICE (MARKETING... persons voting in the referendum and ballots shall be confidential and the contents of the ballots...

  17. 31 CFR 129.5 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 31 Money and Finance: Treasury 1 2013-07-01 2013-07-01 false Confidentiality. 129.5 Section 129.5 Money and Finance: Treasury Regulations Relating to Money and Finance MONETARY OFFICES, DEPARTMENT OF THE TREASURY PORTFOLIO INVESTMENT SURVEY REPORTING § 129.5 Confidentiality. (a) Information...

  18. 42 CFR 2.13 - Confidentiality restrictions.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... CONFIDENTIALITY OF ALCOHOL AND DRUG ABUSE PATIENT RECORDS General Provisions § 2.13 Confidentiality restrictions... place where only alcohol or drug abuse diagnosis, treatment, or referral is provided may be acknowledged... facility if the facility is not publicy identified as only an alcohol or drug abuse diagnosis, treatment...

  19. 5 CFR 2634.909 - Procedures, penalties, and ethics agreements.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... agreements. 2634.909 Section 2634.909 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS... Financial Disclosure Reports § 2634.909 Procedures, penalties, and ethics agreements. (a) The provisions of..., confidential disclosure reports filed under this subpart. (b) For penalties and remedial action which apply...

  20. 5 CFR 2634.909 - Procedures, penalties, and ethics agreements.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... agreements. 2634.909 Section 2634.909 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS... Financial Disclosure Reports § 2634.909 Procedures, penalties, and ethics agreements. (a) The provisions of..., confidential disclosure reports filed under this subpart. (b) For penalties and remedial action which apply...

  1. 5 CFR 2634.909 - Procedures, penalties, and ethics agreements.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ... agreements. 2634.909 Section 2634.909 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS... Financial Disclosure Reports § 2634.909 Procedures, penalties, and ethics agreements. (a) The provisions of..., confidential disclosure reports filed under this subpart. (b) For penalties and remedial action which apply...

  2. 5 CFR 2634.909 - Procedures, penalties, and ethics agreements.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... agreements. 2634.909 Section 2634.909 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS... Financial Disclosure Reports § 2634.909 Procedures, penalties, and ethics agreements. (a) The provisions of..., confidential disclosure reports filed under this subpart. (b) For penalties and remedial action which apply...

  3. 5 CFR 2634.909 - Procedures, penalties, and ethics agreements.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... agreements. 2634.909 Section 2634.909 Administrative Personnel OFFICE OF GOVERNMENT ETHICS GOVERNMENT ETHICS... Financial Disclosure Reports § 2634.909 Procedures, penalties, and ethics agreements. (a) The provisions of..., confidential disclosure reports filed under this subpart. (b) For penalties and remedial action which apply...

  4. Molecular functions and significance of the MTA family in hormone-independent cancer.

    PubMed

    Ning, Zhifeng; Gan, Jinfeng; Chen, Chaoying; Zhang, Dianzheng; Zhang, Hao

    2014-12-01

    The members of the metastasis-associated protein (MTA) family play pivotal roles in both physiological and pathophysiological processes, especially in cancer development and metastasis, and their role as master regulators has come to light. Due to the fact that they were first identified as crucial factors in estrogen receptor-mediated breast cancer metastasis, most of the early studies focused on their hormone-dependent functions. However, the accumulating evidence shows that the members of MTA family are deregulated in most, if not all, the cancers studied so far. Therefore, the levels as well as the activities of the MTA family members are widely accepted as potential biomarkers for diagnosis, prognosis, and predictors of overall survival. They function differently in different cancers with specific mechanisms. p53 and HIF-1α appear to be the respectively common upstream and downstream regulator of the MTA family in both development and metastasis of a wide spectrum of cancers. Here, we review the expression and clinical significance of the MTA family, focusing on hormone-independent cancers. To illustrate the molecular mechanisms, we analyze the MTA family-related signaling pathways in different cancers. Finally, targeting the MTA family directly or the pathways involved in the MTA family indirectly could be invaluable strategies in the development of cancer therapeutics.

  5. Dietary Pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer

    USDA-ARS?s Scientific Manuscript database

    Dietary nutrients with ability to reverse adverse epigenetic events have great potential for cancer chemoprevention. Overexpression of the epigenetic modifier metastasis-associated protein 1 (MTA1) is associated with aggressive human prostate cancer. The purpose of this study was to determine MTA1-d...

  6. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ..., including the provisions of § 90.619 relating to U.S./Canadian and U.S./Mexican border areas. (3) The MTA licensee limits its field strength at any location on the border of the MTA service area in accordance...

  7. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ..., including the provisions of § 90.619 relating to U.S./Canadian and U.S./Mexican border areas. (3) The MTA licensee limits its field strength at any location on the border of the MTA service area in accordance...

  8. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ..., including the provisions of § 90.619 relating to U.S./Canadian and U.S./Mexican border areas. (3) The MTA licensee limits its field strength at any location on the border of the MTA service area in accordance...

  9. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ..., including the provisions of § 90.619 relating to U.S./Canadian and U.S./Mexican border areas. (3) The MTA licensee limits its field strength at any location on the border of the MTA service area in accordance...

  10. 47 CFR 90.663 - MTA-based SMR system operations.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ..., including the provisions of § 90.619 relating to U.S./Canadian and U.S./Mexican border areas. (3) The MTA licensee limits its field strength at any location on the border of the MTA service area in accordance...

  11. MTA1, a transcriptional activator of breast cancer amplified sequence 3

    PubMed Central

    Gururaj, Anupama E.; Singh, Rajesh R.; Rayala, Suresh K.; Holm, Caroline; den Hollander, Petra; Zhang, Hao; Balasenthil, Seetharaman; Talukder, Amjad H.; Landberg, Goran; Kumar, Rakesh

    2006-01-01

    Here we define a function of metastasis-associated protein 1 (MTA1), a presumed corepressor of estrogen receptor α (ERα), as a transcriptional activator of Breast Cancer Amplified Sequence 3 (BCAS3), a gene amplified and overexpressed in breast cancers. We identified BCAS3 as a MTA1 chromatin target in a functional genomic screen. MTA1 stimulation of BCAS3 transcription required ERα and involved a functional ERE half-site in BCAS3. Furthermore, we discovered that MTA1 is acetylated on lysine 626, and that this acetylation is necessary for a productive transcriptional recruitment of RNA polymerase II complex to the BCAS3 enhancer sequence. BCAS3 expression was elevated in mammary tumors from MTA1 transgenic mice and 60% of the human breast tumors, and correlated with the coexpression of MTA1 as well as with tumor grade and proliferation of primary breast tumor samples. These findings reveal a previously unrecognized function of MTA1 in stimulating BCAS3 expression and suggest an important role for MTA1-BCAS3 pathway in promoting cancerous phenotypes in breast tumor cells. PMID:16617102

  12. MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.

    PubMed

    Singh, Rajesh R; Kumar, Rakesh

    2007-09-01

    Since breast cancer and its associated metastasis are a global health problem and a major cause of mortality among women, research efforts to understand the development, morphogenesis, and functioning of the mammary gland are a high priority. Myriad signaling pathways, transcription factors, and associated transcriptional coregulators have been identified in both normal functioning and neoplastic transformation of the mammary gland. The discovery of the metastasis tumor antigen 1 (MTA1) gene, its overexpression in cancer and metastasis and its subsequent identification as an integral part of the chromatin remodeling complex heralded extensive research on its physiological role. Subsequent identification of additional gene family members, namely MTA1s, MTA2, and MTA3, and their functions in the cell has resulted in the establishment of the significance of the MTA family. The role of these proteins in modulating hormonal responses in normal mammary glands and in breast cancer has resulted in their identification as important molecular markers and potential therapeutic targets.

  13. Sealing Ability of MTA Used in Perforation Repair of Permanent Teeth; Literature Review

    PubMed Central

    Baroudi, Kusai; Samir, Samah

    2016-01-01

    There were several materials used to seal different types of perforation defects. MTA is one of these restorative materials that is considered the most effective, biocompatible, non-toxic, and non-irritant; promote bone healing and cementum regeneration. The objective of this article was to review and summarize the sealing ability of MTA compared with the other materials used for sealing different types of root perforations of permanent teeth. A literature search was conducted using Medline, accessed via the National Library of Medicine Pub Med from 2005 to 2015 searching for articles related to sealing ability of MTA. This study found that factors affecting prognosis are the size, site of the perforation and time elapsed as well as the repair material. MTA is an important filling material to be used for sealing different types of perforations when perforated sites sealed immediately with MTA. PMID:27347231

  14. Sealing Ability of MTA Used in Perforation Repair of Permanent Teeth; Literature Review.

    PubMed

    Baroudi, Kusai; Samir, Samah

    2016-01-01

    There were several materials used to seal different types of perforation defects. MTA is one of these restorative materials that is considered the most effective, biocompatible, non-toxic, and non-irritant; promote bone healing and cementum regeneration. The objective of this article was to review and summarize the sealing ability of MTA compared with the other materials used for sealing different types of root perforations of permanent teeth. A literature search was conducted using Medline, accessed via the National Library of Medicine Pub Med from 2005 to 2015 searching for articles related to sealing ability of MTA. This study found that factors affecting prognosis are the size, site of the perforation and time elapsed as well as the repair material. MTA is an important filling material to be used for sealing different types of perforations when perforated sites sealed immediately with MTA.

  15. Sealing ability of ProRoot MTA and MTA-Angelus simulating a one-step apical barrier technique--an in vitro study.

    PubMed

    Lolayekar, Nikita; Bhat, Sham S; Hegde, Sundeep

    2009-01-01

    Endodontic treatment of the pulpless tooth with an immature root apex poses a special challenge for the clinician due to lack of an apical stop against which to compact an interim dressing of calcium hydroxide, or the final obturation material. A one-visit apexification protocol with MTA (Mineral Trioxide Aggregate) has be seen as an alternative to the traditional treatment practices with calcium hydroxide [Ca(OH)2]. The aim of this study was to investigate the use of MTA as a 5mm apical barrier by comparing sealing ability of ProRoot MTA to that of MTA-Angelus. 50 freshly extracted Maxillary and Mandibular single canal sound human incisor teeth were used in this study, which were decoronated to standardized 10mm root lengths. The root segments were prepared to simulate the clinical situation of an open apex with Gates Glidden burs # 51 and randomly assigned into 2 experimental groups of 20 samples each (Group A: ProRoot MTA, Group B: MTA-Angelus) and 10 root segments were used as control (Group C) where no apical barrier was used. After obturation the coronal portion of all samples were sealed with Glass Ionomer and stored at 37 degrees C and 100% humidity for 4 weeks. The root segments were then double coated with nail varnish except for the apical 1mm and apical ends of all root segments were suspended vertically in methylene blue dye for 48 hours at room temperature. After removal from the dye, the samples were sectioned longitudinally and linear dye penetration was measured using a Grid and stereomicroscope. The measurements were tabulated and statistically analyzed. The mean percentage of dye leakage for Group A was 55.5% and for Group B was 53.25%. The results showed no statistically significant difference in the sealing ability of ProRoot MTA and MTA-Angelus when used as apical barriers.

  16. 40 CFR 86.1116-87 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 19 2010-07-01 2010-07-01 false Treatment of confidential information... Vehicles, Including Light-Duty Trucks § 86.1116-87 Treatment of confidential information. (a) Any... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must...

  17. 40 CFR 86.1116-87 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 19 2011-07-01 2011-07-01 false Treatment of confidential information... Vehicles, Including Light-Duty Trucks § 86.1116-87 Treatment of confidential information. (a) Any... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany...

  18. 40 CFR 94.4 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Regulations for Compression-Ignition Marine Engines § 94.4 Treatment of confidential information. (a) Any... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany...

  19. 19 CFR 201.6 - Confidential business information.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 19 Customs Duties 3 2012-04-01 2012-04-01 false Confidential business information. 201.6 Section... Miscellaneous § 201.6 Confidential business information. (a) Definitions—(1) Confidential business information... “confidential business information” includes “proprietary information” within the meaning of section 777(b)...

  20. 29 CFR 90.33 - Confidential business information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... of information submitted in confidence. Business information which is to be treated as confidential... 29 Labor 1 2010-07-01 2010-07-01 true Confidential business information. 90.33 Section 90.33 Labor... General Provisions § 90.33 Confidential business information. (a) Definition. Confidential business...

  1. 40 CFR 82.182 - Confidentiality of data.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 17 2010-07-01 2010-07-01 false Confidentiality of data. 82.182... Confidentiality of data. (a) Clean Air Act provisions. Anyone submitting information must assert a claim of confidentiality at the time of submission for any data they wish to have treated as confidential business...

  2. 44 CFR 295.36 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 44 Emergency Management and Assistance 1 2010-10-01 2010-10-01 false Confidentiality of... § 295.36 Confidentiality of information. Confidential information submitted by individual Claimants is... the availability of confidentiality protection under exemptions to the Freedom of Information Act and...

  3. 19 CFR 201.6 - Confidential business information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 19 Customs Duties 3 2011-04-01 2011-04-01 false Confidential business information. 201.6 Section... Miscellaneous § 201.6 Confidential business information. (a) Definitions. (1) Confidential business information... “confidential business information” includes “proprietary information” within the meaning of section 777(b) of...

  4. 19 CFR 201.6 - Confidential business information.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 3 2013-04-01 2013-04-01 false Confidential business information. 201.6 Section... Miscellaneous § 201.6 Confidential business information. (a) Definitions—(1) Confidential business information... “confidential business information” includes “proprietary information” within the meaning of section 777(b) of...

  5. A defense of unqualified medical confidentiality.

    PubMed

    Kipnis, Kenneth

    2006-01-01

    It is broadly held that confidentiality may be breached when doing so can avert grave harm to a third party. This essay challenges the conventional wisdom. Neither legal duties, personal morality nor personal values are sufficient to ground professional obligations. A methodology is developed drawing on core professional values, the nature of professions, and the justification for distinct professional obligations. Though doctors have a professional obligation to prevent public peril, they do not honor it by breaching confidentiality. It is shown how the protective purpose to be furthered by reporting is defeated by the practice of reporting. Hence there is no conflict between confidentiality and the professional responsibility to protect endangered third parties.

  6. Ion release, porosity, solubility, and bioactivity of MTA Plus tricalcium silicate.

    PubMed

    Gandolfi, Maria Giovanna; Siboni, Francesco; Primus, Carolyn M; Prati, Carlo

    2014-10-01

    The aim of this study was to evaluate MTA Plus (Prevest Denpro Limited, Jammu, India, for Avalon Biomed Inc) material's properties, namely calcium release, the pH change, solubility, water sorption, porosity, surface morphology, and apatite-forming ability after immersion in simulated body fluid. Two tricalcium silicate powders (MTA Plus and ProRoot MTA; Dentsply Tulsa Specialties, Tulsa, OK) and Dycal (Dentsply Caulk, Milford, DE) were tested. After incubation at 37°C and 99% relative humidity, calcium and hydroxyl ion release were tested up to 28 days in deionized water at 37°C. Water absorption, interconnected pores, apparent porosity, and solubility were measured after 24 hours of immersion in deionized water at 37°C. The morphologic and elemental analysis of the materials' surfaces were examined using an environmental scanning electron microscope/energy dispersive x-ray analysis after storage at 37°C for 1-28 days in simulated body fluid using the ISO 23317 method. All 3 materials created an alkaline pH within 3 hours, which continued for 28 days. MTA Plus had a higher ion release than ProRoot MTA and Dycal; the use of the MTA Plus gel enhanced the initial calcium release and the increase of the pH. Both MTA materials were more porous, water soluble, and water sorptive than Dycal and more bioactive. After aging in simulated body fluid, MTA Plus material caused precipitation of an apparent calcium phosphate layer. MTA Plus showed improved reactivity and prolonged capability to release calcium and increase the local pH to alkaline values in comparison with ProRoot MTA. These pronounced ion-releasing properties are interlinked with its noticeable porosity, water sorption, and solubility and with the formation of calcium phosphorus minerals. The finer calcium silicate powder may explain the higher ion release, water sorption, porosity, and solubility of MTA Plus compared with ProRoot MTA. For clinicians, MTA Plus represents a lower-cost bioactive tricalcium

  7. What do Islamic institutional fatwas say about medical and research confidentiality and breach of confidentiality?

    PubMed

    Alahmad, Ghiath; Dierickx, Kris

    2012-08-01

    Protecting confidentiality is an essential value in all human relationships, no less in medical practice and research.(1) Doctor-patient and researcher-participant relationships are built on trust and on the understanding those patients' secrets will not be disclosed.(2) However, this confidentiality can be breached in some situations where it is necessary to meet a strong conflicting duty.(3) Confidentiality, in a general sense, has received much interest in Islamic resources including the Qur'an, Sunnah and juristic writings. However, medical and research confidentiality have not been explored deeply. There are few fatwas about the issue, despite an increased effort by both individuals and Islamic medical organizations to use these institutional fatwas in their research. Infringements on confidentiality make up a significant portion of institutional fatwas, yet they have never been thoroughly investigated. Moreover, the efforts of organizations and authors in this regard still require further exploration, especially on the issue of research confidentiality. In this article, we explore medical and research confidentiality and potential conflicts with this practice as a result of fatwas released by international, regional, and national Islamic Sunni juristic councils. We discuss how these fatwas affect research and publication by Muslim doctors, researchers, and Islamic medical organizations. We argue that more specialized fatwas are needed to clarify Islamic juristic views about medical and research confidentiality, especially the circumstances in which infringements on this confidentiality are justified.

  8. Comparative SEM study of the marginal adaptation of white and grey MTA and Portland cement.

    PubMed

    Bidar, Maryam; Moradi, Saeed; Jafarzadeh, Hamid; Bidad, Salma

    2007-04-01

    The use of a suitable substance that prevents egress of potential contaminants into the periapical tissues is important in endodontic surgery. The aim of the present study was to compare the marginal adaptation of three root-end filling materials (white mineral trioxide aggregate (MTA), grey MTA and Portland cement), using scanning electron microscopy. Seventy-five single-rooted extracted human teeth were used. The canals were instrumented and filled with gutta-percha. Following root-end resection and cavity preparation, root-end cavities were filled with white MTA, grey MTA or Portland cement. Using a diamond saw, roots were longitudinally sectioned into two halves. Under scanning electron microscopy, the gaps between the material and dentinal wall were measured. The data were analysed using Kruskal-Wallis test. The mean of the gap in grey MTA, white MTA and Portland cement was 211.6, 349 and 326.3 microm, respectively. The results indicate that the gap between grey MTA and the dentinal wall is less than other materials, but there was no significant difference between the materials tested in this study (P > 0.05).

  9. The effect of MTA application on the affected dentine remineralization after partial caries excavation (in vivo)

    NASA Astrophysics Data System (ADS)

    Pratiwi, A. R.; Meidyawati, R.; Djauharie, N.

    2017-08-01

    On deep carious lesions, only thin dentine remains, causing a high risk of pulp exposure during the removal of all infected dentine. A minimally invasive technique is required, such as a partial caries excavation method in the infected dentine tissue and the use of bioactive material that can promote (Mineral Trioxide Aggregate) MTA remineralization. To compare the remineralization of deep carious lesion-affected dentine with the removal of some and all the infected dentine after the application of MTA. Subjects were divided into two groups: group I had only some parts of the infected dentine removed before MTA application, while group II had all the infected dentine removed before MTA application. Each group was measured on the pixel grey value before the treatment and again four weeks after the MTA application, and then the results were compared. Furthermore, the enhancement of both groups’ grey values were compared. Remineralization occurred in both groups after the MTA application. There was no significant difference in the remineralization level of the affected dentine in both groups I and II four weeks after the MTA application. Remineralization occurred in the affected dentine in both groups, either by removing only some parts or all the infected dentine in the deep carious lesion.

  10. 40 CFR 710.58 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... linkage of the site with a reportable chemical is confidential and not publicly available. The following... Material Safety Data Sheet (MSDS)? If so, identify all such schemes. Was the linkage claimed...

  11. Law and ethics in conflict over confidentiality?

    PubMed

    Dickens, B M; Cook, R J

    2000-09-01

    Ethical principles that require the preservation of patients' confidential information are reinforced by principles found in several areas of law, such as law on contracts, negligence, defamation and fiduciary duty. However, laws sometimes compel disclosures of medical confidences, and more often may justify or excuse disclosures. Legally contentious issues concern patients' confidences regarding possible unlawful conduct, such as pregnancy termination, and the risk of spread of HIV and other infections. This article reviews the various legal bases of the duty of confidentiality, and legal challenges to the ethical obligation of non-disclosure. It addresses the justifications and limits of exchange of patients' health information among healthcare professionals and trainees, and considers legally recognized limits of confidential duties, and the scope of legitimate disclosure. An underlying theme is how to determine whether physicians are ethically justified in employing the discretion the law sometimes affords them to breach patients' expectations of confidentiality.

  12. 7 CFR 1205.209 - Confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... Procedures for the Conduct of Referenda in Connection With Cotton Research and Promotion Order § 1205.209... furnished to, compiled by, or in the possession of the referendum agent shall be regarded as confidential...

  13. 7 CFR 1217.107 - Confidential information.

    Code of Federal Regulations, 2014 CFR

    2014-01-01

    ..., PROMOTION, CONSUMER EDUCATION AND INDUSTRY INFORMATION ORDER Referendum Procedures § 1217.107 Confidential information. The ballots and other information or reports that reveal, or tend to reveal, the vote of any...

  14. 40 CFR 707.75 - Confidentiality.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ...”, or “trade secret”. (c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will disclose...

  15. 40 CFR 707.75 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ...”, or “trade secret”. (c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will disclose...

  16. 40 CFR 707.75 - Confidentiality.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ...”, or “trade secret”. (c) Notwithstanding any claim of confidentiality, information outlined in § 707.70 will be included in the EPA notice to the foreign government. With this exception, EPA will disclose...

  17. Biosafety data as confidential business information.

    PubMed

    Nielsen, Kaare M

    2013-01-01

    Removal of confidentiality claims on biosafety data is necessary to adhere to standard scientific procedures of quality assurance, to increase transparency, to minimize impacts of conflicts of interests, and ultimately to improve public confidence in GMOs.

  18. 42 CFR 51c.110 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... not be divulged without the individual's consent except as may be required by law or as may be... designee with appropriate safeguards for confidentiality of patient records. Otherwise, information may...

  19. 42 CFR 56.111 - Confidentiality.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... not be divulged without the individual's consent except as may be required by law or as may be... designee with appropriate safeguards for confidentiality of patient records. Otherwise, information may...

  20. 42 CFR 56.111 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... not be divulged without the individual's consent except as may be required by law or as may be... designee with appropriate safeguards for confidentiality of patient records. Otherwise, information may...

  1. 42 CFR 51c.110 - Confidentiality.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... not be divulged without the individual's consent except as may be required by law or as may be... designee with appropriate safeguards for confidentiality of patient records. Otherwise, information may...

  2. Medical confidentiality and the competent patient.

    PubMed

    Niveau, Gerard; Burkhardt, Sandra; Chiesa, Sarah

    2013-11-01

    Confidentiality is both a fundamental principle of medical ethics and a legal obligation. In exceptional situations not covered by legal provisions, doctors may want to waive confidentiality against the wishes of the patient. Swiss law calls for an authority to rule on such cases. In the Canton of Geneva this authority is the Commission for Professional Confidentiality. This paper concerns 41 cases managed by this commission. The study shows that the majority of these requests to the Commission concern the reporting of patients who are not incompetent but need the protection of a legal guardianship. In rare cases, there is another interest higher than confidentiality: public order or functioning of justice. The Commission found that the measure requested was justified in the majority of cases brought before it. This study focuses on exceptional cases but it throws into relief the conflict between the principle of autonomy on the one hand and the need for patient protection and social justice on the other.

  3. 40 CFR 790.7 - Confidentiality.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... words “confidential business information,” “trade secret,” or another appropriate phrase indicating its... processes used in the manufacture or processing of a chemical substance or mixture? Describe how this...

  4. The sealing ability of MTA apical plugs exposed to a phosphate-buffered saline

    PubMed Central

    de ALMEIDA, Josiane; ALVES, Ana Maria Hecke; de MELO, Roberto Ferreira; FELIPPE, Mara Cristina Santos; BORTOLUZZI, Eduardo Antunes; TEIXEIRA, Cleonice da Silveira; FELIPPE, Wilson Tadeu

    2013-01-01

    Objective The aim of this study was to evaluate the influence of exposure of the mineral trioxide aggregate (MTA) - with and without calcium chloride (CaCl2) - to phosphate-buffered saline (PBS) on the apical microleakage using a glucose leakage system. Material and Methods Sixty root segments were randomly divided into 4 experimental groups (n=15). After resecting the apical segments and enlarging the canals with Gates-Glidden drills, the apical cavities were filled with MTA with or without CaCl2 and the root canals were dressed with a moistened cotton pellet or PBS, as follows: 1) MTA/cotton pellet; 2) MTA/PBS; 3) MTA+10%CaCl2/cotton pellet; 4) MTA+10%CaCl2/PBS. All root segments were introduced in floral foams moistened with PBS. After 2 months, all root segments were prepared to evaluate the glucose leakage along the apical plugs. The amount of glucose leakage was measured following an enzymatic reaction and quantified by a spectrophotometer. Four roots were used as controls. The data were analyzed using Kruskal-Wallis and Mann-Whitney tests (p<0.05). Results There were no differences between groups 1 and 2 (p>0.05), and 3 and 4 (p>0.05). The addition of CaCl2 to the MTA significantly decreased its sealing ability (p<0.05). Conclusion The interaction with PBS did not improve the MTA sealing ability. The addition of CaCl2 to the MTA negatively influenced the apical seal. PMID:24037073

  5. Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator*

    PubMed Central

    Bui-Nguyen, Tri M.; Pakala, Suresh B.; Sirigiri, Divijendranatha Reddy; Martin, Emil; Murad, Ferid; Kumar, Rakesh

    2010-01-01

    Nitric oxide has been implicated in the pathogenesis of inflammatory disorders, including hepatitis B virus-associated hepatocellular carcinoma. Transactivator protein HBx, a major regulator of cellular responses of hepatitis B virus, is known to induce the expression of MTA1 (metastasis-associated protein 1) coregulator via NF-κB signaling in hepatic cells. However, the underlying mechanism of HBx regulation of the inducible nitric-oxide synthase (iNOS) pathway remains unknown. Here we provide evidence that MTA1 is a positive regulator of iNOS transcription and plays a mechanistic role in HBx stimulation of iNOS expression and activity. We found that the HBx-MTA1 complex is recruited onto the human iNOS promoter in an NF-κB-dependent manner. Pharmacological inhibition of the NF-κB signaling prevented the ability of HBx to stimulate the transcription, the expression, and the activity of iNOS; nevertheless, these effects could be substantially rescued by MTA1 dysregulation. We further discovered that HBx-mediated stimulation of MTA1 is paralleled by the suppression of miR-661, a member of the small noncoding RNAs, recently shown to target MTA1. We observed that miR-661 controls of MTA1 expression contributed to the expression and activity of iNOS in HBx-expressing HepG2 cells. Accordingly, depletion of MTA1 by either miR-661 or siRNA in HBx-expressing cells severely impaired the ability of HBx to modulate the endogenous levels of iNOS and nitrite production. Together, these findings reveal an inherent role of MTA1 in HBx regulation of iNOS expression and consequently its function in the liver cancer cells. PMID:20022949

  6. Protecting Respondent Confidentiality in Qualitative Research

    PubMed Central

    Kaiser, Karen

    2009-01-01

    For qualitative researchers, maintaining respondent confidentiality while presenting rich, detailed accounts of social life presents unique challenges. These challenges are not adequately addressed in the literature on research ethics and research methods. Using an example from a study of breast cancer survivors, I argue that by carefully considering the audience for one’s research and by re-envisioning the informed consent process, qualitative researchers can avoid confidentiality dilemmas that might otherwise lead them not to report rich, detailed data. PMID:19843971

  7. Conditional shared confidentiality in mental health care.

    PubMed

    Liégeois, Axel; Eneman, Marc

    2015-05-01

    Because of the development towards community care, care providers not only exchange information in a team, but increasingly also in networks. This is a challenge to confidentiality. The ethical question is how care providers can keep information about the care receiver confidential, whilst at the same time exchanging information about that care receiver in a team or network? Can shared confidentiality be extended from a team to a network? To clarify this question, the article refers to the advice of an expert ethics committee in mental health care. The advice regards exchange of information in a network as a further step in enhancing collaboration among care providers. Therefore, the good and evident practice of shared confidentiality in a team can be extended to a network if the same conditions are met. First, the care providers participate in a clearly defined and identifiable team or network. Secondly, they have a shared care responsibility. Thirdly, they have a duty of confidentiality. Fourth, they dialogue with the care receiver and obtain his or her consent. Finally, they apply the filter of relevance. Hence, conditional shared confidentiality is an ethical justification for the exchange of information in a team or network.

  8. Proposal for high pressure RF cavity test in the MTA

    SciTech Connect

    Yonehara, K.; /Fermilab

    2010-09-01

    In order to demonstrate the feasibility of high pressure hydrogen gas filled RF (HPRF) cavities for muon ionization cooling, an HPRF cavity must be tested with a high intensity charged beam. When an HPRF cavity is irradiated with an intense beam each incident particle generates about 1000 electrons and ions per cubic centimeter in a high pressure cavity via ionization. These ionization electrons are influenced by the RF field and the RF quality factor goes down. This Q factor reduction will be a problem with a multi bunch beam, e.g., a muon beam for a muon collider consists of a 12 to 20 bunch train beam with 5 ns timing gap. Thus, the RF field must recover in few nano seconds. We propose to use a 400 MeV proton beam in the MTA and measure a beam loading effect in the HPRF cavity and study the recovery mechanism of the RF field.

  9. Comparison of sealing ability of ProRoot MTA, RetroMTA, and Biodentine as furcation repair materials: An ultraviolet spectrophotometric analysis

    PubMed Central

    Sinkar, Roshan Chandrakant; Patil, Sanjay S; Jogad, Nitin P; Gade, Vandana J

    2015-01-01

    Aim: To evaluate the sealing ability of ProRooT MTA, RetroMTA, and Biodentine as furcation repair materials using dye extraction leakage method. Materials and Methods: Thirty-five mandibular molars were randomly divided into four groups according to the material used for perforation repair. Group I — ProRoot MTA (10 samples), Group II — RetroMTA (10 samples), Group III — Biodentine (10 samples), and Group IV (Control) — left unrepaired (5 samples). All samples were subjected to orthograde and retrograde Methylene blue dye challenge followed by dye extraction with concentration 65% nitric acid. Samples were then analyzed using ultraviolet-visible spectrophotometer using 550 nm wave lengths. Statistical Analysis: One-way analysis of variance, Tukey-Kramer multiple comparisons test. Results: Biodentine showed least dye absorbance while RetroMTA showed highest dye absorbance values when compared with other repair materials. Conclusion: Within the limitations of this study, it was observed that Biodentine showed better sealing ability when compared with other root repair materials. PMID:26752836

  10. Autonomy and confidentiality: patients' perspectives.

    PubMed

    Abdalrahman, Ihab Babiker; Osman, Ahmed Mohammed Abdulrahman; Ali, Baraah Mohammed Adham; Mustafa, El Imam ElGhazali Seddik Mohamed; Ali, Eman Esam Hassan; Muneer, Mohamed Siddig Eltayeb

    2015-04-01

    Little is known about patients' opinions about their rights in autonomy and confidentiality concerning their illness and this study was conducted to assess it. This multi-centred, cross-sectional study was conducted in outpatient clinics in Khartoum, Sudan. It was delivered to 295 respondents. Data were managed using Microsoft Excel 2010 and SPSS. Eighty-five percent of the patients wanted to know about their conditions, of whom 17% wanted to choose their treatment and 29% believed they had the right to refuse treatment. Most of the respondents would not wish to hide information from their doctors. There was a wide variation at the rate of patients hiding information from their relatives, depending on their diagnosis (HIV 90%, malignancy 16.7% and tuberculosis 0%.) Respondents want to choose their treating doctor, know about their diseases, be consulted before a procedure. They would like to leave technical issues to their treating doctors without jeopardising their own rights. © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

  11. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 13 Business Credit and Assistance 1 2010-01-01 2010-01-01 false Confidentiality of Reports, Risk Ratings and related Confidential Information. 120.1060 Section 120.1060 Business Credit and Assistance SMALL BUSINESS ADMINISTRATION BUSINESS LOANS Risk-Based Lender Oversight Supervision §...

  12. Confidentiality and access to sexual health services.

    PubMed

    Ryder, Nathan; McNulty, Anna M

    2009-06-01

    Confidentiality concerns are often described as barriers to seeking sexual health care. There has been little research describing the relative importance of confidentiality to clients of sexual health clinics, and whether members of high-risk groups have greater concerns. This study aimed to determine the importance of confidentiality and anonymity to clients of a public sexual health clinic, and determine associations with gender and sexuality. A self-administered questionnaire was offered to consecutive new English-speaking clients in October and November 2007. Participants were asked to describe the reasons for presenting, likelihood of disclosing identifying information, and concern should specific people and agencies become aware of their attendance. Of 350 eligible clients, 270 (77%) participated in the survey. Expert care was included in the top three reasons for choosing a sexual health clinic rather than a general practitioner by over half of participants, while confidentiality and cost were each included in the top three reasons by one-third of respondents respectively. Over 90% of clients reported they were likely to give accurate identifying information to the clinic. Participants were comfortable with disclosure of information to other health-care workers but became increasingly unwilling for information to be shared with services not directly involved in their care. Overall there were few associations with gender or sexuality. Clients choose to attend our clinic for a variety of reasons, with confidentiality and anonymity being of lesser importance than competence and cost. Confidentiality is important to the majority of clients, whereas few desire anonymity. Most clients would accept information being shared with other health services, suggesting that confidentiality may not be a barrier to the use of electronic health records in sexual health clinics.

  13. [Cytotoxicity of MTA, Dycal and GIC on human periodontal ligament cells in vitro].

    PubMed

    Xia, Lie; Jiang, Long; Zhu, Ya-qin

    2007-12-01

    To compare the cytotoxicity of three endodontic materials (MTA, Dycal and GIC) on human periodontal ligament cells (HPDLCs) in vitro. HPDLCs proliferation was evaluated using methylthiazol tetrazolium (MTT) assay for three endodontic materials in different concentration. SAS6.12 software package was used to analyse the results. There was no statistically significant difference in three subgroups of MTA group (P>0.05). Statistically significant differences were found in Dycal group (P<0.05). In GIC group, there was no statistically significant difference between the control and 10 mg/ml subgroup (P>0.05). At the same time, statistically significant differences were found in between the control and 20 mg/ml or 40 mg/ml subgroup (P<0.05). Dycal and GIC are more cytotoxic than MTA. MTA is superior to Dycal and GIC in biocompatibility.

  14. Outcomes of MTA as root-end filling in endodontic surgery: a systematic review.

    PubMed

    Tang, Yin; Li, Xiaoting; Yin, Shihai

    2010-01-01

    To compare the clinical outcomes of mineral trioxide aggregate (MTA) used as root-end filling with other materials in endodontic surgery to determine which modality offers more favorable outcomes. A computerized literature search was performed in the Cochrane Library (1993-2009), MEDLINE (1993-2009), EMBASE (1993-2009), Science Citation Index (SCI) (1993-2009), Chinese Biomedicine Database (1993-2009), and China National Knowledge Infrastructure (CNKI) (1993-2009) to collect randomized controlled trials and quasi-controlled trials comparing MTA with other materials or placebo. The Cochrane Collaboration's RevMan5 software was used for data analysis. Five studies involving MTA and three other materials were included. No statistically significant difference was found in the clinical effectiveness of MTA and intermediate restorative material (IRM), with relative risk (RR) 0.62 and 95% CI 0.34 to 1.16. A statistically significant difference exists between MTA and amalgam in terms of outcome, with RR 0.35 and 95% CI 0.13 to 0.94. The difference between the gutta-percha and the MTA groups was statistically significant, with RR 0.08 and 95% CI 0.01 to 0.57. MTA as root-end filling is better than amalgam and purely gutta-percha but similar to IRM. There is a limited number of well-designed clinical trials within this research area. Further high-quality, large-scale, and long-term follow-up randomized controlled trials are still required to confirm the long-term outcomes of MTA as root-end filling in endodontic surgery.

  15. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.

    PubMed

    Zeng, Heng; Zhang, Jin-Ming; Du, Yu; Wang, Jiang; Ren, Ye; Li, Mi; Li, Hao; Cai, Zhuo; Chu, Qian; Yang, Caihong

    2016-02-09

    The stress response gene activating transcription factor 4 (ATF4) is involved in metastatic behavior and cellular protection. Here we show that ATF4 is upregulated in osteosarcoma (OS) cell lines and patient clinical samples as compared to matched non-tumor tissue. Overexpression of ATF4 in OS cells promoted cell proliferation, migration and lung metastasis. Furthermore, the expression of ATF4 was markedly reduced in metastasis associated protein (MTA1) or histone deacetylase 1 (HDAC1) knockdown OS cells, but MTA1 overexpression increased the stability and activity of ATF4 protein via ATF4 deacetylation by HDAC1. ATF4 in turn enhanced the expression of MTA1 and HDAC1 at the transcription level, suggesting a positive feedback loop between ATF4 and MTA1/HDAC1. Clinically, the level of ATF4 was positively correlated with that of MTA1 in OS. Mice injected with ATF4-overexpressing cells exhibited a higher rate of tumor growth, and the average weight of these tumors was ~90% greater than the controls. Taken together, these data establish a direct correlation between ATF4-induced OS progression and MTA1/HDAC1-associated metastasis, and support the potential therapeutic value of targeting ATF4 in the treatment of OS.

  16. Comparison of Skin Reaction between MTA (Produced in Iran) and CEM in Rabbit.

    PubMed

    Shokravi, Marziyeh; Tabarsi, Bahareh; Moghaddamnia, Aliakbar; Sohanfaraji, Alieh; Pourghasem, Mohsen

    2012-01-01

    Pathological changes in pulp and periapical tissues are addressed by endodontic treatment. The material used in this treatment must be biocompatible. The aim of this study is to compare the skin reaction of Calcium Enriched Mixture (CEM) and Mineral Trioxide Aggregate (MTA) produced in Iran on rabbit. Sixteen male newzeland albino rabbits weighting 2 kg were used. The animals back hair was shaved, 24 hours before application of each material. The material was applied on two sites (2 × 2 cm) while the third site was used as control. All sites were covered by gauze and bandaged for 4 hours. Then the material's remnants were washed off the sites of application. Observations were performed in 1, 24, 48 and 72 hours after removing the materials. Erythematous surface areas were measured by the morphometric method. After sacrificing animals the skins were dissected and the specimens were prepared for histological evaluation. There were significant differences between CEM and MTA in erythematous surface areas at 1, 24 and 48 hours after removing the materials (p<0.05). However there was no significant difference at 72 hours after removing the materials. Data showed significant differences in counted cells between MTA and control sample (p=0.0001) and between MTA and CEM (p=0.035). There was no significant difference between control and CEM (p>0.05). The average erythematous surface areas were wider in MTA sites than CEM sites. As a conclusion it seems that biocompatibility of CEM could be more than MTA.

  17. Comparison of Skin Reaction between MTA (Produced in Iran) and CEM in Rabbit

    PubMed Central

    Shokravi, Marziyeh; Tabarsi, Bahareh; Moghaddamnia, Aliakbar; Sohanfaraji, Alieh; Pourghasem, Mohsen

    2012-01-01

    Pathological changes in pulp and periapical tissues are addressed by endodontic treatment. The material used in this treatment must be biocompatible. The aim of this study is to compare the skin reaction of Calcium Enriched Mixture (CEM) and Mineral Trioxide Aggregate (MTA) produced in Iran on rabbit. Sixteen male newzeland albino rabbits weighting 2 kg were used. The animals back hair was shaved, 24 hours before application of each material. The material was applied on two sites (2 × 2 cm) while the third site was used as control. All sites were covered by gauze and bandaged for 4 hours. Then the material's remnants were washed off the sites of application. Observations were performed in 1, 24, 48 and 72 hours after removing the materials. Erythematous surface areas were measured by the morphometric method. After sacrificing animals the skins were dissected and the specimens were prepared for histological evaluation. There were significant differences between CEM and MTA in erythematous surface areas at 1, 24 and 48 hours after removing the materials (p<0.05). However there was no significant difference at 72 hours after removing the materials. Data showed significant differences in counted cells between MTA and control sample (p=0.0001) and between MTA and CEM (p=0.035). There was no significant difference between control and CEM (p>0.05). The average erythematous surface areas were wider in MTA sites than CEM sites. As a conclusion it seems that biocompatibility of CEM could be more than MTA. PMID:24551764

  18. Endodontic Surgery of a Symptomatic Overfilled MTA Apical Plug: A Histological and Clinical Case Report.

    PubMed

    Asgary, Saeed; Fayazi, Sara

    2017-01-01

    This case report presents the successful surgical treatment of a symptomatic open apex upper central incisor with a failed overfilled mineral trioxide aggregate (MTA) apical plug. Unintentional overextension of the MTA had occurred two years before the initial visit. An apical lesion adjacent to the excess MTA was radiographically detectable. Endodontic surgery was performed using calcium-enriched mixture (CEM) cement as a root-end filling material. Curettage of the apical lesion showed a mass of unset MTA particles; histopathological examination revealed fragments of MTA and granulation tissues. Up to 18-month follow-up, the tooth was clinically asymptomatic and fully functional. Periapical radiograph and CBCT images showed a normal periodontal ligament around the root. In conclusion, favorable outcomes in this case study suggested that root-end filling with CEM cement might be an appropriate approach; in addition, however many factors probably related to the initial failure of the case, the extrusion of MTA into the periapical area should be avoided.

  19. Endodontic Surgery of a Symptomatic Overfilled MTA Apical Plug: A Histological and Clinical Case Report

    PubMed Central

    Asgary, Saeed; Fayazi, Sara

    2017-01-01

    This case report presents the successful surgical treatment of a symptomatic open apex upper central incisor with a failed overfilled mineral trioxide aggregate (MTA) apical plug. Unintentional overextension of the MTA had occurred two years before the initial visit. An apical lesion adjacent to the excess MTA was radiographically detectable. Endodontic surgery was performed using calcium-enriched mixture (CEM) cement as a root-end filling material. Curettage of the apical lesion showed a mass of unset MTA particles; histopathological examination revealed fragments of MTA and granulation tissues. Up to 18-month follow-up, the tooth was clinically asymptomatic and fully functional. Periapical radiograph and CBCT images showed a normal periodontal ligament around the root. In conclusion, favorable outcomes in this case study suggested that root-end filling with CEM cement might be an appropriate approach; in addition, however many factors probably related to the initial failure of the case, the extrusion of MTA into the periapical area should be avoided. PMID:28808469

  20. In vitro toxicity of formocresol, ferric sulphate, and grey MTA on human periodontal ligament fibroblasts.

    PubMed

    Al-Haj Ali, S N; Al-Jundi, S H; Ditto, D J

    2015-02-01

    This was to assess and compare the in vitro toxicity of formocresol, ferric sulphate and MTA on cultured human periodontal ligament (PDL) fibroblasts. PDL cells were obtained from sound first permanent molars and cultured in Dulbecco's modified Eagle's medium. PDL cells were subjected to different concentrations of formocresol, ferric sulphate, and grey MTA for 24, 48, and 72 h at 37 °C. Cells that were not exposed to the tested materials served as the negative control. In vitro toxicity was assessed using MTT assay. Statistical analysis of data was accomplished using ANOVA and Tukey statistical tests (p<0.05). The overall toxicity ranking of the tested materials was as follows: formocresol>ferric sulphate>grey MTA. Only grey MTA had comparable cell viability to the negative control, the other tested materials were significantly inferior at the three exposure periods (p<0.05). Regarding the viability of PDL fibroblasts, MTA stands as the most promising substitute to formocresol. However, considering MTA's unavailability and high price in Jordan, ferric sulphate may be the best alternative to formocresol in pulpotomy of primary teeth.

  1. Long-Term Cytotoxicity, pH and Dissolution Rate of AH Plus and MTA Fillapex.

    PubMed

    Silva, Emmanuel João Nogueira Leal da; Accorsi-Mendonça, Thais; Pedrosa, Ana Carolina; Granjeiro, José Mauro; Zaia, Alexandre A

    2016-01-01

    The aim of the present study was to verify the long-term cytotoxic effects of the MTA Fillapex and to compare them with AH Plus. Dissolution rate and pH were also evaluated. Human osteoblast cells were incubated with elutes of fresh specimens from AH Plus and MTA Fillapex, and with elutes of the same specimens for 4 successive weeks. Elute's pH was evaluated at each time point. A multiparametric cell viability assay was performed. For dissolution rate, ISO methodology was used. The results were analyzed by one-way analysis of variance, complemented with the Tukey post-test (p<0.05). No significant difference was found among the materials when fresh mixed (p>0.05). After 1 week, AH Plus became non-cytotoxic on all three evaluated parameters. Conversely, MTA Fillapex remained severely and mildly cytotoxic over the entire experimental period (p<0.05). The dissolution rate of AH Plus was significantly lower than MTA Fillapex at all time points (p>0.05). The pH of AH Plus was significantly lower than MTA Fillapex at the second and third week (p<0.05). In the other tested time points no statistical difference was observed. In conclusion, MTA Fillapex remained cytotoxic after 4 weeks and its cytotoxicity may be related to the high dissolution rate of this material.

  2. 12 CFR 346.6 - Disclosure of covered agreements.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... agreement available to any individual or entity upon request. (2) Nondisclosure of confidential and... entity under paragraph (b)(1) of this section, a NGEP, insured depository institution, or affiliate may.... 552 et seq.) (FOIA). (3) Information that must be disclosed. Notwithstanding paragraph (b)(2) of this...

  3. 36 CFR 290.4 - Confidentiality of cave location information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... AGRICULTURE CAVE RESOURCES MANAGEMENT § 290.4 Confidentiality of cave location information. (a) Information... harm, theft, or destruction to cave resources. (b) Requesting confidential information. Notwithstanding... Federal or State governmental agencies, bona fide educational or research institutes, or individuals...

  4. 46 CFR 221.79 - Request for confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... information is— (1) Confidential financial information, trade secrets, or other material exempt from....C. 1905; or (3) Otherwise exempt by law from disclosure. (b) The Person desiring confidential...

  5. 46 CFR 221.79 - Request for confidential treatment.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... information is— (1) Confidential financial information, trade secrets, or other material exempt from....C. 1905; or (3) Otherwise exempt by law from disclosure. (b) The Person desiring confidential...

  6. 46 CFR 221.79 - Request for confidential treatment.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... information is— (1) Confidential financial information, trade secrets, or other material exempt from....C. 1905; or (3) Otherwise exempt by law from disclosure. (b) The Person desiring confidential...

  7. 40 CFR 85.1514 - Treatment of confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... all confidential information has been deleted. If a need arises to publicly release nonconfidential information, EPA will assume that the submitter has accurately deleted the confidential information from this...

  8. 40 CFR 85.1909 - Treatment of confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... all confidential information has been deleted. If a need arises to publicly release nonconfidential information, EPA will assume that the submitter has accurately deleted all confidential information from this...

  9. 29 CFR 90.33 - Confidential business information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... person and are privileged or confidential, as set forth in 5 U.S.C. 552(b) and 29 CFR part 70. (b... confidential shall be submitted on separate sheets each clearly marked at the top, “Business...

  10. The History of Confidentiality in Medicine

    PubMed Central

    Higgins, Gerald L.

    1989-01-01

    The author of this article reviews the history of the confidentiality of medical information relating to patients from its roots in the Hippocratic Oath to the current codes of medical ethics. There has been an important shift in the basis for the demand for confidentiality, from a physician-based commitment to a professional ideal that will improve the physician-patient relationship and thus the physician's therapeutic effectiveness, and replace it with a patientbased right arising from individual autonomy instead of a Hippocratic paternalistic privilege. PMID:11650274

  11. Advanced technology and confidentiality in hand surgery.

    PubMed

    Naam, Nash H; Sanbar, Sandy

    2015-01-01

    Advanced technology has the potential to improve the quality of care for our patients, but it also poses new challenges, especially in maintaining patient confidentiality. The Health Insurance Portability and Accountability Act and the newly enacted Health Information Technology for Economic and Clinical Health Act provide certain guidelines governing patients' medical record confidentiality. This article discusses the other new challenges facing hand surgeons, such as the use of social media, telemedicine, e-mails, and the Internet. Copyright © 2015 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

  12. Confidentiality in crisis: Part I--The duty to inform.

    PubMed

    Glancy, G D; Regehr, C; Bryant, A G

    1998-12-01

    To discuss the ethical and legal imperatives to protect third parties from harm in circumstances often believed to be protected by doctor-patient confidentiality. A review of recent legislative changes and legal decisions pertaining to a psychiatrist's duty to warn. The current legislative and legal climate presents many risks to the concept of doctor-patient confidentiality. Psychiatrists must carefully consider any guarantees of confidentiality made to patients and must discuss the limits of confidentiality when obtaining consent for treatment.

  13. 40 CFR 2.206 - Advance confidentiality determinations.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 1 2010-07-01 2010-07-01 false Advance confidentiality determinations. 2.206 Section 2.206 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY GENERAL PUBLIC INFORMATION Confidentiality of Business Information § 2.206 Advance confidentiality determinations. (a)...

  14. 40 CFR 2.206 - Advance confidentiality determinations.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 1 2011-07-01 2011-07-01 false Advance confidentiality determinations. 2.206 Section 2.206 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY GENERAL PUBLIC INFORMATION Confidentiality of Business Information § 2.206 Advance confidentiality determinations. (a)...

  15. 40 CFR 86.615-84 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 19 2010-07-01 2010-07-01 false Treatment of confidential information....615-84 Treatment of confidential information. (a) Any manufacturer may assert that some or all of the information submitted pursuant to this subpart is entitled to confidential treatment as provided by 40...

  16. 40 CFR 85.1909 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 18 2010-07-01 2010-07-01 false Treatment of confidential information... § 85.1909 Treatment of confidential information. (a) Any manufacturer may assert that some or all of the information submitted pursuant to this subpart is entitled to confidential treatment as...

  17. 77 FR 15286 - Confidential Treatment of Privileged Information

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-15

    ...; ] BUREAU OF CONSUMER FINANCIAL PROTECTION 12 CFR Part 1070 RIN 3170-AA20 Confidential Treatment of... confidential treatment of information obtained from persons in connection with its exercise of authorities... rules regarding the confidential treatment of information obtained from persons in connection with...

  18. 40 CFR 85.1415 - Treatment of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 18 2010-07-01 2010-07-01 false Treatment of confidential information... Treatment of confidential information. (a) Any certifier may assert that some or all of the information submitted pursuant to this subpart is entitled to confidential treatment as provided by 40 CFR part...

  19. 12 CFR 978.5 - Storage of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 12 Banks and Banking 7 2011-01-01 2011-01-01 false Storage of confidential information. 978.5... OPERATIONS AND AUTHORITIES BANK REQUESTS FOR INFORMATION § 978.5 Storage of confidential information. Each Bank shall: (a) Store all identified confidential information in secure storage areas or...

  20. 12 CFR 978.5 - Storage of confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 12 Banks and Banking 7 2010-01-01 2010-01-01 false Storage of confidential information. 978.5... OPERATIONS AND AUTHORITIES BANK REQUESTS FOR INFORMATION § 978.5 Storage of confidential information. Each Bank shall: (a) Store all identified confidential information in secure storage areas or...

  1. 40 CFR 86.1116-87 - Treatment of confidential information.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    .... 86.1116-87 Section 86.1116-87 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED... Vehicles, Including Light-Duty Trucks § 86.1116-87 Treatment of confidential information. (a) Any... confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of confidentiality must accompany...

  2. 19 CFR 143.4 - Confidentiality of data.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 2 2010-04-01 2010-04-01 false Confidentiality of data. 143.4 Section 143.4... TREASURY (CONTINUED) SPECIAL ENTRY PROCEDURES Automated Broker Interface § 143.4 Confidentiality of data. The electronic data received and exchanged by a service bureau shall be considered confidential, and...

  3. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will be... chapter. (b) Any request for confidentiality of the identity of a cosmetic ingredient should contain a...

  4. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will be... chapter. (b) Any request for confidentiality of the identity of a cosmetic ingredient should contain a...

  5. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will be... chapter. (b) Any request for confidentiality of the identity of a cosmetic ingredient should contain a...

  6. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will be... chapter. (b) Any request for confidentiality of the identity of a cosmetic ingredient should contain a...

  7. 26 CFR 301.6111-2 - Confidential corporate tax shelters.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 26 Internal Revenue 18 2013-04-01 2013-04-01 false Confidential corporate tax shelters. 301.6111-2....6111-2 Confidential corporate tax shelters. (a) In general. (1) Under section 6111(d) and this section, a confidential corporate tax shelter is treated as a tax shelter subject to the requirements...

  8. 26 CFR 301.6111-2 - Confidential corporate tax shelters.

    Code of Federal Regulations, 2012 CFR

    2012-04-01

    ... 26 Internal Revenue 18 2012-04-01 2012-04-01 false Confidential corporate tax shelters. 301.6111-2....6111-2 Confidential corporate tax shelters. (a) In general. (1) Under section 6111(d) and this section, a confidential corporate tax shelter is treated as a tax shelter subject to the requirements...

  9. 26 CFR 301.6111-2 - Confidential corporate tax shelters.

    Code of Federal Regulations, 2014 CFR

    2014-04-01

    ... 26 Internal Revenue 18 2014-04-01 2014-04-01 false Confidential corporate tax shelters. 301.6111-2....6111-2 Confidential corporate tax shelters. (a) In general. (1) Under section 6111(d) and this section, a confidential corporate tax shelter is treated as a tax shelter subject to the requirements...

  10. 29 CFR 90.33 - Confidential business information.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 29 Labor 1 2014-07-01 2013-07-01 true Confidential business information. 90.33 Section 90.33 Labor... General Provisions § 90.33 Confidential business information. (a) Definition. Confidential business... of information submitted in confidence. Business information which is to be treated as...

  11. 22 CFR 1304.7 - Confidential commercial information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 2 2011-04-01 2009-04-01 true Confidential commercial information. 1304.7... § 1304.7 Confidential commercial information. (a) Notice to submitters. The FOIA Officer shall, to the extent permitted by law, provide a submitter who provides confidential commercial information to the...

  12. 5 CFR 294.112 - Confidential commercial information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 5 Administrative Personnel 1 2011-01-01 2011-01-01 false Confidential commercial information. 294... § 294.112 Confidential commercial information. (a) In general, OPM will not disclose confidential commercial information in response to a Freedom of Information Act request except in accordance with...

  13. 5 CFR 294.112 - Confidential commercial information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 5 Administrative Personnel 1 2010-01-01 2010-01-01 false Confidential commercial information. 294... § 294.112 Confidential commercial information. (a) In general, OPM will not disclose confidential commercial information in response to a Freedom of Information Act request except in accordance with...

  14. 25 CFR 517.7 - Confidential commercial information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 25 Indians 2 2010-04-01 2010-04-01 false Confidential commercial information. 517.7 Section 517.7... INFORMATION ACT PROCEDURES § 517.7 Confidential commercial information. (a) Notice to submitters. The FOIA Officer shall, to the extent permitted by law, provide a submitter who provides confidential...

  15. 22 CFR 1304.7 - Confidential commercial information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 2 2010-04-01 2010-04-01 true Confidential commercial information. 1304.7... § 1304.7 Confidential commercial information. (a) Notice to submitters. The FOIA Officer shall, to the extent permitted by law, provide a submitter who provides confidential commercial information to the...

  16. 25 CFR 517.7 - Confidential commercial information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 25 Indians 2 2011-04-01 2011-04-01 false Confidential commercial information. 517.7 Section 517.7... INFORMATION ACT PROCEDURES § 517.7 Confidential commercial information. (a) Notice to submitters. The FOIA Officer shall, to the extent permitted by law, provide a submitter who provides confidential...

  17. 14 CFR 121.905 - Confidential commercial information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 14 Aeronautics and Space 3 2011-01-01 2011-01-01 false Confidential commercial information. 121... Confidential commercial information. (a) Each certificate holder that claims that AQP information or data it is... confidential commercial information as described in 5 U.S.C. 552(b)(4), and should be withheld from...

  18. 42 CFR 493.1231 - Standard: Confidentiality of patient information.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 42 Public Health 5 2011-10-01 2011-10-01 false Standard: Confidentiality of patient information... Nonwaived Testing General Laboratory Systems § 493.1231 Standard: Confidentiality of patient information. The laboratory must ensure confidentiality of patient information throughout all phases of the...

  19. 42 CFR 493.1231 - Standard: Confidentiality of patient information.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 5 2010-10-01 2010-10-01 false Standard: Confidentiality of patient information... Nonwaived Testing General Laboratory Systems § 493.1231 Standard: Confidentiality of patient information. The laboratory must ensure confidentiality of patient information throughout all phases of the...

  20. 22 CFR 130.15 - Confidential business information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ..., confidential business information means commercial or financial information which by law is entitled to... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Confidential business information. 130.15... CONTRIBUTIONS, FEES AND COMMISSIONS § 130.15 Confidential business information. (a) Any person who is...

  1. 21 CFR 720.8 - Confidentiality of statements.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ...) COSMETICS VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS § 720.8 Confidentiality of... request for confidentiality of a cosmetic ingredient submitted with such forms or separately will be... chapter. (b) Any request for confidentiality of the identity of a cosmetic ingredient should contain a...

  2. 33 CFR 1.07-35 - Request for confidential treatment.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... treatment. 1.07-35 Section 1.07-35 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... for confidential treatment. (a) In addition to information treated as confidential under § 1.07-30, a request for confidential treatment of a document or portion thereof may be made by the person supplying...

  3. 40 CFR 90.4 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Treatment of confidential information. (a) Any manufacturer may assert that some or all of the information submitted pursuant to this part is entitled to confidential treatment as provided by part 2, subpart B of...

  4. 40 CFR 90.912 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Exclusion and Exemption of Nonroad Engines from Regulations § 90.912 Treatment of confidential information. The provisions for treatment of confidential information described in § 90.4 apply to this subpart. ...

  5. 40 CFR 91.7 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... (CONTINUED) CONTROL OF EMISSIONS FROM MARINE SPARK-IGNITION ENGINES General § 91.7 Treatment of confidential... part is entitled to confidential treatment as provided by part 2, subpart B, of this chapter. (b) Any...

  6. 40 CFR 90.614 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Importation of Nonconforming Engines § 90.614 Treatment of confidential information. The provisions for treatment of confidential information described in § 90.4 apply to this subpart. ...

  7. 12 CFR 1102.309 - Confidential treatment procedures.

    Code of Federal Regulations, 2013 CFR

    2013-01-01

    ... 12 Banks and Banking 9 2013-01-01 2013-01-01 false Confidential treatment procedures. 1102.309... Description of Office, Procedures, Public Information § 1102.309 Confidential treatment procedures. (a) In... submission be afforded confidential treatment under 5 U.S.C. 552(b)(4) (i.e., trade secrets and commercial or...

  8. 40 CFR 89.613 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Importation of Nonconforming Nonroad Engines § 89.613 Treatment of confidential information. The provisions for treatment of confidential information as described in § 89.7 apply. ...

  9. 40 CFR 86.615-84 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 19 2011-07-01 2011-07-01 false Treatment of confidential information....615-84 Treatment of confidential information. (a) Any manufacturer may assert that some or all of the information submitted pursuant to this subpart is entitled to confidential treatment as provided by 40 CFR...

  10. 40 CFR 92.4 - Treatment of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 40 Protection of Environment 20 2011-07-01 2011-07-01 false Treatment of confidential information... Regulations for Locomotives and Locomotive Engines § 92.4 Treatment of confidential information. (a) Any... is entitled to confidential treatment as provided by 40 CFR part 2, subpart B. (b) Any claim of...

  11. 22 CFR 128.14 - Confidentiality of proceedings.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 22 Foreign Relations 1 2010-04-01 2010-04-01 false Confidentiality of proceedings. 128.14 Section 128.14 Foreign Relations DEPARTMENT OF STATE INTERNATIONAL TRAFFIC IN ARMS REGULATIONS ADMINISTRATIVE PROCEDURES § 128.14 Confidentiality of proceedings. Proceedings under this part are confidential. The...

  12. 42 CFR 2a.7 - Effect of Confidentiality Certificate.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 42 Public Health 1 2012-10-01 2012-10-01 false Effect of Confidentiality Certificate. 2a.7 Section 2a.7 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL PROVISIONS PROTECTION OF IDENTITY-RESEARCH SUBJECTS § 2a.7 Effect of Confidentiality Certificate. (a) A Confidentiality...

  13. 42 CFR 2a.7 - Effect of Confidentiality Certificate.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Effect of Confidentiality Certificate. 2a.7 Section 2a.7 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL PROVISIONS PROTECTION OF IDENTITY-RESEARCH SUBJECTS § 2a.7 Effect of Confidentiality Certificate. (a) A Confidentiality...

  14. 42 CFR 2a.7 - Effect of Confidentiality Certificate.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 42 Public Health 1 2014-10-01 2014-10-01 false Effect of Confidentiality Certificate. 2a.7 Section 2a.7 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL PROVISIONS PROTECTION OF IDENTITY-RESEARCH SUBJECTS § 2a.7 Effect of Confidentiality Certificate. (a) A Confidentiality...

  15. 42 CFR 2a.7 - Effect of Confidentiality Certificate.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 42 Public Health 1 2013-10-01 2013-10-01 false Effect of Confidentiality Certificate. 2a.7 Section 2a.7 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES GENERAL PROVISIONS PROTECTION OF IDENTITY-RESEARCH SUBJECTS § 2a.7 Effect of Confidentiality Certificate. (a) A Confidentiality...

  16. 48 CFR 1415.207-71 - Confidentiality of proposal evaluation.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 5 2010-10-01 2010-10-01 false Confidentiality of... Receipt of Proposals and Information 1415.207-71 Confidentiality of proposal evaluation. (a) The... unauthorized disclosure of information. At this meeting each member and advisor shall sign a Confidentiality...

  17. 31 CFR 31.217 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 31 Money and Finance: Treasury 1 2010-07-01 2010-07-01 false Confidentiality of information. 31... RELIEF PROGRAM Conflicts of Interest § 31.217 Confidentiality of information. (a) Nonpublic information... shall take appropriate measures to ensure the confidentiality of nonpublic information and to prevent...

  18. 48 CFR 2152.224-70 - Confidentiality of records.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 48 Federal Acquisition Regulations System 6 2010-10-01 2010-10-01 true Confidentiality of records... PROVISIONS AND CONTRACT CLAUSES Text of Provisions and Clauses 2152.224-70 Confidentiality of records. As prescribed in 2124.104-70, insert the following clause: Confidentiality of Records (OCT 2005) (a) The...

  19. 19 CFR 210.72 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-04-01

    ... 19 Customs Duties 3 2010-04-01 2010-04-01 false Confidentiality of information. 210.72 Section 210.72 Customs Duties UNITED STATES INTERNATIONAL TRADE COMMISSION INVESTIGATIONS OF UNFAIR PRACTICES IN... Confidentiality of information. Confidential information (as defined in § 201.6(a) of this chapter) that is...

  20. 16 CFR 1116.9 - Confidentiality of reports.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 16 Commercial Practices 2 2010-01-01 2010-01-01 false Confidentiality of reports. 1116.9 Section... REPORTS SUBMITTED PURSUANT TO SECTION 37 OF THE CONSUMER PRODUCT SAFETY ACT § 1116.9 Confidentiality of... or references information reported under section 37, the confidentiality provisions of section 6(e...

  1. 40 CFR 80.26 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 16 2010-07-01 2010-07-01 false Confidentiality of information. 80.26... (CONTINUED) REGULATION OF FUELS AND FUEL ADDITIVES Controls and Prohibitions § 80.26 Confidentiality of... treated, in so far as its confidentiality is concerned, in accordance with the provisions of 40 CFR part 2. ...

  2. 32 CFR 776.25 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 32 National Defense 5 2010-07-01 2010-07-01 false Confidentiality of information. 776.25 Section 776.25 National Defense Department of Defense (Continued) DEPARTMENT OF THE NAVY MISCELLANEOUS RULES... Rules of Professional Conduct § 776.25 Confidentiality of information. (a) Confidentiality of...

  3. 40 CFR 144.5 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 22 2010-07-01 2010-07-01 false Confidentiality of information. 144.5... (CONTINUED) UNDERGROUND INJECTION CONTROL PROGRAM General Provisions § 144.5 Confidentiality of information... the procedures in 40 CFR part 2 (Public Information). (b) Claims of confidentiality for the following...

  4. 33 CFR 1.07-35 - Request for confidential treatment.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Request for confidential treatment. 1.07-35 Section 1.07-35 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... for confidential treatment. (a) In addition to information treated as confidential under § 1.07-30,...

  5. 12 CFR 978.3 - Request for confidential information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... 12 Banks and Banking 7 2010-01-01 2010-01-01 false Request for confidential information. 978.3... OPERATIONS AND AUTHORITIES BANK REQUESTS FOR INFORMATION § 978.3 Request for confidential information. A Bank shall make all requests for confidential information to a financial regulatory agency, or to a regional...

  6. 16 CFR 1102.24 - Designation of confidential information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... ACT REGULATIONS PUBLICLY AVAILABLE CONSUMER PRODUCT SAFETY INFORMATION DATABASE (Eff. Jan. 10, 2011... allegedly confidential information is not placed in the database, a request for designation of confidential... publication in the Database until it makes a determination regarding confidential treatment. (e)...

  7. 19 CFR 210.5 - Confidential business information.

    Code of Federal Regulations, 2013 CFR

    2013-04-01

    ... 19 Customs Duties 3 2013-04-01 2013-04-01 false Confidential business information. 210.5 Section... business information. (a) Definition and submission. Confidential business information shall be defined and... law judge, or another section of this part states otherwise, confidential business information shall...

  8. 19 CFR 210.5 - Confidential business information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 19 Customs Duties 3 2011-04-01 2011-04-01 false Confidential business information. 210.5 Section... business information. (a) Definition and submission. Confidential business information shall be defined and... law judge, or another section of this part states otherwise, confidential business information shall...

  9. 22 CFR 130.15 - Confidential business information.

    Code of Federal Regulations, 2011 CFR

    2011-04-01

    ... 22 Foreign Relations 1 2011-04-01 2011-04-01 false Confidential business information. 130.15... CONTRIBUTIONS, FEES AND COMMISSIONS § 130.15 Confidential business information. (a) Any person who is required... person considers to be confidential business information. No person, including any applicant or supplier...

  10. 40 CFR 704.7 - Confidential business information claims.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 40 Protection of Environment 30 2010-07-01 2010-07-01 false Confidential business information... Provisions for Section 8(a) Information-Gathering Rules § 704.7 Confidential business information claims. (a) Any person submitting a notice under this rule may assert a business confidentiality claim covering...

  11. 15 CFR 30.60 - Confidentiality of Electronic Export Information.

    Code of Federal Regulations, 2011 CFR

    2011-01-01

    ... 15 Commerce and Foreign Trade 1 2011-01-01 2011-01-01 false Confidentiality of Electronic Export... § 30.60 Confidentiality of Electronic Export Information. (a) Confidential status. The EEI collected... in any form including but not limited to electronic transmission, paper printout, or certified...

  12. 15 CFR 286.8 - Confidentiality of information.

    Code of Federal Regulations, 2010 CFR

    2010-01-01

    ... VOLUNTARY CONFORMITY ASSESSMENT SYSTEM EVALUATION (NVCASE) PROGRAM § 286.8 Confidentiality of information. All information collected relative to an applicant during an evaluation is maintained as confidential... 15 Commerce and Foreign Trade 1 2010-01-01 2010-01-01 false Confidentiality of information....

  13. Comparative evaluation of push-out bond strength of ProRoot MTA, Biodentine, and MTA Plus in furcation perforation repair

    PubMed Central

    Aggarwal, Vivek; Singla, Mamta; Miglani, Sanjay; Kohli, Sarita

    2013-01-01

    Purpose: Few studies have comparatively evaluated the push-out bond strength of different calcium silicate–based materials (CSMs) used in furcal perforation repair. The objective of this in vitro study was to comparatively evaluate the push-out bond strength of commercially available CSMs used as furcation repair materials, in the presence of blood contamination. Materials and Methods: Furcal perforations were made in 120 molars and were divided on the basis of the repair material used (ProRoot MTA, Biodentine, and MTA Plus), blood contamination, and duration of setting time (24 h vs. 7 days). Push-out bond strength was measured and analyzed by three-way analysis of variance (ANOVA) test. Results: Push-out bond strength increased with time. The 24-h push-out strength of MTA was less than that of Biodentine. Blood contamination affected the push-out bond strength of MTA Plus irrespective of the setting time. Conclusion: Caution should be taken while condensing restorative materials over furcation repair materials. PMID:24082579

  14. Interaction of dental pulp stem cells with Biodentine and MTA after exposure to different environments

    PubMed Central

    Agrafioti, Anastasia; Taraslia, Vasiliki; Chrepa, Vanessa; Lymperi, Stefania; Panopoulos, Panos; Anastasiadou, Ema; Kontakiotis, Evangelos G.

    2016-01-01

    ABSTRACT Objective: The aim of the present study was to evaluate and compare the cytotoxic effects of Biodentine and MTA on dental pulp stem cells (DPSCs) and to assess cell viability and adherence after material exposure to an acidic environment. Material and Methods: DPSCs were cultured either alone or in contact with either: Biodentine; MTA set for 1 hour; or MTA set for 24 hours. After 4 and 7 days, cell viability was measured using the MTT assay. Biodentine and MTA were also prepared and packed into standardized bovine dentin disks and divided into three groups according to the storage media (n=6/group): freshly mixed materials without storage medium (Group A); materials stored in saline (Group B); materials stored in citric acid buffered at pH 5.4 (Group C). After 24 hours, DPSCs were introduced in the wells and cell adherence, viability, and cellular morphology were observed via confocal microscopy after three days of culture. Cell viability was analyzed using repeated-measures analysis of variance test with Tukey's post hoc tests (α=0.05). Results: Biodentine expressed significantly higher cell viability compared with all other groups after 4 days, with no differences after 7 days. Notably, cell viability was significantly greater in 24-hour set MTA compared with 1-hour set MTA and control groups after 7 days. Material exposure to an acidic environment showed an increase in cell adherence and viability in both groups. Conclusions: Biodentine induced a significantly accelerated cell proliferation compared with MTA. Setting of these materials in the presence of citric acid enhanced DPSC viability and adherence. PMID:27812618

  15. Antimicrobial and chemical study of MTA, Portland cement, calcium hydroxide paste, Sealapex and Dycal.

    PubMed

    Estrela, C; Bammann, L L; Estrela, C R; Silva, R S; Pécora, J D

    2000-01-01

    The objective of this study was to investigate the antimicrobial action of mineral trioxide aggregate (MTA), Portland cement, calcium hydroxide paste (CHP), Sealapex and Dycal. The chemical elements of MTA and two Portland cements were also analyzed. Four standard bacterial strains: Staphylococcus aureus (ATCC 6538), Enterococcus faecalis (ATCC 29212), Pseudomonas aeruginosa (ATCC 27853), Bacillus subtilis (ATCC 6633), one wild fungus, Candida albicans (ICB/USP-562), and one mixture of these were used. Thirty Petri plates with 20 ml of BHI agar were inoculated with 0.1 ml of the experimental suspensions. Three cavities, each one measuring 4 mm in depth and 4 mm in diameter, were made in each agar plate using a copper coil and then completely filled with the product to be tested. The plates were pre-incubated for 1 h at environmental temperature followed by incubation at 37 degrees C for 48 h. The diameters of the zones of microbial inhibition were then measured. Samples from diffusion and inhibition halos were extracted from each plate and immersed in 7 ml BHI broth and incubated at 37 degrees C for 48 h. Analyses of chemical elements present in MTA and in two samples of Portland cement were performed with a fluorescence spectrometer Rx. The results showed that the antimicrobial activity of CHP was superior to those of MTA, Portland cement, Sealapex and Dycal, for all microorganisms tested, presenting inhibition zones of 6-9.5 mm and diffusion zones of 10-18 mm. MTA, Portland cement, and Sealapex presented only diffusion zones and among these, Sealapex produced the largest zone. Dycal did not show inhibition or diffusion zones. Portland cements contain the same chemical elements as MTA except that MTA also contains bismuth.

  16. Interfacial characteristics of Biodentine and MTA with dentine in simulated body fluid.

    PubMed

    Kim, Jong Ryul; Nosrat, Ali; Fouad, Ashraf F

    2015-02-01

    Newer tricalcium silicate cements (TSC) may offer biocompatibility with improved working properties. This study aimed to evaluate: (1) the occurrence of mineral deposition at the interface between dentine and two TSC (ProRoot(®) MTA and Biodentine(®)) in simulated body fluid, and (2) to investigate the nature of interfacial layer. Six root dentine segments of 1.5mm thickness were obtained from extracted human teeth and were instrumented with Gates-Glidden drills. The specimens were then randomly filled with either MTA or Biodentine. The specimens were placed in the simulated body fluid containing the same phosphate concentration as blood plasma. After 4 weeks, the specimens were examined with Scanning Electron Microscope (SEM) and Energy Disperse X-ray Spectroscopy (EDX) to measure the thickness of the interfacial layer and Ca/P ratio. Transmission Electron Microscope (TEM) and Selective Area Electron Diffraction (SAED) were conducted to examine the interface ultramicroscopically and to determine the nature of the crystalline structure within interfacial layer. The thickness of interfacial layer was significantly higher in the MTA group (14.5 μm vs 4.8 μm) (p<0.001). However, there was no significant difference between MTA and Biodentine in Ca/P ratio of interfacial layer (4.1 vs 2.7) (p>0.05). From TEM examination, amorphous calcium phosphate (ACP) was observed in the interface along with the surface of dentine. As an alternative to MTA, Biodentine displayed bioactivity by producing an interfacial layer on the root canal dentine even though its thickness was significantly lower than MTA. ACP was observed in the interfacial layer of both biomaterials. Biodentine could be considered as an alternative to MTA due to comparable bioactivity which creates interfacial layer between root canal dentin and Biodentine. Copyright © 2014 Elsevier Ltd. All rights reserved.

  17. Interaction of dental pulp stem cells with Biodentine and MTA after exposure to different environments.

    PubMed

    Agrafioti, Anastasia; Taraslia, Vasiliki; Chrepa, Vanessa; Lymperi, Stefania; Panopoulos, Panos; Anastasiadou, Ema; Kontakiotis, Evangelos G

    2016-01-01

    The aim of the present study was to evaluate and compare the cytotoxic effects of Biodentine and MTA on dental pulp stem cells (DPSCs) and to assess cell viability and adherence after material exposure to an acidic environment. DPSCs were cultured either alone or in contact with either: Biodentine; MTA set for 1 hour; or MTA set for 24 hours. After 4 and 7 days, cell viability was measured using the MTT assay. Biodentine and MTA were also prepared and packed into standardized bovine dentin disks and divided into three groups according to the storage media (n=6/group): freshly mixed materials without storage medium (Group A); materials stored in saline (Group B); materials stored in citric acid buffered at pH 5.4 (Group C). After 24 hours, DPSCs were introduced in the wells and cell adherence, viability, and cellular morphology were observed via confocal microscopy after three days of culture. Cell viability was analyzed using repeated-measures analysis of variance test with Tukey's post hoc tests (α=0.05). Biodentine expressed significantly higher cell viability compared with all other groups after 4 days, with no differences after 7 days. Notably, cell viability was significantly greater in 24-hour set MTA compared with 1-hour set MTA and control groups after 7 days. Material exposure to an acidic environment showed an increase in cell adherence and viability in both groups. Biodentine induced a significantly accelerated cell proliferation compared with MTA. Setting of these materials in the presence of citric acid enhanced DPSC viability and adherence.

  18. An Evaluation of MTA Cements as Coronal Barrier

    PubMed Central

    Mohammadi, Zahed; Khademi, Abbasali

    2006-01-01

    INTRODUCTION: Coronal leakage seems to play an important role in the failure of endodontic treatment. A double seal over root canal filling has been suggested as a means of improving the coronal seal. Several restorative materials have been used in an attempt to produce a coronal barrier. The purpose of this study was to assess gray-coloured mineral trioxide aggregate (GMTA), white-coloured mineral trioxide aggregate MTA (WMTA), and Principle (a resin-modified glass ionomer) as coronal barriers to bacterial leakage. MATERIALS AND METHODS: Fifty-one human anterior teeth were cleaned and obturated with gutta-percha and sealer. In group 1, teeth received a 3 mm barrier of GMTA. In groups 2 and 3, samples received WMTA and Principle, respectively. Obturated teeth without barrier were used as positive control and obturated teeth covered with epoxy resin were used as negative control. A leakage model utilizing Enterococcus faecalis used for the evaluation. Leakage was recorded when turbidity was observed. RESULTS: All controls behaved as expected. Three samples in group 1, three samples in group 2, and four samples leaked in group 3. There was no statistically significant difference in leakage between GMTA and WMTA or between GMTA and Principle. CONCLUSION: It seems that GMTA, WMTA and Principle can be recommended as a coronal barrier for up to 90 days. PMID:24454453

  19. In Vitro Evaluation of ProRoot MTA, Biodentine, and MM-MTA on Human Alveolar Bone Marrow Stem Cells in Terms of Biocompatibility and Mineralization.

    PubMed

    Margunato, Suzan; Taşlı, Pakize Neslihan; Aydın, Safa; Karapınar Kazandağ, Meriç; Şahin, Fikrettin

    2015-10-01

    Stem cell technology has been a great hope for the regeneration of cells of pulp-dentin complex and dental structures together with surrounding bone and periodontium. The main challenge in the regeneration process is a successful combination of stem cells and efficient inductors such as inductive biomaterials. In this regard, today, manufacturers propose novel tooth filling materials. The current study was aimed to compare the effect of ProRoot MTA (Dentsply Tulsa Dental, Tulsa, OK), Biodentine (Septodont, Saint Maur des Fossés, France), and MM-MTA (Micro-Mega, Besançon Cedex, France) on the cell viability, hard tissue deposition capacity, and osteogenic differentiation of human bone marrow stem cells (hBMSCs) derived from mandibular bone. Dental materials were packed into Teflon rings (Grover Corp, Milwaukee, WI) and placed on Transwell inserts (Corning, Corning, NY) to determine the toxicity of tooth filling materials by the 3-(4,5-dimethyl-thiazol-2-yl)-5-(3-carboxy-methoxy-phenyl)-2-(4-sulfo-phenyl)-2H tetrazolium assay on days 1, 3, 7, and 14; 20% dimethyl sulfoxide (DMSO) was used as a positive control for the toxicity assay. hBMSCs were characterized by their surface markers with mesenchymal stem cell antibodies. Teflon rings were cocultured with hBMSCs followed by the induction of osteogenic differentiation. The osteogenic differentiation of hBMSCs and hard tissue formation of the materials were evaluated by analyzing the messenger RNA expression levels of osteonectin, Runt-related transcription factor 2, and collagen type 1A by real-time polymerase chain reaction expression analysis, measurement of alkaline phosphatase activity, and visualization of calcium deposits by alizarin red staining. MTA, Biodentine, and MM-MTA did not exhibit a cytotoxic effect on hBMSCs after 14 days in culture. Even though all the materials significantly stimulate (P < .05) osteogenic differentiation of hBMSCs compared with the negative control, ProRoot MTA showed greater

  20. 13 CFR 120.1060 - Confidentiality of Reports, Risk Ratings and related Confidential Information.

    Code of Federal Regulations, 2012 CFR

    2012-01-01

    ... regulation, Confidential Information is defined in the SBA Lender information portal and by notice issued from time to time. Access to the Lender information portal may be obtained by contacting the OCRM....